WO2020255946A1 - 2,4-dioxo-1,4-dihydrothienopyrimidine compound, agricultural and horticultural bactericide - Google Patents

2,4-dioxo-1,4-dihydrothienopyrimidine compound, agricultural and horticultural bactericide Download PDF

Info

Publication number
WO2020255946A1
WO2020255946A1 PCT/JP2020/023546 JP2020023546W WO2020255946A1 WO 2020255946 A1 WO2020255946 A1 WO 2020255946A1 JP 2020023546 W JP2020023546 W JP 2020023546W WO 2020255946 A1 WO2020255946 A1 WO 2020255946A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
substituted
unsubstituted
formula
groups
Prior art date
Application number
PCT/JP2020/023546
Other languages
French (fr)
Japanese (ja)
Inventor
陽平 宗井
頼人 ▲桑▼原
岩田 淳
貴昭 寺西
拓真 石原
千尋 西野
斎賀 睦幸
Original Assignee
日本曹達株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日本曹達株式会社 filed Critical 日本曹達株式会社
Publication of WO2020255946A1 publication Critical patent/WO2020255946A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Definitions

  • the present invention relates to 2,4-dioxo-1,4-dihydrothienopyrimidine compounds and fungicides for agriculture and horticulture. More specifically, the present invention contains a 2,4-dioxo-1,4-dihydrothienopyrimidine compound having excellent bactericidal activity, excellent safety, and industrially advantageous synthesis, and an active ingredient thereof. Regarding agricultural and horticultural fungicides.
  • the present application claims priority to Japanese Patent Application No. 2019-11199 filed on June 17, 2019, the contents of which are incorporated herein by reference.
  • Patent Document 1 discloses a compound represented by the formula (A) and the like.
  • Patent Document 2 discloses a compound represented by the formula (B) and the like.
  • Patent Document 3 discloses a compound represented by the formula (C) and the like.
  • Patent Document 4 discloses a compound represented by the formula (D) and the like.
  • Patent Document 5 discloses a compound represented by the formula (E) and the like.
  • Patent Document 6 discloses a compound represented by the formula (F) and the like. Further, Patent Document 7 discloses the use of a fungicide for agriculture and horticulture such as a compound represented by the formula (F).
  • Patent Document 8 discloses a compound represented by the formula (G) and the like.
  • Patent Document 9 discloses a compound represented by the formula (H) and the like.
  • An object of the present invention is that a 2,4-dioxo-1,4-dihydrothienopyrimidine compound (hereinafter, simply referred to as "thienopyrimidine compound”) has excellent bactericidal activity, is excellent in safety, and can be synthesized industrially advantageously. There is), as well as an agricultural and horticultural fungicide containing this as an active ingredient.
  • thienopyrimidine compound 2,4-dioxo-1,4-dihydrothienopyrimidine compound
  • R 1 is a substituted or unsubstituted C1-6 alkyl group.
  • R 3 , R 4 , R 5 and R 6 are independently hydrogen atoms or substituted or unsubstituted C1-6 alkyl groups.
  • R 3 and R 4 may be combined together to form a C2-6 alkylene group.
  • R 3 and R 5 may be combined together to form a C1-5 alkylene group.
  • R 5 and R 6 may be combined together to form a C2-6 alkylene group.
  • R 7 is a hydrogen atom, a hydroxyl group, a substituted or unsubstituted C1 to 6 alkoxy group, a substituted or unsubstituted C1 to 6 alkylcarbonyloxy group, or a substituted or unsubstituted C2 to 6 alkenyloxy group.
  • R 8 is a hydrogen atom.
  • R 7 and R 8 may be combined together to form a substituted or unsubstituted C1-6 alkoxyimino group.
  • X is a halogeno group or a substituted or unsubstituted C1-6 alkoxy group.
  • n is an integer of 0 to 5, and when n is 2 or more, X may be the same or different from each other.
  • Q is a group represented by the formula (Q-1), the formula (Q-2) or the formula (Q-3).
  • R g is a hydrogen atom and R h is a substituted or unsubstituted C1-6 alkyl group.
  • R e and R f are independently hydrogen atoms or substituted or unsubstituted C1 to 6 alkyl groups.
  • R i is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group.
  • the thienopyrimidine compound of the present invention has excellent bactericidal activity, reliable effect, excellent safety, and can be synthesized industrially advantageously.
  • the fungicide for agriculture and horticulture of the present invention has an excellent control effect, does not cause phytotoxicity to plants, and has little toxicity to humans, livestock and fish and has little influence on the environment.
  • the thienopyrimidine compound of the present invention is a compound represented by the formula (I) (hereinafter, may be referred to as compound (I)) or a salt of compound (I).
  • the term "unsubstituted” means that there are only parental groups. When only the name of the parent group is described, it means “unsubstituted” unless otherwise specified.
  • the term “substituted” means that any hydrogen atom of the parent group is substituted with a group having the same or different structure as the mother nucleus. Therefore, a "substituent” is another group attached to a parent group.
  • the number of substituents may be one or two or more. The two or more substituents may be the same or different.
  • the "substituent” is chemically acceptable and is not particularly limited as long as it has the effect of the present invention.
  • groups that can be “substituents” include the following groups. Halogeno groups such as fluoro group, chloro group, bromo group, iod group; C1-6 such as methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, n-hexyl group, etc.
  • Alkyl group Vinyl group, 1-propenyl group, 2-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-methyl-2-propenyl group, 2-methyl-2-propenyl group, 1-pentenyl group , 2-Pentenyl group, 3-Pentenyl group, 4-Pentenyl group, 1-methyl-2-butenyl group, 2-Methyl-2-butenyl group, 1-hexenyl group, 2-hexenyl group, 3-hexenyl group, 4 -C2-6 alkenyl groups such as hexenyl group, 5-hexenyl group;
  • Ethynyl group 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-methyl-2-propynyl group, 2-methyl-3-butynyl group, 1-pentynyl group , 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-methyl-2-butynyl group, 2-methyl-3-pentynyl group, 1-hexynyl group, 1,1-dimethyl-2-butynyl group, etc.
  • C2-6 alkynyl groups C3-8 cycloalkyl groups such as cyclopropyl group, cyclobutyl group, cyclopentyl group, cyclohexyl group, cycloheptyl group, cubicyl group; C3-8 cycloalkenyl groups such as 2-cyclopropenyl group, 2-cyclopentenyl group, 3-cyclohexenyl group, 4-cyclooctenyl group; C6-10 aryl groups such as phenyl group and naphthyl group; 5-membered heteroaryl groups such as pyrrolyl group, frill group, thienyl group, imidazolyl group, pyrazolyl group, oxazolyl group, isooxazolyl group, thiazolyl group, isothiazolyl group, triazolyl group, oxadiazolyl group, thiadiazolyl group, tetrazolyl group; A 6-membered heteroaryl
  • Oxy group C1-6 alkoxy groups such as methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, t-butoxy group; C2-6 alkenyloxy groups such as vinyloxy group, allyloxy group, propenyloxy group, butenyloxy group; C2-6 alkynyloxy groups such as ethynyloxy group and propargyloxy group; C6-10 aryloxy groups such as phenoxy group and naphthoxy group; 5- to 6-membered heteroaryloxy groups such as thiazolyloxy groups and pyridyloxy groups;
  • Carboxylic group comprising: Formylation group; C1-6 alkylcarbonyl groups such as acetyl group, propionyl group; Formyloxy group; C1-6 alkylcarbonyloxy groups such as acetyloxy group, propionyloxy group; C1-6 alkoxycarbonyl groups such as methoxycarbonyl group, ethoxycarbonyl group, n-propoxycarbonyl group, i-propoxycarbonyl group, n-butoxycarbonyl group, t-butoxycarbonyl group;
  • C1-6 haloalkyl groups such as chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, 1-fluoro-n-butyl group, perfluoro-n-pentyl group; C2-6 haloalkenyl groups such as 2-chloro-1-propenyl group, 2-fluoro-1-butenyl group; C2-6 haloalkynyl groups such as 4,4-dichloro-1-butynyl group, 4-fluoro-1-pentynyl group, 5-bromo-2-pentynyl group; C3-6 halocycloalkyl groups such as 3,3-difluorocyclobutyl group; C1-6 haloalkoxy groups such as 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, trifluoromethoxy group, 2,2,2-trifluoroethoxy group; C2-6 haloalken
  • Cyano group Nitro group; Amino group; C1-6 alkylamino groups such as methylamino group, dimethylamino group, diethylamino group; C6-10 arylamino groups such as anilino group and naphthylamino group; Formylamino group; C1-6 alkylcarbonylamino groups such as acetylamino group, propanoylamino group, butyrylamino group, i-propylcarbonylamino group; C1-6 alkoxycarbonylamino groups such as methoxycarbonylamino group, ethoxycarbonylamino group, n-propoxycarbonylamino group, i-propoxycarbonylamino group; C1-6 alkyl sulfoxide imino groups such as S, S-dimethyl sulfoxide imino groups;
  • Aminocarbonyl group C1-6 alkylaminocarbonyl groups such as methylaminocarbonyl group, dimethylaminocarbonyl group, ethylaminocarbonyl group, i-propylaminocarbonyl group, etc.; Imino C1-6 alkyl groups such as iminomethyl group, 1-iminoethyl group, 1-imino-n-propyl group; Hydroxyimino C1-6 alkyl groups such as hydroxyiminomethyl group, 1- (hydroxyimino) ethyl group, 1- (hydroxyimino) -n-propyl group; C1-6 alkoxyimino C1-6 alkyl groups such as methoxyiminomethyl group, 1- (methoxyimino) ethyl group;
  • C1-6 alkylthio groups such as methylthio group, ethylthio group, n-propylthio group, i-propylthio group, n-butylthio group, i-butylthio group, s-butylthio group, t-butylthio group; C1-6 haloalkylthio groups such as trifluoromethylthio group, 2,2,2-trifluoroethylthio group; C2-6 alkenylthio groups such as vinylthio groups and allylthio groups; C2-6 alkynylthio groups such as ethynylthio group and propargylthio group; C1-6 alkylsulfinyl groups such as methylsulfinyl group, ethylsulfinyl group, t-butylsulfinyl group; C1-6 haloalkylsulfinyl groups such as trifluoro
  • Tri-C1-6 alkylsilyl groups such as trimethylsilyl group, triethylsilyl group, t-butyldimethylsilyl group; Tri-C6-10 arylsilyl groups such as triphenylsilyl groups
  • any hydrogen atom in the substituent may be substituted with a group having a different structure.
  • C1 to 6 indicate that the number of carbon atoms of the parent group is 1 to 6 or the like. This number of carbon atoms does not include the number of carbon atoms present in the substituent.
  • an ethoxybutyl group is classified as a C2 alkoxy C4 alkyl group because the parent group is a butyl group and the substituent is an ethoxy group.
  • R 1 is a substituted or unsubstituted C1-6 alkyl group.
  • the "C1 to 6 alkyl group" in R 1 may be a straight chain or a branched chain.
  • alkyl group a methyl group, an ethyl group, an n-propyl group, an n-butyl group, an n-pentyl group, an n-hexyl group, an i-propyl group, an i-butyl group, an s-butyl group, and a t-butyl group.
  • I-pentyl group neopentyl group, 2-methylbutyl group, 2,2-dimethylpropyl group, i-hexyl group and the like.
  • a halogeno group such as a fluoro group, a chloro group, a bromo group, an iodo group; a methoxy group, an ethoxy group, an n-propoxy group, an i-propoxy group, C1-6 alkoxy groups such as n-butoxy group, s-butoxy group, i-butoxy group, t-butoxy group; 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, trifluoromethoxy group and the like.
  • Examples thereof include C1 to 6 alkoxy-substituted phenyl groups such as C1 to 6 haloalkoxy groups; cyano groups; methoxyphenyl groups and ethoxyphenyl groups.
  • Examples of the "C1 to 6 alkoxycarbonyl group" in R 2 include a methoxycarbonyl group, an ethoxycarbonyl group, an n-propoxycarbonyl group, an i-propoxycarbonyl group, an n-butoxycarbonyl group, and a t-butoxycarbonyl group. it can.
  • a halogeno group such as a fluoro group, a chloro group, a bromo group and an iodo group can be mentioned.
  • the "5- to 6-membered heteroaryl group" in R 2 includes a pyrrolyl group, a furyl group, a thienyl group, an imidazolyl group, a pyrazolyl group, an oxazolyl group, an isooxazolyl group, a thiazolyl group, an isothiazolyl group, a triazolyl group, an oxadiazolyl group and a thiadiazolyl group.
  • a 5-membered heteroaryl group such as a tetrazolyl group
  • a 6-membered heteroaryl group such as a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridadinyl group and a triazinyl group can be mentioned.
  • a halogeno group such as a fluoro group, a chloro group, a bromo group and an iod group can be mentioned.
  • R 2 - R a in "formula”
  • CR a N-OR b
  • group represented by is hydrogen atom
  • R b is a substituted or unsubstituted C1 ⁇ 6 alkyl group.
  • Examples of the "substituted or unsubstituted C1 to 6 alkyl groups" in R b include the same ones specifically exemplified in R 1 .
  • R 3 , R 4 , R 5 , R 6 are independently hydrogen atoms or substituted or unsubstituted C1 to 6 alkyl groups.
  • R 3 , R 4 , R 5 and R 6 include the same ones specifically exemplified in R 1 .
  • R 3 and R 4 may be combined to form a C2-6 alkylene group.
  • Examples of the "C2 to 6 alkylene group" formed by R 3 and R 4 together include an ethylene group, a trimethylene group, a tetramethylene group, and a pentamethylene group.
  • R 3 and R 5 may be combined together to form a C1-5 alkylene group.
  • Examples of the "C1 to C5 alkylene group" formed by R 3 and R 5 together include a methylene group, an ethylene group, a trimethylene group, a tetramethylene group, and a pentamethylene group.
  • R 5 and R 6 may be combined to form a C2-6 alkylene group.
  • Examples of the "C2 to 6 alkylene group" formed by R 5 and R 6 together include those similar to those described above.
  • R 7 is a hydrogen atom, a hydroxyl group, a substituted or unsubstituted C1 to 6 alkoxy group, a substituted or unsubstituted C1 to 6 alkylcarbonyloxy group, or a substituted or unsubstituted C2 to 6 alkenyloxy group.
  • Examples of the "C1 to 6 alkoxy group" in R 7 include a methoxy group, an ethoxy group, an n-propoxy group, an i-propoxy group, an n-butoxy group, an s-butoxy group, an i-butoxy group, and a t-butoxy group. Can be mentioned.
  • Examples of the "C1 to 6 alkylcarbonyloxy group” in R 7 include an acetyloxy group and a propionyloxy group.
  • Examples of the “C2 to 6 alkenyloxy group” in R 7 include C2 to 6 alkenyloxy groups such as vinyloxy group, allyloxy group, propenyloxy group and butenyloxy group.
  • As the substituent on the "C1-6 alkoxy group”, “C1-6 alkylcarbonyloxy group” and “C2-6alkenyloxy group” in R 7 preferably a fluoro group, a chloro group, a bromo group, an iodo group and the like are used. Halogeno group; cyano group, C1-6 alkoxy group can be mentioned.
  • R 8 is a hydrogen atom.
  • R 7 and R 8 may be combined together to form a substituted or unsubstituted C1-6 alkoxyimino group.
  • Examples of the "C1 to 6 alkoxyimino group" formed by R 7 and R 8 together include a methoxyimino group and an ethoxyimino group.
  • a halogeno group such as a fluoro group, a chloro group, a bromo group and an iodo group can be mentioned.
  • X is a halogeno group or a substituted or unsubstituted C1-6 alkoxy group.
  • halogeno group examples include a fluoro group, a chloro group, a bromo group, an iod group and the like.
  • substituted or unsubstituted C1 to 6 alkoxy groups examples include the same groups specifically exemplified in R 7 .
  • n is an integer of 0 to 5, and when n is 2 or more, X may be the same or different from each other.
  • Q is a group represented by formula (Q-1), formula (Q-2) or (Q-3).
  • R c and R d are independently hydrogen atoms, substituted or unsubstituted C1 to 6 alkyl groups, substituted or unsubstituted C1 to 6 alkoxy groups, substituted or unsubstituted.
  • a C3 to 8 cycloalkyl group, a substituted or unsubstituted 5-membered heterocyclyl group, or a group represented by the formula "-CR g N-OR h ".
  • R h is a substituted or unsubstituted C1 to 6 alkyl group.
  • R e and R f are independently hydrogen atoms or substituted or unsubstituted C1 to 6 alkyl groups.
  • R i is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group.
  • R c and R d examples include the same ones specifically exemplified in R 1 , and "substituted or unsubstituted C1 to 6 alkoxy groups". , The same as those specifically exemplified in R 7 can be mentioned.
  • Examples of the "C3-8 cycloalkyl group" in R c and R d include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cubicyl group and the like.
  • Preferred examples of the substituent on the "C3-8 cycloalkyl group" in R c and R d include a halogeno group such as a fluoro group, a chloro group, a bromo group and an iodo group; and a cyano group.
  • the "5-membered heterocyclyl group" in R c and R d includes 1 to 4 hetero atoms selected from the group consisting of nitrogen atom, oxygen atom and sulfur atom as ring constituent atoms.
  • Examples of the "5-membered heterocyclyl group” include a 5-membered saturated heterocyclyl group, a 5-membered heteroaryl group, and a 5-membered partially unsaturated heterocyclyl group.
  • Examples of the 5-membered saturated heterocyclyl group include a pyrrolidinyl group, a tetrahydrofuranyl group, a tetrahydrothiophenyl group, an imidazolidinyl group, a pyrazolidinyl group, an oxazolidinyl group, an isooxazolidinyl group, a thiazolidinyl group and an isothiazolidinyl group. ..
  • Examples of the 5-membered heteroaryl group include a pyrrolyl group, a frill group, a thienyl group, an imidazolyl group, a pyrazolyl group, an oxazolyl group, an isooxazolyl group, a thiazolyl group, an isothiazolyl group, a triazolyl group, an oxadiazolyl group, a thiadiazolyl group and a tetrazolyl group. Can be done.
  • Examples of the 5-membered partially unsaturated heterocyclyl group include a pyrrolinyl group, a dihydrofuranyl group, a dihydrothiophenyl group, an imidazolinyl group, a pyrazolinyl group, an oxazolinyl group, an isooxazolinyl group, a thiazolinyl group and an isothiazolinyl group. ..
  • a halogeno group such as a fluoro group, a chloro group, a bromo group and an iodo group
  • a methyl group, an ethyl group, an n-propyl group and an i- C1-6 alkyl groups such as propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group
  • difluoromethyl group, trifluoromethyl group, 2,2-difluoroethyl group, 2,2,2-trifluoroethyl group C1 to 6 haloalkyl groups such as; cyano group;
  • Examples of the "substituted or unsubstituted C1 to 6 alkyl groups" in R h include the same ones specifically exemplified in R 1 .
  • Examples of the "substituted or unsubstituted C1 to 6 alkyl groups" in R e and R f include the same ones specifically exemplified in R 1 .
  • the salt of compound (I) is not particularly limited as long as it is an horticulturally acceptable salt.
  • salts of inorganic acids such as hydrochloric acid and sulfuric acid
  • salts of organic acids such as acetic acid and lactic acid
  • salts of alkali metals such as lithium, sodium and potassium
  • salts of alkaline earth metals such as calcium and magnesium
  • iron, copper and the like Transition metal salts
  • salts of organic bases such as triethylamine, tributylamine, pyridine, hydrazine; ammonia and the like.
  • the method for producing the compound (I) or the salt of the compound (I) is not limited.
  • the compound (I) of the present invention or the salt of the compound (I) can be obtained by a known method as described in Examples and the like. Further, the salt of compound (I) can be obtained from compound (I) by a known method.
  • the agricultural and horticultural fungicide of the present invention contains at least one selected from the group consisting of compound (I) and a salt thereof as an active ingredient.
  • the amount of compound (I) or a salt thereof contained in the bactericidal agent for agriculture and horticulture of the present invention is not particularly limited as long as it exhibits a bactericidal effect.
  • the agricultural and horticultural fungi of the present invention include a wide variety of filamentous fungi, such as algae fungi (Oomycetes), ascomycetes (Ascomycetes), imperfect fungi (Deuteromycetes), basidiomycetes, and zygomycetes. It can be used to control plant diseases derived from fungi belonging to fungi (Zygomycetes).
  • Cercospora beticola black root disease (Aphanomyces cochlioides), root rot (Thanatephorus cucumeris), leaf rot (Thanatephorus cucumeris), rust (Uromyces betae), powdery mildew (Oidium sp.), Spots Diseases (Ramularia beticola), seedling blight (Aphanomyces cochlioides, Pythium ultimum), etc .
  • Peanuts brown spot (Mycosphaerella arachidis), plaque (Ascochyta sp.), Rust (Puccinia arachidis), blight (Pythium debaryanum), rust (Alternaria alternata), white silk (Sclerotium rolfsii) black Astringency (Mycosphaerella berkeleyi), etc .; Cucumber: Udonko disease (Sphaero
  • Tomatoes Botrytis cinerea, Cladosporium fulvum, Phytophthora infestans, Verticillium albo-atrum, Verticillium dahliae, powdery mildew (Oidium neolycopersici), powdery mildew (Alternaria) solani), powdery mildew (Pseudocercospora fuligena), etc .
  • Eggplant Botrytis cinerea, Corynespora melongenae, powdery mildew (Erysiphe cichoracearum), soot mold (Mycovellosiella nattrassii), sclerotinia sclerotiorum, Verticillium dah Brown spot disease (Phomopsis vexans), etc .
  • Strawberries Botrytis cinerea, powdery mildew (Sphaerotheca humuli), coll
  • Campestris black rot (Pseudomonas syringae pv. Maculicola, P. s. Pv. Alisalensis), downy mildew Diseases (Peronospora parasitica), sclerotinia sclerotiorum, black rot (Alternaria brassicicola), Botrytis cinerea, etc.; Green beans: Sclerotinia sclerotiorum, Botrytis cinerea, Colletotrichum lindemuthianum, Phaeoisariopsis griseola, etc.;
  • Apples Udonko disease (Podosphaera leucotricha), scab (Venturia inaequalis), Monilinia mali, black spot disease (Mycosphaerella pomi), rot disease (Valsa mali), spot deciduous disease (Alternaria mali), gymnosporangium yamadae), ring pattern disease (Botryosphaeria berengeriana), charcoal disease (Glomerella cingulata, Colletotrichum acutatum), brown spot disease (Diplocarpon mali), soot spot disease (Zygophiala jamaicensis), soot spot disease (Gloeodes pomigena), purple spot feather disease (Helicobasidium mompa), Botrytis cinerea, Erwinia amylovora, etc .; Plum: Cladosporium carpophilum, Botrytis cinerea, Monilinia mumecola, Peltaster sp., Etc.
  • Potatoes plague (Phytophthora infestans), summer plague (Alternaria solani), black blight (Thanatephorus cucumeris), half-body wilt (Verticillium albo-atrum, V. dahliae, V. nigrescens), black rot (Pectobacterium atrosepticum) Diseases (Pectobacterium carotovorum), etc .; Bananas: Panama disease (Fusarium oxysporum), black sigatoka disease (Mycosphaerella fijiensis, M.
  • the fungicide for agriculture and horticulture of the present invention is used for cereals; vegetables; root vegetables; potatoes; fruit trees, tea, coffee, cacao and other trees; pastures; turf; cotton and other plants. Is preferable.
  • the agricultural and horticultural fungicides of the present invention can be applied to various parts of plants, for example, leaves, stems, stalks, flowers, buds, fruits, seeds, sprouts, roots, stems, roots, shoots, cuttings and the like. ..
  • improved varieties / varieties of these plants, cultivars, mutants, hybrids, and genetically modified organisms (GMOs) can also be targeted.
  • the fungicide for agricultural and horticultural use of the present invention is used for seed treatment, foliage spraying, soil application, water surface application, etc., which are performed to control various diseases occurring in agricultural and horticultural crops including flowers, turf, and grass. Can be done.
  • the agricultural and horticultural fungicide of the present invention may contain components other than the thienopyrimidine compound of the present invention.
  • other components include known carriers used for formulation.
  • conventionally known fungicides, insecticides / acaricides, nematode insecticides, soil pesticides, plant regulators, synergists, fertilizers, soil conditioners, animal feeds and the like can be mentioned. be able to. By containing such other components, a synergistic effect may be produced.
  • Nucleic acid biosynthesis inhibitor (A) RNA polymerase I inhibitor: Benalaxil, Benalaxil-M, Flaluxil, Metalaxil, Metalaxil-M; Oxadixil; Closilacon, Offrace; (B) Adenosine deaminase inhibitors: bupirimate, dimethilimol, etilimol; (C) DNA / RNA synthesis inhibitors: himexazole, octinenone; (D) DNA topoisomerase II inhibitor: oxolinic acid.
  • Mitotic and fission inhibitors (A) ⁇ -tubulin polymerization inhibitor: benomyl, carbendazim, chlorphenazole, fuberidazole, thiabendazole; thiophanate, thiophanate-methyl; dietofencarb; zoxamide; etaboxam; (B) Cell division inhibitor: pencyclon; (C) Inhibitor of spectrin-like protein delocalization: fluoricolide.
  • Respiratory inhibitor (A) Complex I-NADH Oxidoreductase Inhibitor: Diflumetrim; Torfenpyrad; (B) Complex II-succinate dehydrogenase inhibitors: benodanyl, flutranyl, mepronil; isofetamide; fluopirum; fenfurum, flumecyclox; carboxin, oxycarboxyne; tifluzamide; benzobindiflupill, bixaphen, fluxapiroki Sad, flametopil, isopyrazam, penflufen, penthiopyrado, sedaxan; boscalide, pidiflumethofen, isoflusifram, pyraziflumid, impylfurxam; (C) Complex III-ubiquinol oxidase Qo inhibitors: azoxystrobin, spumoxystrobin, kumethoxystrobin, enoxastrobin, fluphenoxystrobin, picoxystrobin,
  • Amino acid and protein synthesis inhibitors (A) Methionine biosynthesis inhibitors: andprim, cyprodinyl, mepanipyrim, pyrimethanyl; (B) Protein synthesis inhibitor: Blasticidin-S, casugamycin, casugamycin hydrochloride, streptomycin, oxytetracycline.
  • Signal transduction inhibitor (A) Signal transduction inhibitors: quinoxyphen, proquinazide; (B) MAP / histidine kinase inhibitors in osmotic signaling: fenpicronyl, fludioxonyl; clozolinate, iprodion, procymidone, vinclozoline.
  • Lipid and cell membrane synthesis inhibitor (A) Phospholipid biosynthesis, methyltransferase inhibitor: edifenephos, iprobenphos, pyrazophos; isoprothiolane; (B) Lipid oxidizers: biphenyl, chloroneb, dichloran, kinden, technazen, turquophosmethyl; etridiazole; (C) Agents acting on cell membranes: iodocarb, propamocarb, propamocarb hydrochloride, propamocarb hosetylate, prothiocarb; (D) Pathogens Microorganisms that disrupt cell membranes: Bacillus subtilis, Bacillus subtilis QST713, Bacillus subtilis FZB24, Bacillus subtilis MBI600, Bacillus subtilis D747; (E) Agent that disturbs cell membranes: Extract of Gosei Kayupte (tea tree).
  • Cell membrane sterol biosynthesis inhibitor (A) Demethylation inhibitor at position C14 in sterol biosynthesis: trifoline; pyriphenox, pyrisoxazole; phenalimol, fluconazole, nuarimol; imazalyl, imazalyl sulfate, oxypoconazole, pefrazoate, prochloraz, fluconazole , Biniconazole; azaconazole, bitertanol, bromconazole, cyproconazole, diclobutrazole, diphenoconazole, diniconazole, diniconazole-M, epoxyconazole, etaconazole, fenbuconazole, fluconazole, fluconazole, fluconazole Fluconazole-cis, hexaconazole, imibenconazole, ipconazole, metconazole, microbutanyl, penconazole, propiconazole, fluconazole, flucon
  • Trehalase inhibitor validamycin
  • Chitin synthase inhibitors polyoxine, polyoxolim
  • C Cellulose Synthetic Enzyme Inhibitors: Dimethmorph, Fulmorph, Pyrimorph; Bench Avaricarb, Iprovaricarb, Variphenalate; Mandipropamide.
  • Melanin biosynthesis inhibitor (a) Melanin biosynthesis reductase inhibitor: fusalide; pyrokyron; tricyclazole; (B) Dehydrating enzyme inhibitor for melanin biosynthesis: calpropamide; diclosimet; phenoxanyl; (C) Inhibitor of melanin biosynthesis polyketide synthesis: toluprocarb.
  • Host plant resistance inducer (A) Agent acting on the salicylic acid synthesis pathway: acibenzolar-S-methyl; (B) Others: probenazole, thiazinyl, isothianil, diclobenazox, laminarin, Reynoutria sachalinensis extract.
  • Agents of unknown activity simoxanyl, Josetylaluminum, phosphate (phosphate), tecrophthalam, triazoxide, flusulfamide, dichromedin, metasulfocarb, ciflufenamide, metrafenone, pyriophenone, dodine, dodine free base, fluthianyl.
  • Agents having multiple points of action copper (copper salt), Bordeaux solution, copper hydroxide, copper naphthalate, copper oxide, copper oxychloride, copper sulfate, sulfur, sulfur products, calcium polysulfide; ferbum, mancozeb, maneb, Mancopper, methylam, polycarbamate, propineb, tiram, dineb, dilam; captan, captahole, folpet; chlorotalonyl; diclofluanide, trillfluanide; guazatin, iminoctadine acetate, iminoctadine albesilate (iminoctadine) trialbesilate); anilazine; dithianone; quinomethionate; fluorimide.
  • insecticides / acaricides, nematodes, soil pesticides, anthelmintics, etc. that can be mixed or used in combination with the agricultural and horticultural fungicides of the present invention are shown below.
  • Acetylcholinesterase inhibitor (A) Carbamates: Aranicalb, Aldicarb, Bengiocarb, Benfracarb, Butocarboxim, Butoxycarboxim, Carbaryl, Carbofuran, Carbosulfan, Ethiophenacarb, Phenoccarb, Formanate, Frathiocarb, Isoprocarb, Methiocarb, Methomyl, Oxamil, Pyrimicarb, Propoxyl, Thiodicarb, thiofanox, triazamate, trimetacarb, XMC, xylylcarb, phenothiocarb, MIMOC, MPMC, MTMC, aldicarb, alixicalve, aminocarb, butocarboxim, chlorocarb, metam sodium, promecarb;
  • GABA-operated chlorine ion channel antagonists acetoprol, chlordane, endosulfan, ethiprol, fipronil, pilafprowl, pyriprol, campechlor, heptachlor, dienochlor.
  • Nicotinic acetylcholine receptor agonists acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, nithiazine, thiacloprid, thiamethoxam, sulfoxaflor, nicotine, flupyradiflon.
  • Nicotinic acetylcholine receptor allosteric modulator spinetram, spinosad.
  • Chloride channel activator abamectin, emamectin benzoate, repimectin, milbemectin; ivermectin, selamectin, dramectin, eprinomectin, moxidectin, milbemycin, milbemycin oxime, nemadetin.
  • Juvenile hormone-like substances hydroprene, quinoprene, mesoprene, phenoxycarb, pyriproxyfen; diophenolan, epophenonan, triprene.
  • Other non-specific inhibitors methyl bromide, chloropicrin, sulfuryl fluoride, borax, liquor stone.
  • Diptera selective feeding inhibitors fronicamid, pimetrodin, pyrifluquinazone.
  • Tick growth inhibitors clofentezine, difluorovidazine, hexitiazox, etoxazole.
  • Microbial-derived insect mid-intestinal membrane-destroying agent Bacillus thuringiensis subspecies Isla Elenshi, Bacillus thuringiensis subspecies Isla Elenshi, Bacillus thuringensis subspecies Isawai, Bacillus thuringiensis subspecies Kurstaki, Bacillus thuringiensis subspecies Teneblionis, Bt Crop proteins (Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb, Cry34Ab1 / Cry35Ab1).
  • Mitochondrial ATP biosynthetic enzyme inhibitor diafentiurone, azocyclotin, cyhexatin, fenbutatin oxide, propargite, tetradiphon.
  • Oxidative phosphorylation decoupling agent chlorfenapyr, sulfamide, DNOC, binapacryl, dinobutone, dinocup.
  • Nicotinic Acetylcholine Receptor Channel Blocker Bensultap, Cartap Hydrochloride; Nelystoxin; Thiosultap Monosodium Salt, Thiocyclum.
  • Chitin synthesis inhibitors bistrifluron, chlorflubenzuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumron, lufenuron, novalron, nobiflumron, teflubenzuron, triflubenzuron, buprofezin, fluazuron.
  • Diptera molting disturber Cyromazine.
  • Moulting hormone receptor agonists chromaphenozide, halophenozide, methoxyphenozide, tebufenozide.
  • Octopamine receptor agonists Amitraz, Demiditraz, Chlordimeform.
  • Mitochondrial electron transport chain complex III inhibitor acequinosyl, fluacripirim, hydramethylnon.
  • Mitochondrial electron transport chain complex I inhibitor phenazakin, phenpyroximate, pyrimidiphen, pyridaben, tebufenpyrado, tolfenpyrad, rotenone.
  • Voltage-gated sodium channel blockers indoxacarb, metaflumisone.
  • Acetyl-CoA carboxylase inhibitor spirodiclophen, spiromesiphen, spirotetramato.
  • Mitochondrial electron transport chain complex IV inhibitor aluminum phosphide, calcium phosphide, phosphine, zinc phosphide, cyanide.
  • Mitochondrial electron transport chain complex II inhibitor sienopyraphen, siflumethofen, pifrubmid.
  • Ryanodine receptor modulators chloranthraniliprole, cyantraniliprole, flubendiamide, cyclaniliprole, tetraniliprole.
  • Anthelmintic (A) Benzimidazole system: fenbendazole, albendazole, triclabendazole, oxybendazole, mebendazole, oxfendazole, perbendazole, flubendazole; fevantel, netobimin, thiophanate; thiabendazole, cambendazole; (B) Salicylanilide system: closantel, oxyclozanide, lafoxanide, niclosamide; (C) Substituted phenolic system: nitroxynyl, nitroscanate; (D) Pyrimidines: Pyrantel, Morantel; (E) Imidazothiazole type: levamisole, tetramisole; (F) Tetrahydropyrimidines: Praziquantel, Epsiprantel; (G) Other anthelmintics: cyclodiene, liania, chlorthrone, metronidazole,
  • the agricultural and horticultural fungicide of the present invention is not particularly limited depending on the dosage form.
  • dosage forms such as wettable powders, emulsions, powders, granules, aqueous solvents, suspensions, granule wettable powders, and tablets can be mentioned.
  • the preparation method for the preparation is not particularly limited, and a known preparation method can be adopted depending on the dosage form.
  • (Formulation Example 6: Granule wettable powder) 40 parts of thienopyrimidine compound of the present invention, 36 parts of clay, 10 parts of potassium chloride, 1 part of sodium alkylbenzene sulfonic acid salt, 8 parts of sodium lignin sulfonic acid salt and 5 parts of formaldehyde condensate of sodium alkylbenzene sulfonic acid salt are uniformly mixed. After finely crushing, add an appropriate amount of water and knead to make it clay-like. The clay-like material is granulated and then dried to obtain a granule wettable powder containing 40% of the active ingredient.
  • the solvent was distilled off under reduced pressure, the obtained residue was dissolved in t-butyl alcohol (180 ml), cesium carbonate (39 g) was added, and the mixture was stirred at 80 ° C. for 5 hours.
  • the reaction mixture was concentrated, saturated aqueous ammonium chloride solution was added, and the mixture was extracted with ethyl acetate.
  • the organic layer was washed with water and saturated brine, and dried over anhydrous sodium sulfate.
  • the solvent was evaporated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: chloroform / ethyl acetate) to obtain 11.5 g of the target compound.
  • Step 2 Ethyl 1-(2- (5-fluoro-2-methoxyphenyl) -2-oxoethyl) -3- (3- (isopropylamino) -2,2-dimethyl-3-oxopropyl) -5-methyl-2,4-dioxo Synthesis of -1,2,3,4-tetrahydrothieno [2,3-d] pyrimidine-6-carboxylate
  • the obtained solid was dissolved in methylene chloride (250 ml), trifluoroacetic acid (25 ml) was added, and the mixture was stirred overnight at room temperature.
  • the reaction mixture was concentrated under reduced pressure, methylene chloride (230 ml), isopropylamine (12 g), triethylamine (11 g), 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphorinan.
  • 40 ml of -2,4,6-trioxide (50% ethyl acetate solution, about 1.7 mol / L) was added, and the mixture was stirred overnight at room temperature.
  • the reaction mixture was concentrated, a 2N HCl aqueous solution (50 ml) was added, the mixture was extracted with ethyl acetate, the organic layer was washed with water and saturated brine, and dried over anhydrous sodium sulfate.
  • the solvent was evaporated under reduced pressure, the obtained residue was dissolved in tetrahydrofuran (250 ml), carbonyldiimidazole (6 g) was added, and the mixture was stirred at room temperature for 1 hour.
  • the reaction solution was added to water (250 ml) in which sodium borohydride (2.2 g) was dissolved, and the mixture was stirred overnight at room temperature.
  • the reaction mixture was filtered, the mother liquor was concentrated, the obtained residue was dissolved in ethanol (35 ml), pyridine (0.6 g) and methoxyamine hydrochloride (0.6 g) were added at 70 ° C., and the mixture was stirred for 10 minutes.
  • the 1 H-NMR of the obtained target product is shown below.
  • Ethyl 2-amino-4-methyl-5- (2H-1,2,3-triazol-2-yl) thiophene-3-carboxylate (4.64 g) was dissolved in dichloromethane (90 ml), and at room temperature, triphosgene (triphosgene) 1.86 g) was added. Triethylamine (5.59 g) was added dropwise to this solution under ice-cooling, and the mixture was stirred at room temperature for 2 hours. The reaction mixture was ice-cooled again, tert-butyl 3-amino-2,2-dimethylpropanoate (3.20 g) was added, and the mixture was stirred overnight at room temperature.
  • the reaction mixture was poured into ice water, extracted with ethyl acetate, the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate.
  • the solvent was evaporated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain 5.88 g of the target compound. Yield 58%
  • the 1 H-NMR of the obtained target product is shown below.
  • Step 4 3- (1- (2- (5-fluoro-2-methoxyphenyl) -2-oxoethyl) -5-methyl-2,4-dioxo-6- (2H-1,2,3-triazol-2-yl) Synthesis of -1,4-dihydrothieno [2,3-d] pyrimidin-3 (2H) -yl) -N-isopropyl-2,2-dimethylpropanamide
  • the reaction mixture was concentrated under reduced pressure, and the obtained residue was suspended in dichloromethane (30 ml), isopropylamine (1.22 g), N, N-diisopropylethylamine (2.66 g), O- (7-azabenzotriazole-).
  • 1-Il) -N, N, N', N'-tetramethyluronium hexafluorophosphate (3.92 g) was added, and the mixture was stirred overnight at room temperature.
  • the reaction mixture was concentrated under reduced pressure, poured into ice water, extracted with ethyl acetate, washed with water and saturated brine, and dried over anhydrous magnesium sulfate.
  • Step 5 3- (1- (2- (5-fluoro-2-methoxyphenyl) -2-hydroxyethyl) -5-methyl-2,4-dioxo-6- (2H-1,2,3-triazol-2-yl) Synthesis of -1,4-dihydrothieno [2,3-d] pyrimidin-3 (2H) -yl) -N-isopropyl-2,2-dimethylpropanamide
  • the reaction mixture was concentrated under reduced pressure, poured into ice water, extracted with ethyl acetate, washed with water and saturated brine, and dried over anhydrous magnesium sulfate.
  • the solvent was evaporated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain 3.10 g of the target compound. Yield 89%
  • the 1 H-NMR of the obtained target product is shown below.
  • Step 6 3- (1- (2- (2-cyanoethoxy) -2- (5-fluoro-2-methoxyphenyl) ethyl) -5-methyl-2,4-dioxo-6- (2H-1,2,3-triazol) -2-yl) -1,4-dihydrothieno [2,3-d] pyrimidin-3 (2H) -yl) -Synthesis of N-isopropyl-2,2-dimethylpropanamide
  • the reaction mixture was poured into ice water, extracted with ethyl acetate, the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate.
  • the solvent was evaporated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain 0.24 g of the target compound. Yield 91%
  • the 1 H-NMR of the obtained target product is shown below.
  • Tables 1 and 2 show some of the compounds of the present invention produced by the same method as in the above Examples. In the table, the physical properties, melting point (mp) or refractive index (n D ) of each compound are also shown.
  • the configuration E or Z in Table 1 indicates the geometric isomer of the oxime group in R 2 .
  • “E” indicates an E configuration
  • “Z” indicates a Z configuration
  • “E / Z” indicates that the compound is a mixture of compounds in both configurations.
  • Me indicates a methyl group
  • Et indicates an ethyl group
  • an arrow indicates a binding site.
  • the configuration E or Z in Table 2 indicates the geometric isomer of the oxime group.
  • E indicates an E configuration
  • Z indicates a Z configuration
  • E / Z indicates that the compound is a mixture of compounds in both configurations.
  • the control price was calculated by the following formula.
  • Control value (%) 100- ⁇ Ratio of lesion area in treated plot / Ratio of lesion area in untreated plot ⁇ ⁇ 100
  • the thienopyrimidine compounds of the present invention have a bactericidal effect, including compounds that could not be exemplified. It is a compound that does not cause phytotoxicity to plants and has little toxicity to humans, livestock and fish and has little impact on the environment, and is useful as a pesticide.

Abstract

The present invention provides: a 2,4-dioxo-1,4-dihydrothienopyrimidine compound which has excellent bactericidal activity and safety, and can be industrially advantageously synthesized; and an agricultural and horticultural bactericide containing the same as an active ingredient. The 2,4-dioxo-1,4-dihydrothienopyrimidine compound is a compound represented by formula (I) or a salt thereof. In formula (I), R1 is a substituted or unsubstituted C1-C6 alkyl group, and R2 is a substituted or an unsubstituted C1-C6 alkoxycarbonyl group, or the like. R3, R4, R5, and R6 are each independently a hydrogen atom, or a substituted or an unsubstituted C1-C6 alkyl group, or the like. R7 is a hydrogen atom, or a hydroxyl group, or the like, and R8 is a hydrogen atom. X is a halogeno group, or the like. Q is a group represented by formula (Q-1), or formula (Q-2), or the like.

Description

2,4-ジオキソ-1,4-ジヒドロチエノピリミジン化合物及び農園芸用殺菌剤2,4-Dioxo-1,4-dihydrothienopyrimidine compounds and fungicides for agriculture and horticulture
 本発明は、2,4-ジオキソ-1,4-ジヒドロチエノピリミジン化合物及び農園芸用殺菌剤に関する。より詳細には、本発明は、殺菌活性に優れ、安全性に優れ、且つ工業的に有利に合成できる2,4-ジオキソ-1,4-ジヒドロチエノピリミジン化合物、及びこれを有効成分として含有する農園芸用殺菌剤に関する。
本願は、2019年6月17日に出願された日本国特許出願第2019-111799号に対し優先権を主張し、その内容をここに援用する。
The present invention relates to 2,4-dioxo-1,4-dihydrothienopyrimidine compounds and fungicides for agriculture and horticulture. More specifically, the present invention contains a 2,4-dioxo-1,4-dihydrothienopyrimidine compound having excellent bactericidal activity, excellent safety, and industrially advantageous synthesis, and an active ingredient thereof. Regarding agricultural and horticultural fungicides.
The present application claims priority to Japanese Patent Application No. 2019-11199 filed on June 17, 2019, the contents of which are incorporated herein by reference.
 農園芸作物の栽培に当り、作物の病害に対して防除活性を有する化合物が種々提案されている。そのような化合物を農園芸用殺菌剤として実用するためには、効力が十分に高いだけでなく、薬剤抵抗性が生じ難いこと、植物に対する薬害や土壌汚染を生じさせないこと、家畜や魚類などに対する毒性が低いことなどが要求される。 In cultivating agricultural and horticultural crops, various compounds having control activity against diseases of crops have been proposed. In order to put such a compound into practical use as a fungicide for agriculture and horticulture, it is not only highly effective, it is unlikely to cause drug resistance, it does not cause phytotoxicity or soil contamination to plants, and it is resistant to livestock and fish. It is required to have low toxicity.
 ところで、特許文献1には、式(A)で表される化合物などが開示されている。
Figure JPOXMLDOC01-appb-C000003
By the way, Patent Document 1 discloses a compound represented by the formula (A) and the like.
Figure JPOXMLDOC01-appb-C000003
 特許文献2には、式(B)で表される化合物などが開示されている。
Figure JPOXMLDOC01-appb-C000004
Patent Document 2 discloses a compound represented by the formula (B) and the like.
Figure JPOXMLDOC01-appb-C000004
 特許文献3には、式(C)で表される化合物などが開示されている。
Figure JPOXMLDOC01-appb-C000005
Patent Document 3 discloses a compound represented by the formula (C) and the like.
Figure JPOXMLDOC01-appb-C000005
 特許文献4には、式(D)で表される化合物などが開示されている。
Figure JPOXMLDOC01-appb-C000006
Patent Document 4 discloses a compound represented by the formula (D) and the like.
Figure JPOXMLDOC01-appb-C000006
 特許文献5には、式(E)で表される化合物などが開示されている。
Figure JPOXMLDOC01-appb-C000007
Patent Document 5 discloses a compound represented by the formula (E) and the like.
Figure JPOXMLDOC01-appb-C000007
 特許文献6には、式(F)で表される化合物などが開示されている。また、特許文献7には、式(F)で表される化合物などの農園芸用殺菌剤用途が開示されている。
Figure JPOXMLDOC01-appb-C000008
Patent Document 6 discloses a compound represented by the formula (F) and the like. Further, Patent Document 7 discloses the use of a fungicide for agriculture and horticulture such as a compound represented by the formula (F).
Figure JPOXMLDOC01-appb-C000008
特許文献8には、式(G)で表される化合物などが開示されている。
Figure JPOXMLDOC01-appb-C000009
Patent Document 8 discloses a compound represented by the formula (G) and the like.
Figure JPOXMLDOC01-appb-C000009
特許文献9には、式(H)で表される化合物などが開示されている。
Figure JPOXMLDOC01-appb-C000010
Patent Document 9 discloses a compound represented by the formula (H) and the like.
Figure JPOXMLDOC01-appb-C000010
WO 2013/071169 AWO 2013/071169 A WO 2015/007451 AWO 2015/007451 A WO 2017/075056 AWO 2017/075056 A WO 2017/091600 AWO 2017/091600 A WO 2017/091602 AWO 2017/091602 A WO 2017/091617 AWO 2017/091617 A WO 2017/091627 AWO 2017/091627 A WO 2018/171698 AWO 2018/171698 A WO 2018/171699 AWO 2018/171699 A
 本発明の課題は、殺菌活性に優れ、安全性に優れ、且つ工業的に有利に合成できる2,4-ジオキソ-1,4-ジヒドロチエノピリミジン化合物(以下、単に「チエノピリミジン化合物」ということがある。)、並びにこれを有効成分として含有する農園芸用殺菌剤を提供することである。 An object of the present invention is that a 2,4-dioxo-1,4-dihydrothienopyrimidine compound (hereinafter, simply referred to as "thienopyrimidine compound") has excellent bactericidal activity, is excellent in safety, and can be synthesized industrially advantageously. There is), as well as an agricultural and horticultural fungicide containing this as an active ingredient.
 本発明者らは、上記課題を解決すべく鋭意検討した結果、以下の形態を包含する本発明を完成するに至った。
〔1〕式(I)で表される化合物又はその塩。
Figure JPOXMLDOC01-appb-C000011
As a result of diligent studies to solve the above problems, the present inventors have completed the present invention including the following forms.
[1] A compound represented by the formula (I) or a salt thereof.
Figure JPOXMLDOC01-appb-C000011
(式(I)中、
 R1は、置換又は無置換のC1~6アルキル基である。
 R2は、置換若しくは無置換のC1~6アルコキシカルボニル基、置換若しくは無置換の5~6員ヘテロアリール基、シアノ基又は式「-CR=N-OR」で表される基である。
 Rは、水素原子であり、Rは、置換又は無置換のC1~6アルキル基である。
 R、R、R及びRは、それぞれ独立して、水素原子又は置換若しくは無置換のC1~6アルキル基である。
 RとRは、それらが一緒になって、C2~6アルキレン基を形成してもよい。
 RとR5 は、それらが一緒になって、C1~5アルキレン基を形成してもよい。
 RとRは、それらが一緒になって、C2~6アルキレン基を形成してもよい。
 Rは、水素原子、水酸基、置換若しくは無置換のC1~6アルコキシ基、置換若しくは無置換のC1~6アルキルカルボニルオキシ基又は置換若しくは無置換のC2~6アルケニルオキシ基である。
 Rは、水素原子である。
 RとRは、それらが一緒になって、置換又は無置換のC1~6アルコキシイミノ基を形成してもよい。
 Xは、ハロゲノ基又は置換若しくは無置換のC1~6アルコキシ基である。
 nは、0~5のいずれかの整数であり、nが2以上のときXは互いに同じでも異なってもよい。
 Qは、式(Q-1)、式(Q-2)又は式(Q-3)で表される基である。
(In formula (I),
R 1 is a substituted or unsubstituted C1-6 alkyl group.
R 2 is a substituted or unsubstituted C1 to 6 alkoxycarbonyl group, a substituted or unsubstituted 5- to 6-membered heteroaryl group, a cyano group or a group represented by the formula "-CR a = N-OR b ". ..
R a is a hydrogen atom and R b is a substituted or unsubstituted C1-6 alkyl group.
R 3 , R 4 , R 5 and R 6 are independently hydrogen atoms or substituted or unsubstituted C1-6 alkyl groups.
R 3 and R 4 may be combined together to form a C2-6 alkylene group.
R 3 and R 5 may be combined together to form a C1-5 alkylene group.
R 5 and R 6 may be combined together to form a C2-6 alkylene group.
R 7 is a hydrogen atom, a hydroxyl group, a substituted or unsubstituted C1 to 6 alkoxy group, a substituted or unsubstituted C1 to 6 alkylcarbonyloxy group, or a substituted or unsubstituted C2 to 6 alkenyloxy group.
R 8 is a hydrogen atom.
R 7 and R 8 may be combined together to form a substituted or unsubstituted C1-6 alkoxyimino group.
X is a halogeno group or a substituted or unsubstituted C1-6 alkoxy group.
n is an integer of 0 to 5, and when n is 2 or more, X may be the same or different from each other.
Q is a group represented by the formula (Q-1), the formula (Q-2) or the formula (Q-3).
Figure JPOXMLDOC01-appb-C000012
Figure JPOXMLDOC01-appb-C000012
 式(Q-1)、式(Q-2)及び式(Q-3)中、矢印は結合部位を示す。
 式(Q-1)中、R及びRは、それぞれ独立して、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC1~6アルコキシ基、置換若しくは無置換のC3~8シクロアルキル基、置換若しくは無置換の5員環のヘテロシクリル基 又は式「-CR=N-OR」で表される基である。
 Rは水素原子であり、Rは置換又は無置換のC1~6アルキル基である。
 式(Q-2)中、R及びRは、それぞれ独立して、水素原子又は置換若しくは無置換のC1~6アルキル基である。
 式(Q-3)中、Rは又は水素原子、置換若しくは無置換のC1~6アルキル基である。)
〔2〕〔1〕に記載の化合物又はその塩からなる群から選ばれる少なくとも1つを有効成分として含有する農園芸用殺菌剤。
In formulas (Q-1), formulas (Q-2) and formulas (Q-3), arrows indicate binding sites.
In formula (Q-1), R c and R d are independently hydrogen atoms, substituted or unsubstituted C1 to 6 alkyl groups, substituted or unsubstituted C1 to 6 alkoxy groups, substituted or unsubstituted. It is a C3-8 cycloalkyl group, a substituted or unsubstituted 5-membered heterocyclyl group, or a group represented by the formula "-CR g = N-OR h ".
R g is a hydrogen atom and R h is a substituted or unsubstituted C1-6 alkyl group.
In formula (Q-2), R e and R f are independently hydrogen atoms or substituted or unsubstituted C1 to 6 alkyl groups.
In formula (Q-3), R i is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group. )
[2] A fungicide for agriculture and horticulture containing at least one selected from the group consisting of the compound according to [1] or a salt thereof as an active ingredient.
 本発明のチエノピリミジン化合物は、殺菌活性に優れ、効果が確実で、安全性に優れ、且つ工業的に有利に合成できる。
 本発明の農園芸用殺菌剤は、優れた防除効果を有し、植物体に薬害を生じることがなく、人畜魚類に対する毒性や環境への影響が少ない。
The thienopyrimidine compound of the present invention has excellent bactericidal activity, reliable effect, excellent safety, and can be synthesized industrially advantageously.
The fungicide for agriculture and horticulture of the present invention has an excellent control effect, does not cause phytotoxicity to plants, and has little toxicity to humans, livestock and fish and has little influence on the environment.
〔チエノピリミジン化合物〕
 本発明のチエノピリミジン化合物は、式(I)で表される化合物(以下、化合物(I)と表記することがある。)、又は化合物(I)の塩である。
[Thienopyrimidine compound]
The thienopyrimidine compound of the present invention is a compound represented by the formula (I) (hereinafter, may be referred to as compound (I)) or a salt of compound (I).
Figure JPOXMLDOC01-appb-C000013
Figure JPOXMLDOC01-appb-C000013
 本発明において、用語「無置換(unsubstituted)」は、母核となる基のみであることを意味する。母核となる基の名称のみで記載しているときは、別段の断りがない限り「無置換」の意味である。
 一方、用語「置換(substituted)」は、母核となる基のいずれかの水素原子が、母核と同一又は異なる構造の基で置換されていることを意味する。従って、「置換基」は、母核となる基に結合した他の基である。置換基は1個であってもよいし、2個以上であってもよい。2個以上の置換基は同一であってもよいし、異なるものであってもよい。
In the present invention, the term "unsubstituted" means that there are only parental groups. When only the name of the parent group is described, it means "unsubstituted" unless otherwise specified.
On the other hand, the term "substituted" means that any hydrogen atom of the parent group is substituted with a group having the same or different structure as the mother nucleus. Therefore, a "substituent" is another group attached to a parent group. The number of substituents may be one or two or more. The two or more substituents may be the same or different.
 「置換基」は化学的に許容され、本発明の効果を有する限りにおいて特に制限されない。
 「置換基」となり得る基の具体例としては、以下の基を挙げることができる。
 フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;
 メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基、n-ペンチル基、n-ヘキシル基などのC1~6アルキル基;
 ビニル基、1-プロペニル基、2-プロペニル基、1-ブテニル基、2-ブテニル基、3-ブテニル基、1-メチル-2-プロペニル基、2-メチル-2-プロペニル基、1-ペンテニル基、2-ペンテニル基、3-ペンテニル基、4-ペンテニル基、1-メチル-2-ブテニル基、2-メチル-2-ブテニル基、1-ヘキセニル基、2-ヘキセニル基、3-ヘキセニル基、4-ヘキセニル基、5-ヘキセニル基などのC2~6アルケニル基;
The "substituent" is chemically acceptable and is not particularly limited as long as it has the effect of the present invention.
Specific examples of groups that can be "substituents" include the following groups.
Halogeno groups such as fluoro group, chloro group, bromo group, iod group;
C1-6 such as methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, n-hexyl group, etc. Alkyl group;
Vinyl group, 1-propenyl group, 2-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-methyl-2-propenyl group, 2-methyl-2-propenyl group, 1-pentenyl group , 2-Pentenyl group, 3-Pentenyl group, 4-Pentenyl group, 1-methyl-2-butenyl group, 2-Methyl-2-butenyl group, 1-hexenyl group, 2-hexenyl group, 3-hexenyl group, 4 -C2-6 alkenyl groups such as hexenyl group, 5-hexenyl group;
 エチニル基、1-プロピニル基、2-プロピニル基、1-ブチニル基、2-ブチニル基、3-ブチニル基、1-メチル-2-プロピニル基、2-メチル-3-ブチニル基、1-ペンチニル基、2-ペンチニル基、3-ペンチニル基、4-ペンチニル基、1-メチル-2-ブチニル基、2-メチル-3-ペンチニル基、1-ヘキシニル基、1,1-ジメチル-2-ブチニル基などのC2~6アルキニル基;
 シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基、シクロヘプチル基、キュバニル基などのC3~8シクロアルキル基;
 2-シクロプロペニル基、2-シクロペンテニル基、3-シクロヘキセニル基、4-シクロオクテニル基などのC3~8シクロアルケニル基;
 フェニル基、ナフチル基などのC6~10アリール基;
 ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基などの5員環のヘテロアリール基;
 ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員環のヘテロアリール基;
 インドリル基、ベンゾフリル基、ベンゾチエニル基、ベンゾイミダゾリル基、ベンゾオキサゾリル基、ベンゾチアゾリル基、キノリル基、イソキノリル基、キノキサリニル基などの縮合環のヘテロアリール基;
 オキシラニル基、テトラヒドロフリル基、ジオキソラニル基、ジオキサニル基などの環状エーテル基;
 アジリジニル基、ピロリジニル基、ピペリジル基、ピペラジニル基、モルホリニル基などの環状アミノ基;
Ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-methyl-2-propynyl group, 2-methyl-3-butynyl group, 1-pentynyl group , 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-methyl-2-butynyl group, 2-methyl-3-pentynyl group, 1-hexynyl group, 1,1-dimethyl-2-butynyl group, etc. C2-6 alkynyl groups;
C3-8 cycloalkyl groups such as cyclopropyl group, cyclobutyl group, cyclopentyl group, cyclohexyl group, cycloheptyl group, cubicyl group;
C3-8 cycloalkenyl groups such as 2-cyclopropenyl group, 2-cyclopentenyl group, 3-cyclohexenyl group, 4-cyclooctenyl group;
C6-10 aryl groups such as phenyl group and naphthyl group;
5-membered heteroaryl groups such as pyrrolyl group, frill group, thienyl group, imidazolyl group, pyrazolyl group, oxazolyl group, isooxazolyl group, thiazolyl group, isothiazolyl group, triazolyl group, oxadiazolyl group, thiadiazolyl group, tetrazolyl group;
A 6-membered heteroaryl group such as a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridadinyl group, and a triazinyl group;
Heteroaryl groups of fused rings such as indrill groups, benzofuryl groups, benzothienyl groups, benzoimidazolyl groups, benzoxazolyl groups, benzothiazolyl groups, quinolyl groups, isoquinolyl groups, quinoxalinyl groups;
Cyclic ether groups such as oxylanyl group, tetrahydrofuryl group, dioxolanyl group, dioxanyl group;
Cyclic amino groups such as aziridinyl group, pyrrolidinyl group, piperidyl group, piperazinyl group, morpholinyl group;
 水酸基;
 オキソ基;
 メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;
 ビニルオキシ基、アリルオキシ基、プロペニルオキシ基、ブテニルオキシ基などのC2~6アルケニルオキシ基;
 エチニルオキシ基、プロパルギルオキシ基などのC2~6アルキニルオキシ基;
 フェノキシ基、ナフトキシ基などのC6~10アリールオキシ基;
 チアゾリルオキシ基、ピリジルオキシ基などの5~6員環のヘテロアリールオキシ基;
Hydroxy group;
Oxy group;
C1-6 alkoxy groups such as methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, t-butoxy group;
C2-6 alkenyloxy groups such as vinyloxy group, allyloxy group, propenyloxy group, butenyloxy group;
C2-6 alkynyloxy groups such as ethynyloxy group and propargyloxy group;
C6-10 aryloxy groups such as phenoxy group and naphthoxy group;
5- to 6-membered heteroaryloxy groups such as thiazolyloxy groups and pyridyloxy groups;
 カルボキシル基;
 ホルミル基;
 アセチル基、プロピオニル基などのC1~6アルキルカルボニル基;
 ホルミルオキシ基;
 アセチルオキシ基、プロピオニルオキシ基などのC1~6アルキルカルボニルオキシ基;
 メトキシカルボニル基、エトキシカルボニル基、n-プロポキシカルボニル基、i-プロポキシカルボニル基、n-ブトキシカルボニル基、t-ブトキシカルボニル基などのC1~6アルコキシカルボニル基;
Carboxylic group;
Formylation group;
C1-6 alkylcarbonyl groups such as acetyl group, propionyl group;
Formyloxy group;
C1-6 alkylcarbonyloxy groups such as acetyloxy group, propionyloxy group;
C1-6 alkoxycarbonyl groups such as methoxycarbonyl group, ethoxycarbonyl group, n-propoxycarbonyl group, i-propoxycarbonyl group, n-butoxycarbonyl group, t-butoxycarbonyl group;
 クロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基、パーフルオロ-n-ペンチル基などのC1~6ハロアルキル基;
 2-クロロ-1-プロペニル基、2-フルオロ-1-ブテニル基などのC2~6ハロアルケニル基;
 4,4-ジクロロ-1-ブチニル基、4-フルオロ-1-ペンチニル基、5-ブロモ-2-ペンチニル基などのC2~6ハロアルキニル基;
3,3-ジフルオロシクロブチル基などのC3~6ハロシクロアルキル基;
 2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基、2,2,2-トリフルオロエトキシ基などのC1~6ハロアルコキシ基;
 2-クロロプロペニルオキシ基、3-ブロモブテニルオキシ基などのC2~6ハロアルケニルオキシ基;
 クロロアセチル基、トリフルオロアセチル基、トリクロロアセチル基などのC1~6ハロアルキルカルボニル基;
C1-6 haloalkyl groups such as chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, 1-fluoro-n-butyl group, perfluoro-n-pentyl group;
C2-6 haloalkenyl groups such as 2-chloro-1-propenyl group, 2-fluoro-1-butenyl group;
C2-6 haloalkynyl groups such as 4,4-dichloro-1-butynyl group, 4-fluoro-1-pentynyl group, 5-bromo-2-pentynyl group;
C3-6 halocycloalkyl groups such as 3,3-difluorocyclobutyl group;
C1-6 haloalkoxy groups such as 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, trifluoromethoxy group, 2,2,2-trifluoroethoxy group;
C2-6 haloalkenyloxy groups such as 2-chloropropenyloxy group, 3-bromobutenyloxy group;
C1-6 haloalkylcarbonyl groups such as chloroacetyl group, trifluoroacetyl group, trichloroacetyl group;
 シアノ基;
 ニトロ基;
 アミノ基;
 メチルアミノ基、ジメチルアミノ基、ジエチルアミノ基などのC1~6アルキルアミノ基;
 アニリノ基、ナフチルアミノ基などのC6~10アリールアミノ基;
 ホルミルアミノ基;
 アセチルアミノ基、プロパノイルアミノ基、ブチリルアミノ基、i-プロピルカルボニルアミノ基などのC1~6アルキルカルボニルアミノ基;
 メトキシカルボニルアミノ基、エトキシカルボニルアミノ基、n-プロポキシカルボニルアミノ基、i-プロポキシカルボニルアミノ基などのC1~6アルコキシカルボニルアミノ基;
 S,S-ジメチルスルホキシイミノ基などのC1~6アルキルスルホキシイミノ基;
Cyano group;
Nitro group;
Amino group;
C1-6 alkylamino groups such as methylamino group, dimethylamino group, diethylamino group;
C6-10 arylamino groups such as anilino group and naphthylamino group;
Formylamino group;
C1-6 alkylcarbonylamino groups such as acetylamino group, propanoylamino group, butyrylamino group, i-propylcarbonylamino group;
C1-6 alkoxycarbonylamino groups such as methoxycarbonylamino group, ethoxycarbonylamino group, n-propoxycarbonylamino group, i-propoxycarbonylamino group;
C1-6 alkyl sulfoxide imino groups such as S, S-dimethyl sulfoxide imino groups;
 アミノカルボニル基;
 メチルアミノカルボニル基、ジメチルアミノカルボニル基、エチルアミノカルボニル基、i-プロピルアミノカルボニル基、などのC1~6アルキルアミノカルボニル基;
 イミノメチル基、1-イミノエチル基、1-イミノ-n-プロピル基などのイミノC1~6アルキル基;
 ヒドロキシイミノメチル基、1-(ヒドロキシイミノ)エチル基、1-(ヒドロキシイミノ)-n-プロピル基などのヒドロキシイミノC1~6アルキル基;
 メトキシイミノメチル基、1-(メトキシイミノ)エチル基などのC1~6アルコキシイミノC1~6アルキル基;
Aminocarbonyl group;
C1-6 alkylaminocarbonyl groups such as methylaminocarbonyl group, dimethylaminocarbonyl group, ethylaminocarbonyl group, i-propylaminocarbonyl group, etc.;
Imino C1-6 alkyl groups such as iminomethyl group, 1-iminoethyl group, 1-imino-n-propyl group;
Hydroxyimino C1-6 alkyl groups such as hydroxyiminomethyl group, 1- (hydroxyimino) ethyl group, 1- (hydroxyimino) -n-propyl group;
C1-6 alkoxyimino C1-6 alkyl groups such as methoxyiminomethyl group, 1- (methoxyimino) ethyl group;
 メルカプト基;
 メチルチオ基、エチルチオ基、n-プロピルチオ基、i-プロピルチオ基、n-ブチルチオ基、i-ブチルチオ基、s-ブチルチオ基、t-ブチルチオ基などのC1~6アルキルチオ基;
 トリフルオロメチルチオ基、2,2,2-トリフルオロエチルチオ基などのC1~6ハロアルキルチオ基;
 ビニルチオ基、アリルチオ基などのC2~6アルケニルチオ基;
 エチニルチオ基、プロパルギルチオ基などのC2~6アルキニルチオ基;
 メチルスルフィニル基、エチルスルフィニル基、t-ブチルスルフィニル基などのC1~6アルキルスルフィニル基;
 トリフルオロメチルスルフィニル基、2,2,2-トリフルオロエチルスルフィニル基などのC1~6ハロアルキルスルフィニル基;
 アリルスルフィニル基などのC2~6アルケニルスルフィニル基;
 プロパルギルスルフィニル基などのC2~6アルキニルスルフィニル基;
 メチルスルホニル基、エチルスルホニル基、t-ブチルスルホニル基などのC1~6アルキルスルホニル基;
 トリフルオロメチルスルホニル基、2,2,2-トリフルオロエチルスルホニル基などのC1~6ハロアルキルスルホニル基;
 アリルスルホニル基などのC2~6アルケニルスルホニル基;
 プロパルギルスルホニル基などのC2~6アルキニルスルホニル基;
 アミノチオカルボニル基;
Mercapto group;
C1-6 alkylthio groups such as methylthio group, ethylthio group, n-propylthio group, i-propylthio group, n-butylthio group, i-butylthio group, s-butylthio group, t-butylthio group;
C1-6 haloalkylthio groups such as trifluoromethylthio group, 2,2,2-trifluoroethylthio group;
C2-6 alkenylthio groups such as vinylthio groups and allylthio groups;
C2-6 alkynylthio groups such as ethynylthio group and propargylthio group;
C1-6 alkylsulfinyl groups such as methylsulfinyl group, ethylsulfinyl group, t-butylsulfinyl group;
C1-6 haloalkylsulfinyl groups such as trifluoromethylsulfinyl groups, 2,2,2-trifluoroethylsulfinyl groups;
C2-6 alkenylsulfinyl groups such as allylsulfinyl groups;
C2-6 alkynylsulfinyl groups such as propargylsulfinyl groups;
C1-6 alkylsulfonyl groups such as methylsulfonyl groups, ethylsulfonyl groups, t-butylsulfonyl groups;
C1-6 haloalkylsulfonyl groups such as trifluoromethylsulfonyl groups, 2,2,2-trifluoroethylsulfonyl groups;
C2-6 alkenylsulfonyl groups such as allylsulfonyl groups;
C2-6 alkynylsulfonyl groups such as propargylsulfonyl groups;
Aminothiocarbonyl group;
 トリメチルシリル基、トリエチルシリル基、t-ブチルジメチルシリル基などのトリC1~6アルキルシリル基;
 トリフェニルシリル基などのトリC6~10アリールシリル基
Tri-C1-6 alkylsilyl groups such as trimethylsilyl group, triethylsilyl group, t-butyldimethylsilyl group;
Tri-C6-10 arylsilyl groups such as triphenylsilyl groups
 これらの「置換基」は、当該置換基中のいずれかの水素原子が、異なる構造の基で置換されていてもよい。 In these "substituents", any hydrogen atom in the substituent may be substituted with a group having a different structure.
 「C1~6」などの用語は、母核となる基の炭素原子数が1~6個などであることを表している。この炭素原子数には、置換基の中に在る炭素原子の数を含まない。例えば、エトキシブチル基は、母核となる基がブチル基であり、置換基がエトキシ基であるので、C2アルコキシC4アルキル基に分類する。 Terms such as "C1 to 6" indicate that the number of carbon atoms of the parent group is 1 to 6 or the like. This number of carbon atoms does not include the number of carbon atoms present in the substituent. For example, an ethoxybutyl group is classified as a C2 alkoxy C4 alkyl group because the parent group is a butyl group and the substituent is an ethoxy group.
〔R1
 式(I)中、R1は、置換若しくは無置換のC1~6アルキル基である。
[R 1 ]
In formula (I), R 1 is a substituted or unsubstituted C1-6 alkyl group.
 R1における「C1~6アルキル基」は、直鎖であってもよいし、分岐鎖であってもよい。アルキル基としては、メチル基、エチル基、n-プロピル基、n-ブチル基、n-ペンチル基、n-ヘキシル基、i-プロピル基、i-ブチル基、s-ブチル基、t-ブチル基、i-ペンチル基、ネオペンチル基、2-メチルブチル基、2,2-ジメチルプロピル基、i-ヘキシル基などを挙げることができる。 The "C1 to 6 alkyl group" in R 1 may be a straight chain or a branched chain. As the alkyl group, a methyl group, an ethyl group, an n-propyl group, an n-butyl group, an n-pentyl group, an n-hexyl group, an i-propyl group, an i-butyl group, an s-butyl group, and a t-butyl group. , I-pentyl group, neopentyl group, 2-methylbutyl group, 2,2-dimethylpropyl group, i-hexyl group and the like.
 R1における「C1~6アルキル基」上の置換基として、好ましくはフルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基、トリフルオロメトキシ基などのC1~6ハロアルコキシ基;シアノ基;メトキシフェニル基、エトキシフェニル基などのC1~6アルコキシ置換フェニル基を挙げることができる。 As the substituent on the "C1-6 alkyl group" in R 1 , preferably a halogeno group such as a fluoro group, a chloro group, a bromo group, an iodo group; a methoxy group, an ethoxy group, an n-propoxy group, an i-propoxy group, C1-6 alkoxy groups such as n-butoxy group, s-butoxy group, i-butoxy group, t-butoxy group; 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group, trifluoromethoxy group and the like. Examples thereof include C1 to 6 alkoxy-substituted phenyl groups such as C1 to 6 haloalkoxy groups; cyano groups; methoxyphenyl groups and ethoxyphenyl groups.
〔R2
 式(I)中、R2は、置換若しくは無置換のC1~6アルコキシカルボニル基、置換若しくは無置換の5~6員ヘテロアリール基、シアノ基、又は式「-CR=N-OR」で表される基である。
[R 2 ]
In formula (I), R 2 is a substituted or unsubstituted C1-6 alkoxycarbonyl group, a substituted or unsubstituted 5- to 6-membered heteroaryl group, a cyano group, or the formula "-CR a = N-OR b ". It is a group represented by.
 R2における「C1~6アルコキシカルボニル基」としては、メトキシカルボニル基、エトキシカルボニル基、n-プロポキシカルボニル基、i-プロポキシカルボニル基、n-ブトキシカルボニル基、t-ブトキシカルボニル基などを挙げることができる。 Examples of the "C1 to 6 alkoxycarbonyl group" in R 2 include a methoxycarbonyl group, an ethoxycarbonyl group, an n-propoxycarbonyl group, an i-propoxycarbonyl group, an n-butoxycarbonyl group, and a t-butoxycarbonyl group. it can.
 R2における「C1~6アルコキシカルボニル基」上の置換基として、好ましくはフルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基を挙げることができる。 As the substituent on the "C1 to 6 alkoxycarbonyl group" in R 2 , preferably, a halogeno group such as a fluoro group, a chloro group, a bromo group and an iodo group can be mentioned.
 R2における「5~6員ヘテロアリール基」としては、ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基などの5員ヘテロアリール基;ピリジル基、ピラジニル基、ピリミジニル基、ピリダジニル基、トリアジニル基などの6員ヘテロアリール基を挙げることができる。 The "5- to 6-membered heteroaryl group" in R 2 includes a pyrrolyl group, a furyl group, a thienyl group, an imidazolyl group, a pyrazolyl group, an oxazolyl group, an isooxazolyl group, a thiazolyl group, an isothiazolyl group, a triazolyl group, an oxadiazolyl group and a thiadiazolyl group. , A 5-membered heteroaryl group such as a tetrazolyl group; a 6-membered heteroaryl group such as a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridadinyl group and a triazinyl group can be mentioned.
 R2における「5~6員ヘテロアリール基」上の置換基として、好ましくはフルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基を挙げることができる。 As the substituent on the "5- to 6-membered heteroaryl group" in R 2 , preferably, a halogeno group such as a fluoro group, a chloro group, a bromo group and an iod group can be mentioned.
 R2における「式:「-CR=N-OR」で表される基」中のRは、水素原子であり、Rは、置換若しくは無置換のC1~6アルキル基である。
 Rにおける「置換若しくは無置換のC1~6アルキル基」としては、R1において具体的に例示したそれらと同じものを挙げることができる。
In R 2: - R a in "formula" CR a = N-OR b "group represented by" is hydrogen atom, R b is a substituted or unsubstituted C1 ~ 6 alkyl group.
Examples of the "substituted or unsubstituted C1 to 6 alkyl groups" in R b include the same ones specifically exemplified in R 1 .
 R2における「式:「-CR=N-OR」で表される基」としては、メトキシイミノメチル基、エトキシイミノメチル基、n-プロポキシイミノメチル基、イソプロポキシイミノメチル基などを挙げることができる。 Examples of the "group represented by the formula:" -CR a = N-OR b "" in R 2 include a methoxyiminomethyl group, an ethoxyiminomethyl group, an n-propoxyiminomethyl group, an isopropoxyiminomethyl group and the like. be able to.
 〔R3、R4、R5、R6
 式(I)中、R、R、R及びRは、それぞれ独立して、水素原子又は置換若しくは無置換のC1~6アルキル基である。
 R、R、R及びRにおける「置換若しくは無置換のC1~6アルキル基」としては、R1において具体的に例示したそれらと同じものを挙げることができる。
[R 3 , R 4 , R 5 , R 6 ]
In formula (I), R 3 , R 4 , R 5 and R 6 are independently hydrogen atoms or substituted or unsubstituted C1 to 6 alkyl groups.
Examples of the "substituted or unsubstituted C1 to 6 alkyl groups" in R 3 , R 4 , R 5 and R 6 include the same ones specifically exemplified in R 1 .
 RとRは、それらが一緒になってC2~6アルキレン基を形成してもよい。
 RとRが、一緒になって形成する「C2~6アルキレン基」としては、エチレン基、トリメチレン基、テトラメチレン基、ペンタメチレン基などを挙げることができる。
R 3 and R 4 may be combined to form a C2-6 alkylene group.
Examples of the "C2 to 6 alkylene group" formed by R 3 and R 4 together include an ethylene group, a trimethylene group, a tetramethylene group, and a pentamethylene group.
 RとR は、それらが一緒になって、C1~5アルキレン基を形成してもよい。
 RとR が、一緒になって形成する「C1~C5アルキレン基」としては、メチレン基、エチレン基、トリメチレン基、テトラメチレン基、ペンタメチレン基などを挙げることができる。
R 3 and R 5 may be combined together to form a C1-5 alkylene group.
Examples of the "C1 to C5 alkylene group" formed by R 3 and R 5 together include a methylene group, an ethylene group, a trimethylene group, a tetramethylene group, and a pentamethylene group.
 RとRは、それらが一緒になってC2~6アルキレン基を形成してもよい。
 RとR6が、一緒になって形成する「C2~6アルキレン基」としては、前記したものと同様のものが挙げられる。
R 5 and R 6 may be combined to form a C2-6 alkylene group.
Examples of the "C2 to 6 alkylene group" formed by R 5 and R 6 together include those similar to those described above.
 〔R7
 式(I)中、Rは、水素原子、水酸基、置換若しくは無置換のC1~6アルコキシ基、置換若しくは無置換のC1~6アルキルカルボニルオキシ基又は置換若しくは無置換のC2~6アルケニルオキシ基である。
 Rにおける「C1~6アルコキシ基」としては、メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などを挙げることができる。
[R 7 ]
In formula (I), R 7 is a hydrogen atom, a hydroxyl group, a substituted or unsubstituted C1 to 6 alkoxy group, a substituted or unsubstituted C1 to 6 alkylcarbonyloxy group, or a substituted or unsubstituted C2 to 6 alkenyloxy group. Is.
Examples of the "C1 to 6 alkoxy group" in R 7 include a methoxy group, an ethoxy group, an n-propoxy group, an i-propoxy group, an n-butoxy group, an s-butoxy group, an i-butoxy group, and a t-butoxy group. Can be mentioned.
 Rにおける「C1~6アルキルカルボニルオキシ基」としては、アセチルオキシ基、プロピオニルオキシ基などを挙げることができる。
 Rにおける「C2~6アルケニルオキシ基」としては、ビニルオキシ基、アリルオキシ基、プロペニルオキシ基、ブテニルオキシ基などのC2~6アルケニルオキシ基を挙げることができる。
 Rにおける「C1~6アルコキシ基」、「C1~6アルキルカルボニルオキシ基」及び「C2~6アルケニルオキシ基」上の置換基として、好ましくはフルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;シアノ基、C1~6アルコキシ基を挙げることができる。
Examples of the "C1 to 6 alkylcarbonyloxy group" in R 7 include an acetyloxy group and a propionyloxy group.
Examples of the "C2 to 6 alkenyloxy group" in R 7 include C2 to 6 alkenyloxy groups such as vinyloxy group, allyloxy group, propenyloxy group and butenyloxy group.
As the substituent on the "C1-6 alkoxy group", "C1-6 alkylcarbonyloxy group" and "C2-6alkenyloxy group" in R 7 , preferably a fluoro group, a chloro group, a bromo group, an iodo group and the like are used. Halogeno group; cyano group, C1-6 alkoxy group can be mentioned.
〔R8
 式(I)中、Rは、水素原子である。
 RとRは、それらが一緒になって、置換若しくは無置換のC1~6アルコキシイミノ基を形成してもよい。
 RとR8が一緒になって形成する「C1~6アルコキシイミノ基」としては、メトキシイミノ基、エトキシイミノ基が挙げられる。
 RとR8が一緒になって形成する「C1~6アルコキシイミノ基」上の置換基として、好ましくはフルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基を挙げることができる。
[R 8 ]
In formula (I), R 8 is a hydrogen atom.
R 7 and R 8 may be combined together to form a substituted or unsubstituted C1-6 alkoxyimino group.
Examples of the "C1 to 6 alkoxyimino group" formed by R 7 and R 8 together include a methoxyimino group and an ethoxyimino group.
As the substituent on the "C1-6 alkoxyimino group" formed by R 7 and R 8 together, preferably, a halogeno group such as a fluoro group, a chloro group, a bromo group and an iodo group can be mentioned.
 〔X〕
 式(I)中、Xは、ハロゲノ基又は置換若しくは無置換のC1~6アルコキシ基である。
 Xにおける「ハロゲノ基」としては、フルオロ基、クロロ基、ブロモ基、イオド基などを挙げることができる。
 Xにおける「置換若しくは無置換のC1~6アルコキシ基」としては、R7において具体的に例示したそれらと同じものを挙げることができる。
[X]
In formula (I), X is a halogeno group or a substituted or unsubstituted C1-6 alkoxy group.
Examples of the "halogeno group" in X include a fluoro group, a chloro group, a bromo group, an iod group and the like.
Examples of the "substituted or unsubstituted C1 to 6 alkoxy groups" in X include the same groups specifically exemplified in R 7 .
 〔n〕
 式(I)中、nは、0~5のいずれかの整数であり、nが2以上のときXは互いに同じでも異なってもよい。
[N]
In formula (I), n is an integer of 0 to 5, and when n is 2 or more, X may be the same or different from each other.
〔Q〕
 式(I)中、Qは、式(Q-1)、式(Q-2)又は(Q-3)で表される基である。
[Q]
In formula (I), Q is a group represented by formula (Q-1), formula (Q-2) or (Q-3).
Figure JPOXMLDOC01-appb-C000014
Figure JPOXMLDOC01-appb-C000014
 式(Q-1)、式(Q-2)及び(Q-3)中、矢印は結合部位を示す。
 式(Q-1)中、R及びRは、それぞれ独立して、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC1~6アルコキシ基、置換若しくは無置換のC3~8シクロアルキル基、置換若しくは無置換の5員環のヘテロシクリル基又は式「-CR=N-OR」で表される基である。
 式(Q-1)における「式「-CR=N-OR」で表される基」中のRは、水素原子であり、Rは、置換又は無置換のC1~6アルキル基である。
 式(Q-2)中、R及びRは、それぞれ独立して、水素原子又は置換若しくは無置換のC1~6アルキル基である。
 式(Q-3)中、Rは、水素原子、置換若しくは無置換のC1~6アルキル基である。
In formulas (Q-1), formulas (Q-2) and (Q-3), arrows indicate binding sites.
In formula (Q-1), R c and R d are independently hydrogen atoms, substituted or unsubstituted C1 to 6 alkyl groups, substituted or unsubstituted C1 to 6 alkoxy groups, substituted or unsubstituted. A C3 to 8 cycloalkyl group, a substituted or unsubstituted 5-membered heterocyclyl group, or a group represented by the formula "-CR g = N-OR h ".
R g in the "group represented by the formula" -CR g = N-OR h "" in the formula (Q-1) is a hydrogen atom, and R h is a substituted or unsubstituted C1 to 6 alkyl group. Is.
In formula (Q-2), R e and R f are independently hydrogen atoms or substituted or unsubstituted C1 to 6 alkyl groups.
In formula (Q-3), R i is a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group.
 R及びRにおける「置換若しくは無置換のC1~6アルキル基」としては、R1において具体的に例示したそれらと同じものを挙げることができ、「置換若しくは無置換のC1~6アルコキシ基」としては、R7において具体的に例示したそれらと同じものを挙げることができる。 Examples of the "substituted or unsubstituted C1 to 6 alkyl groups" in R c and R d include the same ones specifically exemplified in R 1 , and "substituted or unsubstituted C1 to 6 alkoxy groups". , The same as those specifically exemplified in R 7 can be mentioned.
 R及びRにおける「C3~8シクロアルキル基」としては、シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基、シクロヘプチル基、キュバニル基などを挙げることができる。
 R及びRにおける「C3~8シクロアルキル基」上の置換基として、好ましくはフルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;シアノ基を挙げることができる。
Examples of the "C3-8 cycloalkyl group" in R c and R d include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cubicyl group and the like.
Preferred examples of the substituent on the "C3-8 cycloalkyl group" in R c and R d include a halogeno group such as a fluoro group, a chloro group, a bromo group and an iodo group; and a cyano group.
 R及びRにおける「5員環のヘテロシクリル基」とは、窒素原子、酸素原子および硫黄原子からなる群から選ばれる1~4個のヘテロ原子を環の構成原子として含むものである。
 「5員環のヘテロシクリル基」としては、5員飽和ヘテロシクリル基、5員ヘテロアリール基、5員部分不飽和ヘテロシクリル基を挙げることができる。
The "5-membered heterocyclyl group" in R c and R d includes 1 to 4 hetero atoms selected from the group consisting of nitrogen atom, oxygen atom and sulfur atom as ring constituent atoms.
Examples of the "5-membered heterocyclyl group" include a 5-membered saturated heterocyclyl group, a 5-membered heteroaryl group, and a 5-membered partially unsaturated heterocyclyl group.
 5員飽和ヘテロシクリル基としては、ピロリジニル基、テトラヒドロフラニル基、テトラヒドロチオフェニル基、イミダゾリジニル基、ピラゾリジニル基、オキサゾリジニル基、イソオキサゾリジニル基、チアゾリジニル基、イソチアゾリジニル基などを挙げることができる。
 5員ヘテロアリール基としては、ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基などを挙げることができる。
 5員部分不飽和へテロシクリル基としては、ピロリニル基、ジヒドロフラニル基、ジヒドロチオフェニル基、イミダゾリニル基、ピラゾリニル基、オキサゾリニル基、イソオキサゾリニル基、チアゾリニル基、イソチアゾリニル基などを挙げることができる。
Examples of the 5-membered saturated heterocyclyl group include a pyrrolidinyl group, a tetrahydrofuranyl group, a tetrahydrothiophenyl group, an imidazolidinyl group, a pyrazolidinyl group, an oxazolidinyl group, an isooxazolidinyl group, a thiazolidinyl group and an isothiazolidinyl group. ..
Examples of the 5-membered heteroaryl group include a pyrrolyl group, a frill group, a thienyl group, an imidazolyl group, a pyrazolyl group, an oxazolyl group, an isooxazolyl group, a thiazolyl group, an isothiazolyl group, a triazolyl group, an oxadiazolyl group, a thiadiazolyl group and a tetrazolyl group. Can be done.
Examples of the 5-membered partially unsaturated heterocyclyl group include a pyrrolinyl group, a dihydrofuranyl group, a dihydrothiophenyl group, an imidazolinyl group, a pyrazolinyl group, an oxazolinyl group, an isooxazolinyl group, a thiazolinyl group and an isothiazolinyl group. ..
 R及びRにおける「5員環のヘテロシクリル基」上の置換基としては、フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基; メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基などのC1~6アルキル基; メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基; ジフルオロメチル基、トリフルオロメチル基、2,2-ジフルオロエチル基、2,2,2-トリフルオロエチル基などのC1~6ハロアルキル基; シアノ基;オキソ基などを挙げることができる。 As the substituent on the "5-membered heterocyclyl group" in R c and R d, a halogeno group such as a fluoro group, a chloro group, a bromo group and an iodo group; a methyl group, an ethyl group, an n-propyl group and an i- C1-6 alkyl groups such as propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group; methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group , S-butoxy group, i-butoxy group, t-butoxy group and other C1-6 alkoxy groups; difluoromethyl group, trifluoromethyl group, 2,2-difluoroethyl group, 2,2,2-trifluoroethyl group C1 to 6 haloalkyl groups such as; cyano group; oxo group and the like can be mentioned.
 Rにおける「置換若しくは無置換のC1~6アルキル基」としては、R1において具体的に例示したそれらと同じものを挙げることができる。
 R及びRにおける「置換若しくは無置換のC1~6アルキル基」としては、R1において具体的に例示したそれらと同じものを挙げることができる。
Examples of the "substituted or unsubstituted C1 to 6 alkyl groups" in R h include the same ones specifically exemplified in R 1 .
Examples of the "substituted or unsubstituted C1 to 6 alkyl groups" in R e and R f include the same ones specifically exemplified in R 1 .
 〔塩〕
 化合物(I)の塩は、農園芸学的に許容される塩であれば、特に制限されない。例えば、塩酸、硫酸などの無機酸の塩;酢酸、乳酸などの有機酸の塩;リチウム、ナトリウム、カリウムなどのアルカリ金属の塩;カルシウム、マグネシウムなどのアルカリ土類金属の塩;鉄、銅などの遷移金属の塩;トリエチルアミン、トリブチルアミン、ピリジン、ヒドラジンなどの有機塩基の塩;アンモニアなどを挙げることができる。
〔salt〕
The salt of compound (I) is not particularly limited as long as it is an horticulturally acceptable salt. For example, salts of inorganic acids such as hydrochloric acid and sulfuric acid; salts of organic acids such as acetic acid and lactic acid; salts of alkali metals such as lithium, sodium and potassium; salts of alkaline earth metals such as calcium and magnesium; iron, copper and the like. Transition metal salts; salts of organic bases such as triethylamine, tributylamine, pyridine, hydrazine; ammonia and the like.
 〔製造方法〕
 化合物(I)又は化合物(I)の塩の製造方法は、限定されない。例えば、本発明の化合物(I)又は化合物(I)の塩は、実施例等に記載したような公知の手法によって得ることができる。また、化合物(I)の塩は、化合物(I)から公知の手法によって得ることができる。
〔Production method〕
The method for producing the compound (I) or the salt of the compound (I) is not limited. For example, the compound (I) of the present invention or the salt of the compound (I) can be obtained by a known method as described in Examples and the like. Further, the salt of compound (I) can be obtained from compound (I) by a known method.
 〔農園芸用殺菌剤〕
 本発明の農園芸用殺菌剤は、化合物(I)及びその塩からなる群から選ばれる少なくとも1つを有効成分として含有するものである。本発明の農園芸用殺菌剤に含まれる化合物(I)又はその塩の量は殺菌効果を示す限りにおいて特に制限されない。
[Fungicide for agriculture and horticulture]
The agricultural and horticultural fungicide of the present invention contains at least one selected from the group consisting of compound (I) and a salt thereof as an active ingredient. The amount of compound (I) or a salt thereof contained in the bactericidal agent for agriculture and horticulture of the present invention is not particularly limited as long as it exhibits a bactericidal effect.
 本発明の農園芸用殺菌剤は、広範囲の種類の糸状菌、例えば、藻菌類(Oomycetes)、子のう(嚢)菌類(Ascomycetes)、不完全菌類(Deuteromycetes)、担子菌類(Basidiomycetes)、接合菌類(Zygomycetes)に属する菌に由来する植物病害の防除に使用できる。 The agricultural and horticultural fungi of the present invention include a wide variety of filamentous fungi, such as algae fungi (Oomycetes), ascomycetes (Ascomycetes), imperfect fungi (Deuteromycetes), basidiomycetes, and zygomycetes. It can be used to control plant diseases derived from fungi belonging to fungi (Zygomycetes).
 防除の対象となる植物病害(病原菌)の例を以下に示す。
 テンサイ:褐斑病(Cercospora beticola)、黒根病(Aphanomyces cochlioides )、根腐病(Thanatephorus cucumeris)、葉腐病(Thanatephorus cucumeris)、さび病(Uromyces betae)、うどんこ病(Oidium sp.)、斑点病(Ramularia beticola)、苗立枯病(Aphanomyces cochlioides、Pythium ultimum)など;
 ラッカセイ:褐斑病(Mycosphaerella arachidis)、汚斑病(Ascochyta sp.)、さび病(Puccinia arachidis)、立枯病(Pythium debaryanum)、さび斑病(Alternaria alternata)、白絹病(Sclerotium rolfsii)黒渋病(Mycosphaerella berkeleyi)など;
 キュウリ:うどんこ病(Sphaerotheca fuliginea)、べと病(Pseudoperonospora cubensis)、つる枯病(Mycosphaerella melonis)、つる割病(Fusarium oxysporum)、菌核病(Sclerotinia sclerotiorum)、灰色かび病(Botrytis cinerea)、炭そ病(Colletotrichum orbiculare)、黒星病(Cladosporium cucumerinum)、褐斑病(Corynespora cassiicola)、苗立枯病(Pythium debaryanum、Rhizoctonia solani Kuhn)、ホモプシス根腐病(Phomopsis sp.)斑点細菌病(Pseudomonas syringae pv. Lechrymans)など;
 トマト:灰色かび病(Botrytis cinerea)、葉かび病(Cladosporium fulvum)、疫病(Phytophthora infestans)、半身萎凋病(Verticillium albo-atrum、 Verticillium dahliae)、うどんこ病(Oidium neolycopersici)、輪紋病(Alternaria solani)、すすかび病(Pseudocercospora fuligena)など;
 ナス:灰色かび病(Botrytis cinerea)、黒枯病(Corynespora melongenae)、うどんこ病(Erysiphe cichoracearum)、すすかび病(Mycovellosiella nattrassii)、菌核病(Sclerotinia sclerotiorum)、半身萎凋病(Verticillium dahliae)、褐紋病(Phomopsis vexans)など;
 イチゴ:灰色かび病(Botrytis cinerea)、うどんこ病(Sphaerotheca humuli)、炭そ病(Colletotrichum acutatum、Colletotrichum fragariae)、疫病(Phytophthora cactorum)、軟腐病(Rhizopus stolonifer)、萎黄病(Fusarium oxysporum)、萎凋病(Verticillium dahliae)など;
 タマネギ:灰色腐敗病(Botrytis allii)、灰色かび病(Botrytis cinerea)、白斑葉枯病(Botrytis squamosa)、べと病(Peronospora destructor)、白色疫病(Phytophthora porri)、小菌核病(Ciborinia allii)など;
 ネギ:軟腐病(Pectobacterium carotovorum)、べと病(Peronospora destructor)、葉枯病(Pleospora allii)、黒腐菌核病(Sclerotium cepivorum)、さび病(Puccinia allii)、白斑葉枯病(Botrytis squamosa)など;
 キャベツ:根こぶ病(Plasmodiophora brassicae)、軟腐病(Erwinia carotovora)、黒腐病(Xanthomonas campesrtis pv. campestris)、黒斑細菌病(Pseudomonas syringae pv. maculicola、P. s. pv. alisalensis)、べと病(Peronospora parasitica)、菌核病(Sclerotinia sclerotiorum)、黒すす病(Alternaria brassicicola)、灰色かび病(Botrytis cinerea)など;
 インゲン:菌核病(Sclerotinia sclerotiorum)、灰色かび病(Botrytis cinerea)、炭疽病(Colletotrichum lindemuthianum)、角斑病(Phaeoisariopsis griseola)など;
Examples of plant diseases (pathogens) to be controlled are shown below.
Cercospora beticola, black root disease (Aphanomyces cochlioides), root rot (Thanatephorus cucumeris), leaf rot (Thanatephorus cucumeris), rust (Uromyces betae), powdery mildew (Oidium sp.), Spots Diseases (Ramularia beticola), seedling blight (Aphanomyces cochlioides, Pythium ultimum), etc .;
Peanuts: brown spot (Mycosphaerella arachidis), plaque (Ascochyta sp.), Rust (Puccinia arachidis), blight (Pythium debaryanum), rust (Alternaria alternata), white silk (Sclerotium rolfsii) black Astringency (Mycosphaerella berkeleyi), etc .;
Cucumber: Udonko disease (Sphaerotheca fuliginea), sticky disease (Pseudoperonospora cubensis), vine blight (Mycosphaerella melonis), vine blight (Fusarium oxysporum), mycorrhizal disease (Sclerotinia sclerotiorum), Botrytis cinerea Colletotrichum orbiculare, Cladosporium cucumerinum, Corynespora cassiicola, Pythium debaryanum, Rhizoctonia solani Kuhn, Phomopsis sp. syringae pv. Lechrymans) etc .;
Tomatoes: Botrytis cinerea, Cladosporium fulvum, Phytophthora infestans, Verticillium albo-atrum, Verticillium dahliae, powdery mildew (Oidium neolycopersici), powdery mildew (Alternaria) solani), powdery mildew (Pseudocercospora fuligena), etc .;
Eggplant: Botrytis cinerea, Corynespora melongenae, powdery mildew (Erysiphe cichoracearum), soot mold (Mycovellosiella nattrassii), sclerotinia sclerotiorum, Verticillium dah Brown spot disease (Phomopsis vexans), etc .;
Strawberries: Botrytis cinerea, powdery mildew (Sphaerotheca humuli), colletotrichum acutatum, Colletotrichum fragariae, plague (Phytophthora cactorum), soft rot (Rhizopus stolonifer), chlorosis (Fusarium oxyspor) Disease (Verticillium dahliae) etc .;
Onions: Botrytis allii, Botrytis cinerea, Botrytis squamosa, Peronospora destructor, Phytophthora porri, Ciborinia allii Such;
Welsh onion: soft rot (Pectobacterium carotovorum), downy mildew (Peronospora destructor), leaf blight (Pleospora allii), black rotium cepivorum (Sclerotium cepivorum), rust (Puccinia allii), white spot blight (Botrytis squamosa) Such;
Cabbage: root-knot disease (Plasmodiophora brassicae), soft rot (Erwinia carotovora), black rot (Xanthomonas campesrtis pv. Campestris), black rot (Pseudomonas syringae pv. Maculicola, P. s. Pv. Alisalensis), downy mildew Diseases (Peronospora parasitica), sclerotinia sclerotiorum, black rot (Alternaria brassicicola), Botrytis cinerea, etc.;
Green beans: Sclerotinia sclerotiorum, Botrytis cinerea, Colletotrichum lindemuthianum, Phaeoisariopsis griseola, etc.;
 りんご:うどんこ病(Podosphaera leucotricha)、黒星病(Venturia inaequalis)、モニリア病(Monilinia mali)、黒点病(Mycosphaerella pomi)、腐らん病(Valsa mali)、斑点落葉病(Alternaria mali)、赤星病(Gymnosporangium yamadae)、輪紋病(Botryosphaeria berengeriana)、炭そ病(Glomerella cingulata、Colletotrichum acutatum)、褐斑病(Diplocarpon mali)、すす点病(Zygophiala jamaicensis)、すす斑病(Gloeodes pomigena)、紫紋羽病(Helicobasidium mompa)、灰色かび病(Botrytis cinerea)、火傷病(Erwinia amylovora)など;
 ウメ:黒星病(Cladosporium carpophilum)、灰色かび病(Botrytis cinerea)、灰星病(Monilinia mumecola)、すす斑病(Peltaster sp.)など;
 カキ:うどんこ病(Phyllactinia kakicola)、炭そ病(Gloeosporium kaki)、角斑落葉病(Cercospora kaki)、円星落葉病(Mycosphaerella nawae)など;
 モモ:灰星病(Monilinia fructicola)、黒星病(Cladosporium carpophilum)、ホモプシス腐敗病(Phomopsis sp.)、穿孔細菌病(Xanthomonas campestris pv. pruni)、縮葉病(Taphrina deformans)、炭そ病(Colletotrichum gloeosporioides)など;
 アーモンド:灰星病(Monilinia laxa)、斑点病(Stigmina carpophila)、黒星病(Cladosporium carpophilum)、葉ぶくれ病(Polystigma rubrum)、斑点落葉病(Alternaria alternata)、炭疽病(Colletotrichum gloeospoides)など;
 オウトウ:灰星病(Monilinia fructicola)、炭そ病(Colletotrichum acutatum)、黒斑病(Alternaria sp.)、幼果菌核病(Monilinia kusanoi)、褐色せん孔病(Mycosphaerella cerasella)など;
 ブドウ:灰色かび病(Botrytis cinerea)、うどんこ病(Uncinula necator)、晩腐病(Glomerella cingulata、Colletotrichum acutatum)、べと病(Plasmopara viticola)、黒とう病(Elsinoe ampelina)、褐斑病(Pseudocercospora vitis)、黒腐病(Guignardia bidwellii)、白腐病(Coniella castaneicola)、さび病(Phakopsora ampelopsidis)、白色綿雪症(病原菌未同定)など;
 ナシ:黒星病(Venturia nashicola)、赤星病(Gymnosporangium asiaticum)、黒斑病(Alternaria kikuchiana)、輪紋病(Botryosphaeria berengeriana)、うどんこ病(Phyllactinia mali)、胴枯病(Phomopsis fukushii)、褐色斑点病(Stemphylium vesicarium)、炭そ病(Glomerella cingulata)など;
 チャ:輪斑病(Pestalotiopsis longiseta、 P. theae)、炭そ病(Colletotrichum theae-sinensis)、網もち病(Exobasidium reticulatum)など;
 カンキツ:そうか病(Elsinoe fawcettii)、青かび病(Penicillium italicum)、緑かび病(Penicillium digitatum)、灰色かび病(Botrytis cinerea)、黒点病(Diaporthe citri)、かいよう病(Xanthomonas campestris pv.Citri)、うどんこ病(Oidium sp.)、疫病(Phytophthora citrophthora)、炭そ病(Colletotrichum fioriniae)など;
Apples: Udonko disease (Podosphaera leucotricha), scab (Venturia inaequalis), Monilinia mali, black spot disease (Mycosphaerella pomi), rot disease (Valsa mali), spot deciduous disease (Alternaria mali), gymnosporangium yamadae), ring pattern disease (Botryosphaeria berengeriana), charcoal disease (Glomerella cingulata, Colletotrichum acutatum), brown spot disease (Diplocarpon mali), soot spot disease (Zygophiala jamaicensis), soot spot disease (Gloeodes pomigena), purple spot feather disease (Helicobasidium mompa), Botrytis cinerea, Erwinia amylovora, etc .;
Plum: Cladosporium carpophilum, Botrytis cinerea, Monilinia mumecola, Peltaster sp., Etc.;
Persimmon: Powdery mildew (Phyllactinia kakicola), charcoal disease (Gloeosporium kaki), keratosespora kaki, deciduous circle (Mycosphaerella nawae), etc.;
Peach: Monilinia fructicola, Cladosporium carpophilum, Phomopsis sp., Xanthomonas campestris pv. Pruni, Taphrina deformans, Colletotrichum gloeosporioides) etc .;
Almonds: Monilinia laxa, Stigmina carpophila, Cladosporium carpophilum, Polystigma rubrum, Alternaria alternata, Colletotrichum gloeospoides, etc .;
Outou: Monilinia fructicola, Colletotrichum acutatum, Alternaria sp., Monilinia kusanoi, Mycosphaerella cerasella, etc.;
Grapes: Botrytis cinerea, powdery mildew (Uncinula necator), late rot (Glomerella cingulata, Colletotrichum acutatum), downy mildew (Plasmopara viticola), black rot (Elsinoe ampelina), brown spot (Pseudocercospora) vitis), black rot (Guignardia bidwellii), white rot (Coniella castaneicola), downy mildew (Phakopsora ampelopsidis), Botrytis cinerea (pathogen unidentified), etc.;
Pear: Black spot disease (Venturia nashicola), Gymnosporangium asiaticum, Black spot disease (Alternaria kikuchiana), Ring stain disease (Botryosphaeria berengeriana), Powdery mildew (Phyllactinia mali), Body blight (Phomopsis fukushii), Brown spots Diseases (Stemphylium vesicarium), powdery mildew (Glomerella cingulata), etc .;
Cha: Ring spot disease (Pestalotiopsis longiseta, P. theae), charcoal disease (Colletotrichum theae-sinensis), net blast disease (Exobasidium reticulatum), etc.;
Cankits: powdery mildew (Elsinoe fawcettii), blue mold (Penicillium italicum), green mold (Penicillium digitatum), gray mold (Botrytis cinerea), black spot (Diaporthe citri), powdery mildew (Xanthomonas campestris pv.Citri), Powdery mildew (Oidium sp.), Epidemic (Phytophthora citrophthora), Charcoal disease (Colletotrichum fioriniae), etc .;
 コムギ:うどんこ病(Blumeria graminis f.sp. tritici)、赤かび病(Gibberella zeae)、赤さび病(Puccinia recondita)、黄さび病(Puccinia striiformis)、褐色雪腐病(Pythium iwayamai)、紅色雪腐病(Monographella nivalis)、眼紋病(Pseudocercosporella herpotrichoides)、葉枯病(Septoria tritici)、ふ枯病(Leptosphaeria nodorum)、雪腐小粒菌核病(Typhula incarnata)、雪腐大粒菌核病(Myriosclerotinia borealis)、立枯病(Gaeumannomyces graminis)、麦角病(Claviceps purpurea)、なまぐさ黒穂病(Tilletia caries)、裸黒穂病(Ustilago nuda)、いもち病(Pyricularia grisea)など;
 オオムギ:斑葉病(Pyrenophora graminea)、網斑病(Pyrenophora teres)、雲形病(Rhynchosporium secalis)、裸黒穂病(Ustilago tritici、U.nuda)など;
 イネ:いもち病(Pyricularia oryzae)、紋枯病(Rhizoctonia solani)、馬鹿苗病(Gibberella fujikuroi)、ごま葉枯病(Cochliobolus miyabeanus)、苗立枯病(Pythiumgraminicola)、白葉枯病(Xanthomonas oryzae)、苗立枯細菌病(Burkholderia plantarii)、褐条病(Acidovorax avenae)、もみ枯細菌病(Burkholderia glumae)、すじ葉枯病(Cercospora oryzae)、稲こうじ病(Ustilaginoidea virens)、褐色米(Alternaria alternata、Curvularia intermedia)、腹黒米(Alternaria padwickii)、紅変米(Epicoccum purpurascens)など;
 タバコ:菌核病(Sclerotinia sclerotiorum)、うどんこ病(Erysiphe cichoracearum)、疫病(Phytophthora nicotianae)など;
 チューリップ:灰色かび病(Botrytis cinerea)など;
 ヒマワリ:べと病(Plasmopara halstedii)、菌核病(Sclerotinia sclerotiorum)、灰色かび病(Botrytis cinerea)など;
 ベントグラス:雪腐大粒菌核病(Sclerotinia borealis)、ラージパッチ(Rhizoctonia solani)、ブラウンパッチ(Rhizoctonia solani)、ダラースポット(Sclerotinia homoeocarpa)、いもち病(Pyricularia sp.)、赤焼病(Pythium aphanidermatum)、炭そ病(Colletotrichum graminicola)など;
 オーチャードグラス:うどんこ病(Erysiphe graminis)など;
 ダイズ:紫斑病(Cercospora kikuchii)、べと病(Peronospora manshurica)、茎疫病(Phytophthora sojae)、さび病(Phakopsora pachyrhizi)、菌核病(Sclerotinia sclerotiorum)、炭そ病(Colletotrichum truncatum)、灰色かび病(Botrytis cinerea)、黒とう病(Elsinoe glycines)、黒点病(Diaporthe phaseolorum var. sojae)など;
 ジャガイモ:疫病(Phytophthora infestans)、夏疫病(Alternaria solani)、黒あざ病(Thanatephorus cucumeris)、半身萎凋病(Verticillium albo-atrum、V. dahliae、V. nigrescens)、黒あし病(Pectobacterium atrosepticum)、軟腐病(Pectobacterium carotovorum)など;
 バナナ:パナマ病(Fusarium oxysporum)、シガトカ病(Mycosphaerella fijiensis、M. musicola)など;
 マンゴー:炭そ病(Colletotrichum aenigma)など;
 ナタネ:菌核病(Sclerotinia sclerotiorum)、根朽病(Phoma lingam)、黒斑病(Alternaria brassicae)など;
 コーヒー:さび病(Hemileia vastatrix)、炭疽病(Colletotrichum coffeanum)、褐眼病(Cercospora coffeicola)など;
 サトウキビ:褐さび病(Puccinia melanocephala)など;
 トウモロコシ:ひょう紋病(Gloeocercospora sorghi)、さび病(Puccinia sorghi)、南方さび病(Puccinia polysora)、黒穂病(Ustilago maydis)、ごま葉枯病(Cochliobolus heterostrophus)、すす紋病(Setosphaeria turcica)など;
 ワタ:苗立枯病(Pythium sp.)、さび病(Phakopsora gossypii)、白かび病(Mycosphaerella areola)、炭疽病(Glomerella gossypii)など。
Wheat: Udonko disease (Blumeria graminis f.sp. Tritici), Fusarium head blight (Gibberella zeae), Fusarium head blight (Puccinia recondita), Yellow rust (Puccinia striiformis), Brown snow rot (Pythium iwayamai), Monographella nivalis Disease (Monographella nivalis), Eye print disease (Pseudocercosporella herpotrichoides), Leaf blight (Septoria tritici), Fusarium head blight (Leptosphaeria nodorum), Typhula incarnata, Myriosclerotinia borealis ), Gaeumannomyces graminis, Claviceps purpurea, Tilletia caries, Ustilago nuda, Pyricularia grisea, etc.;
Barley: Pyrenophora graminea, Pyrenophora teres, Rhynchosporium secalis, Ustilago tritici, U.nuda, etc.;
Rice: blast (Pyricularia oryzae), blight (Rhizoctonia solani), bakanae (Gibberella fujikuroi), sesame leaf blight (Cochliobolus miyabeanus), seedling blight (Pythiumgraminicola), white leaf blight (Xanthomonas oryzae), Seedling blight (Burkholderia plantarii), brown streak (Acidovorax avenae), fir blight (Burkholderia glumae), streak leaf blight (Cercospora oryzae), rice plant disease (Ustilaginoidea virens), brown rice (Alternaria alternata, Curvularia intermedia), belly black rice (Alternaria padwickii), red rice (Epicoccum purpurascens), etc.;
Tobacco: Sclerotinia sclerotiorum, powdery mildew (Erysiphe cichoracearum), plague (Phytophthora nicotianae), etc.;
Tulips: Botrytis cinerea, etc .;
Sunflower: Downy mildew (Plasmopara halstedii), sclerotinia sclerotiorum, Botrytis cinerea, etc .;
Bentgrass: Sclerotinia borealis, Large patch (Rhizoctonia solani), Brown patch (Rhizoctonia solani), Dollar spot (Sclerotinia homoeocarpa), Blast (Pyricularia sp.), Red burn (Pythium aphanidermatum), Charcoal disease (Colletotrichum graminicola), etc .;
Orchardgrass: Powdery mildew (Erysiphe graminis), etc .;
Soybeans: purple spot disease (Cercospora kikuchii), downy mildew (Peronospora manshurica), stem epidemic (Phytophthora sojae), rust disease (Phakopsora pachyrhizi), sclerotinia sclerotiorum, Botrytis cinerea (Colletotrichum truncatum) (Botrytis cinerea), black downy mildew (Elsinoe glycines), black spot disease (Diaporthe phaseolorum var. Sojae), etc.;
Potatoes: plague (Phytophthora infestans), summer plague (Alternaria solani), black blight (Thanatephorus cucumeris), half-body wilt (Verticillium albo-atrum, V. dahliae, V. nigrescens), black rot (Pectobacterium atrosepticum) Diseases (Pectobacterium carotovorum), etc .;
Bananas: Panama disease (Fusarium oxysporum), black sigatoka disease (Mycosphaerella fijiensis, M. musicola), etc .;
Mango: Colletotrichum aenigma, etc .;
Rapeseed: Sclerotinia sclerotiorum, Phoma lingam, Alternaria brassicae, etc .;
Coffee: rust (Hemileia vastatrix), anthrax (Colletotrichum coffeanum), brown eye disease (Cercospora coffeicola), etc .;
Sugar cane: brown rust (Puccinia melanocephala), etc .;
Corn: Gloeocercospora sorghi, Puccinia sorghi, Puccinia polysora, Ustilago maydis, Cochliobolus heterostrophus, Setosphaeria turcica, etc.;
Cotton: Seedling blight (Pythium sp.), Rust (Phakopsora gossypii), Mildew (Mycosphaerella areola), Anthrax (Glomerella gossypii), etc.
 本発明の農園芸用殺菌剤は、穀物類;野菜類;根菜類;イモ類;果樹類、茶、コーヒー、カカオなどの樹木類;牧草類;芝類;ワタなどの植物に対して用いることが好ましい。 The fungicide for agriculture and horticulture of the present invention is used for cereals; vegetables; root vegetables; potatoes; fruit trees, tea, coffee, cacao and other trees; pastures; turf; cotton and other plants. Is preferable.
 本発明の農園芸用殺菌剤は、植物類の各部位、たとえば、葉、茎、柄、花、蕾、果実、種子、スプラウト、根、塊茎、塊根、苗条、挿し木などに施用することができる。また、これら植物類の改良品種・変種、栽培品種、さらには突然変異体、ハイブリッド体、遺伝子組み換え体(GMO)を対象とすることもできる。 The agricultural and horticultural fungicides of the present invention can be applied to various parts of plants, for example, leaves, stems, stalks, flowers, buds, fruits, seeds, sprouts, roots, stems, roots, shoots, cuttings and the like. .. In addition, improved varieties / varieties of these plants, cultivars, mutants, hybrids, and genetically modified organisms (GMOs) can also be targeted.
 本発明の農園芸用殺菌剤は、花卉、芝、牧草を含む農園芸作物に発生する種々の病害の防除をするために行われる種子処理、茎葉散布、土壌施用、水面施用などに使用することができる。 The fungicide for agricultural and horticultural use of the present invention is used for seed treatment, foliage spraying, soil application, water surface application, etc., which are performed to control various diseases occurring in agricultural and horticultural crops including flowers, turf, and grass. Can be done.
 本発明の農園芸用殺菌剤は、本発明のチエノピリミジン化合物以外の成分を含有してもよい。他の成分として、製剤化のために使用する公知の担体などを挙げることができる。また、他の成分として、従来公知の、殺菌剤、殺虫・殺ダニ剤、殺線虫剤、殺土壌害虫剤、植物調節剤、共力剤、肥料、土壌改良剤、動物用飼料などを挙げることができる。このような他の成分を含有することによって、相乗効果を奏することがある。 The agricultural and horticultural fungicide of the present invention may contain components other than the thienopyrimidine compound of the present invention. Examples of other components include known carriers used for formulation. In addition, as other components, conventionally known fungicides, insecticides / acaricides, nematode insecticides, soil pesticides, plant regulators, synergists, fertilizers, soil conditioners, animal feeds and the like can be mentioned. be able to. By containing such other components, a synergistic effect may be produced.
 本発明の農園芸用殺菌剤と混用又は併用することができる、殺菌剤の具体例を以下に示す。
(1)核酸生合成阻害剤:
 (a)RNAポリメラーゼI阻害剤:ベナラキシル、ベナラキシル-M、フララキシル、メタラキシル、メタラキシル-M;オキサジキシル;クロジラコン、オフレース;
 (b)アデノシンデアミナーゼ阻害剤:ブピリメート、ジメチリモール、エチリモール;
 (c)DNA/RNA合成阻害剤:ヒメキサゾール、オクチリノン;
 (d)DNAトポイソメラーゼII阻害剤:オキソリン酸。
Specific examples of the fungicide that can be mixed or used in combination with the agricultural and horticultural fungicide of the present invention are shown below.
(1) Nucleic acid biosynthesis inhibitor:
(A) RNA polymerase I inhibitor: Benalaxil, Benalaxil-M, Flaluxil, Metalaxil, Metalaxil-M; Oxadixil; Closilacon, Offrace;
(B) Adenosine deaminase inhibitors: bupirimate, dimethilimol, etilimol;
(C) DNA / RNA synthesis inhibitors: himexazole, octinenone;
(D) DNA topoisomerase II inhibitor: oxolinic acid.
(2)有糸核分裂阻害剤及び細胞分裂阻害剤:
 (a)β-チューブリン重合阻害剤:ベノミル、カルベンダジム、クロルフェナゾール、フベリダゾール、チアベンダゾール;チオファネート、チオファネートメチル;ジエトフェンカルブ;ゾキサミド;エタボキサム;
 (b)細胞分裂阻害剤:ペンシクロン;
 (c)スペクトリン様タンパク質の非局在化阻害剤:フルオピコリド。
(2) Mitotic and fission inhibitors:
(A) β-tubulin polymerization inhibitor: benomyl, carbendazim, chlorphenazole, fuberidazole, thiabendazole; thiophanate, thiophanate-methyl; dietofencarb; zoxamide; etaboxam;
(B) Cell division inhibitor: pencyclon;
(C) Inhibitor of spectrin-like protein delocalization: fluoricolide.
(3)呼吸阻害剤:
 (a)複合体I-NADH酸化還元酵素阻害剤:ジフルメトリム;トルフェンピラド;
 (b)複合体II-コハク酸脱水素酵素阻害剤:ベノダニル、フルトラニル、メプロニル;イソフェタミド;フルオピラム;フェンフラム、フルメシクロックス;カルボキシン、オキシカルボキシン;チフルザミド;ベンゾビンジフルピル、ビキサフェン、フルキサピロキサド、フラメトピル、イソピラザム、ペンフルフェン、ペンチオピラド、セダキサン;ボスカリド、ピジフルメトフェン、イソフルシフラム、ピラジフルミド、インピルフルキサム(inpyrfluxam);
 (c)複合体III-ユビキノールオキシダーゼQo阻害剤:アゾキシストロビン、クモキシストロビン、クメトキシストロビン、エノキサストロビン、フルフェノキシストロビン、ピコキシストロビン、ピラオキシストロビン;ピラクロストロビン、ピラメトストロビン、トリクロピリカルブ;クレソキシム-メチル、トリフロキシストロビン;ジモキシストロビン、フェナミンストロビン、メトミノストロビン、オリサストロビン;ファモキサドン;フルオキサストロビン;フェンアミドン;ピリベンカルブ;メチルテトラプロール;マンデストロビン;
 (d)複合体III-ユビキノール還元酵素Qi阻害剤:シアゾファミド;アミスルブロム;フェンピコキサミド
 (e)酸化的リン酸化の脱共役剤:ビナパクリル、メプチルジノカップ、ジノカップ;フルアジナム;フェリムゾン;
 (f)酸化的リン酸化阻害剤(ATP合成酵素の阻害剤):フェンチンアセテート、塩化フェンチン、水酸化フェンチン;
 (g)ATP生産阻害剤:シルチオファム;
 (h)複合体III:シトクロームbc1(ユビキノン還元酵素)のQx(未知)阻害剤:アメトクトラジン。
(3) Respiratory inhibitor:
(A) Complex I-NADH Oxidoreductase Inhibitor: Diflumetrim; Torfenpyrad;
(B) Complex II-succinate dehydrogenase inhibitors: benodanyl, flutranyl, mepronil; isofetamide; fluopirum; fenfurum, flumecyclox; carboxin, oxycarboxyne; tifluzamide; benzobindiflupill, bixaphen, fluxapiroki Sad, flametopil, isopyrazam, penflufen, penthiopyrado, sedaxan; boscalide, pidiflumethofen, isoflusifram, pyraziflumid, impylfurxam;
(C) Complex III-ubiquinol oxidase Qo inhibitors: azoxystrobin, spumoxystrobin, kumethoxystrobin, enoxastrobin, fluphenoxystrobin, picoxystrobin, pyraoxystrobin; pyracrostrobin , Pyrametostrobin, triclopyricalve; cresoxime-methyl, trifloxystrobin; dymoxystrobin, phenaminestrobin, metminostrobin, orythastrobin; famoxadon; fluoroxastrobin; phenamiden; pyribenecarb; methyltetraprol; man Destrobin;
(D) Complex III-Ubiquinol Reductase Qi Inhibitor: Siazofamide; Amisulbrom; Fempicoxamide (e) Decoupling agent for oxidative phosphorylation: Binapacryl, Meptyldinocup, Dinocup; Fluazinum; Felimzone;
(F) Oxidative phosphorylation inhibitor (inhibitor of ATP synthase): fentin acetate, fentin chloride, fentin hydroxide;
(G) ATP production inhibitor: silthiofam;
(H) Complex III: Qx (unknown) inhibitor of cytochrome bc1 (ubiquinone reductase): amethoctrazine.
(4)アミノ酸及びタンパク質合成阻害剤:
 (a)メチオニン生合成阻害剤:アンドプリム、シプロジニル、メパニピリム、ピリメタニル;
 (b)タンパク質合成阻害剤:ブラストサイジン-S、カスガマイシン、カスガマイシン塩酸塩、ストレプトマイシン、オキシテトラサイクリン。
(4) Amino acid and protein synthesis inhibitors:
(A) Methionine biosynthesis inhibitors: andprim, cyprodinyl, mepanipyrim, pyrimethanyl;
(B) Protein synthesis inhibitor: Blasticidin-S, casugamycin, casugamycin hydrochloride, streptomycin, oxytetracycline.
(5)シグナル伝達阻害剤:
 (a)シグナル伝達阻害剤: キノキシフェン、プロキナジド;
 (b)浸透圧シグナル伝達におけるMAP・ヒスチジンキナーゼ阻害剤:フェンピクロニル、フルジオキソニル;クロゾリネート、イプロジオン、プロシミドン、ビンクロゾリン。
(5) Signal transduction inhibitor:
(A) Signal transduction inhibitors: quinoxyphen, proquinazide;
(B) MAP / histidine kinase inhibitors in osmotic signaling: fenpicronyl, fludioxonyl; clozolinate, iprodion, procymidone, vinclozoline.
(6)脂質及び細胞膜合成阻害剤:
 (a)りん脂質生合成、メチルトランスフェラーゼ阻害剤:エジフェンホス、イプロベンホス、ピラゾホス;イソプロチオラン;
 (b)脂質の過酸化剤:ビフェニル、クロロネブ、ジクロラン、キンドゼン、テクナゼン、トルクロホスメチル;エトリジアゾール;
 (c)細胞膜に作用する剤:ヨードカルブ、プロパモカルブ、プロパモカルブ塩酸塩、プロパモカルブホセチレート、プロチオカルブ;
 (d)病原菌細胞膜を撹乱する微生物:バチルスズブチリス菌、バチルスズブチリスQST713株、バチルスズブチリスFZB24株、バチルスズブチリスMBI600株、バチルスズブチリスD747株;
 (e)細胞膜を撹乱する剤:ゴセイカユプテ(ティーツリー)の抽出物。
(6) Lipid and cell membrane synthesis inhibitor:
(A) Phospholipid biosynthesis, methyltransferase inhibitor: edifenephos, iprobenphos, pyrazophos; isoprothiolane;
(B) Lipid oxidizers: biphenyl, chloroneb, dichloran, kinden, technazen, turquophosmethyl; etridiazole;
(C) Agents acting on cell membranes: iodocarb, propamocarb, propamocarb hydrochloride, propamocarb hosetylate, prothiocarb;
(D) Pathogens Microorganisms that disrupt cell membranes: Bacillus subtilis, Bacillus subtilis QST713, Bacillus subtilis FZB24, Bacillus subtilis MBI600, Bacillus subtilis D747;
(E) Agent that disturbs cell membranes: Extract of Gosei Kayupte (tea tree).
(7)細胞膜のステロール生合成阻害剤:
 (a)ステロール生合成におけるC14位の脱メチル化阻害剤:トリホリン;ピリフェノックス、ピリソキサゾール;フェナリモル、フルルプリミドール、ヌアリモル;イマザリル、イマザリル硫酸塩、オキスポコナゾール、ペフラゾエート、プロクロラズ、トリフルミゾール、ビニコナゾール;アザコナゾール、ビテルタノール、ブロムコナゾール、シプロコナゾール、ジクロブトラゾール、ジフェノコナゾール、ジニコナゾール、ジニコナゾール-M、エポキシコナゾール、エタコナゾール、フェンブコナゾール、フルキンコナゾール、フルシラゾール、フルトリアホール、フルコナゾール、フルコナゾール-シス、ヘキサコナゾール、イミベンコナゾール、イプコナゾール、メトコナゾール、ミクロブタニル、ペンコナゾール、プロピコナゾール、フルキンコナゾール、シメコナゾール、テブコナゾール、テトラコナゾール、トリアジメホン、トリアジメノール、トリチコナゾール;プロチオコナゾール、ボリコナゾール、メフェントリフルコナゾール;
 (b)ステロール生合成におけるΔ14還元酵素及びΔ8→Δ7-イソメラーゼの阻害剤:アルジモルフ、ドデモルフ、ドデモルフ酢酸塩、フェンプロピモルフ、トリデモルフ;フェンプロピジン、ピペラリン;スピロキサミン;
 (c)ステロール生合成系のC4位脱メチル化における3-ケト還元酵素阻害剤:フェンヘキサミド;フェンピラザミン;
 (d)ステロール生合成系のスクワレンエポキシダーゼ阻害剤:ピリブチカルブ;ナフチフィン、テルビナフィン。
(7) Cell membrane sterol biosynthesis inhibitor:
(A) Demethylation inhibitor at position C14 in sterol biosynthesis: trifoline; pyriphenox, pyrisoxazole; phenalimol, fluconazole, nuarimol; imazalyl, imazalyl sulfate, oxypoconazole, pefrazoate, prochloraz, fluconazole , Biniconazole; azaconazole, bitertanol, bromconazole, cyproconazole, diclobutrazole, diphenoconazole, diniconazole, diniconazole-M, epoxyconazole, etaconazole, fenbuconazole, fluconazole, fluconazole, fluconazole Fluconazole-cis, hexaconazole, imibenconazole, ipconazole, metconazole, microbutanyl, penconazole, propiconazole, fluconazole, simeconazole, tebuconazole, tetraconazole, triazimephone, triazimenol, triticonazole; prothioconazole, Voriconazole, mefentrifluconazole;
(B) Inhibitors of Δ14 reductase and Δ8 → Δ7-isomerase in sterol biosynthesis: aldimorph, dodemorph, dodemorph acetate, fenpropimorph, tridemorph; fenpropidine, piperarin; spiroxamine;
(C) 3-keto reductase inhibitor in C4 demethylation of sterol biosynthesis system: fenhexamide; fenpyrazamine;
(D) Squalene epoxidease inhibitor of sterol biosynthesis system: pyribuchicarb; naftifine, terbinafine.
(8)細胞壁合成阻害:
 (a)トレハラーゼ阻害剤:バリダマイシン;
 (b)キチン合成酵素阻害剤:ポリオキシン、ポリオクソリム;
 (c)セルロース合成酵素阻害剤:ジメトモルフ、フルモルフ、ピリモルフ;ベンチアバリカルブ、イプロバリカルブ、バリフェナレート;マンジプロパミド。
(8) Inhibition of cell wall synthesis:
(A) Trehalase inhibitor: validamycin;
(B) Chitin synthase inhibitors: polyoxine, polyoxolim;
(C) Cellulose Synthetic Enzyme Inhibitors: Dimethmorph, Fulmorph, Pyrimorph; Bench Avaricarb, Iprovaricarb, Variphenalate; Mandipropamide.
(9)メラニン生合成阻害剤
 (a)メラニン生合成の還元酵素阻害剤:フサライド;ピロキロン;トリシクラゾール;
 (b)メラニン生合成の脱水酵素阻害剤:カルプロパミド;ジクロシメット;フェノキサニル;
 (c)メラニン生合成のポリケタイド合成阻害剤:トルプロカルブ。
(9) Melanin biosynthesis inhibitor (a) Melanin biosynthesis reductase inhibitor: fusalide; pyrokyron; tricyclazole;
(B) Dehydrating enzyme inhibitor for melanin biosynthesis: calpropamide; diclosimet; phenoxanyl;
(C) Inhibitor of melanin biosynthesis polyketide synthesis: toluprocarb.
(10)宿主植物の抵抗性誘導剤:
 (a)サリチル酸合成経路に作用する剤:アシベンゾラル-S-メチル;
 (b)その他:プロベナゾール、チアジニル、イソチアニル、ジクロベンチアゾクス、ラミナリン、オオイタドリ抽出液。
(10) Host plant resistance inducer:
(A) Agent acting on the salicylic acid synthesis pathway: acibenzolar-S-methyl;
(B) Others: probenazole, thiazinyl, isothianil, diclobenazox, laminarin, Reynoutria sachalinensis extract.
(11)作用性が不明な剤:シモキサニル、ホセチルアルミニウム、リン酸(リン酸塩)、テクロフタラム、トリアゾキシド、フルスルファミド、ジクロメジン、メタスルホカルブ、シフルフェナミド、メトラフェノン、ピリオフェノン、ドジン、ドジン遊離塩基、フルチアニル。 (11) Agents of unknown activity: simoxanyl, Josetylaluminum, phosphate (phosphate), tecrophthalam, triazoxide, flusulfamide, dichromedin, metasulfocarb, ciflufenamide, metrafenone, pyriophenone, dodine, dodine free base, fluthianyl.
(12)多作用点を有する剤:銅(銅塩)、ボルドー液、水酸化銅、銅ナフタレート、酸化銅、オキシ塩化銅、硫酸銅、硫黄、硫黄製品、多硫化カルシウム;ファーバム、マンコゼブ、マネブ、マンカッパー、メチラム、ポリカーバメート、プロピネブ、チラム、ジネブ、ジラム;キャプタン、カプタホール、フォルペット;クロロタロニル;ジクロフルアニド、トリルフルアニド;グアザチン、イミノクタジン酢酸塩(iminoctadine triacetate)、イミノクタジンアルベシル酸塩(iminoctadine trialbesilate);アニラジン;ジチアノン;キノメチオネート;フルオルイミド。 (12) Agents having multiple points of action: copper (copper salt), Bordeaux solution, copper hydroxide, copper naphthalate, copper oxide, copper oxychloride, copper sulfate, sulfur, sulfur products, calcium polysulfide; ferbum, mancozeb, maneb, Mancopper, methylam, polycarbamate, propineb, tiram, dineb, dilam; captan, captahole, folpet; chlorotalonyl; diclofluanide, trillfluanide; guazatin, iminoctadine acetate, iminoctadine albesilate (iminoctadine) trialbesilate); anilazine; dithianone; quinomethionate; fluorimide.
(13)その他の剤: DBEDC、フルオロフォルペット、グアザチンアセテート、ビス(8-キノリノラト)銅(II)、プロパミジン、クロロピクリン、シプロフラム、アグロバクテリウム、ベトキサジン、ジフェニルアミン、メチルイソチアネート(MITC)、ミルデオマイシン、カプサイシン、クフラネブ、シプロスルファミド、ダゾメット、デバカルブ、ジクロロフェン、ジフェンゾクワット、ジフェンゾクワットメチルスルホネート、フルメトベル、ホセチルカルシウム、ホセチルナトリウム、イルママイシン、ナタマイシン、ニトロタールイソプロピル、オキサモカルブ、ピロールニトリン、テブフロキン、トルニファニド、ザリラミド、アルゴフェーズ(Algophase)、アミカルチアゾール(Amicarthiazol)、オキサチアピプロリン(Oxathiapiprolin)、メチラム亜鉛、ベンチアゾール、トリクラミド、ユニコナゾール、ミルデオマイシン、オキシフェンチイン(Oxyfenthiin)、ピカルブトラゾクス(Picarbutrazox)、キノフメリン(Quinofumelin)、フロリルピコキサミド(Florylpicoxamid)、ピラプロポイン(Pyrapropoyne)、フルインダピル(Fluindapyr)、アミノピリフェン(Aminopyrifen)、ピリダクロメチル(pyridachlomethyl)、イプフルフェノキン(ipflufenoquin)。 (13) Other agents: DBEDC, fluorofolpet, guazatin acetate, bis (8-quinolinolato) copper (II), propamidin, chloropyrrolnitrin, cyprofram, agrobacterium, betoxazine, diphenylamine, methylisothianate (MITC) ), Mildeomycin, Capsaicin, Cufraneb, Ciprosulfamide, Dazomet, Devacarb, Dichlorophene, Diphenzoquat, Difenzoquat Methylsulfonate, Flumetbel, Josetil Calcium, Josetyl Sodium, Irmamycin, Natamicin, Nitrotal Isopropyl , Oxamocarb, pyrrolnitrin, tevflokin, tornifanide, zariramid, algophase, Amicarthiazol, oxathiapiprolin, methylamzinc, benchazole, tricramide, uniconazole, myldeomycin, oxyphene Oxyfenthiin, Picarbutrazox, Quinofumelin, Florylpicoxamid, Pyrapropoyne, Fluindapyr, Aminopyrifen, pyridalomethyl , Ipflufenoquin.
 本発明の農園芸用殺菌剤と混用又は併用することができる、殺虫・殺ダニ剤、殺線虫剤、殺土壌害虫剤、駆虫剤などの具体例を以下に示す。 Specific examples of insecticides / acaricides, nematodes, soil pesticides, anthelmintics, etc. that can be mixed or used in combination with the agricultural and horticultural fungicides of the present invention are shown below.
(1)アセチルコリンエステラーゼ阻害剤:
 (a)カーバメート系:アラニカルブ、アルジカルブ、ベンジオカルブ、ベンフラカルブ、ブトカルボキシム、ブトキシカルボキシム、カルバリル、カルボフラン、カルボスルファン、エチオフェンカルブ、フェノブカルブ、ホルメタネート、フラチオカルブ、イソプロカルブ、メチオカルブ、メソミル、オキサミル、ピリミカルブ、プロポキスル、チオジカルブ、チオファノックス、トリアザメート、トリメタカルブ、XMC、キシリルカルブ、フェノチオカルブ、MIPC、MPMC、MTMC、アルドキシカルブ、アリキシカルブ、アミノカルブ、ブフェンカルブ、クロエトカルブ、メタム・ナトリウム、プロメカルブ;
(1) Acetylcholinesterase inhibitor:
(A) Carbamates: Aranicalb, Aldicarb, Bengiocarb, Benfracarb, Butocarboxim, Butoxycarboxim, Carbaryl, Carbofuran, Carbosulfan, Ethiophenacarb, Phenoccarb, Formanate, Frathiocarb, Isoprocarb, Methiocarb, Methomyl, Oxamil, Pyrimicarb, Propoxyl, Thiodicarb, thiofanox, triazamate, trimetacarb, XMC, xylylcarb, phenothiocarb, MIMOC, MPMC, MTMC, aldicarb, alixicalve, aminocarb, butocarboxim, chlorocarb, metam sodium, promecarb;
 (b)有機リン系: アセフェート、アザメチホス、アジンホス-エチル、アジンホス-メチル、カズサホス、クロルエトキシホス、クロルフェンビンホス、クロルメホス、クロルピリホス、クロルピリホス-メチル、クマホス、シアノホス、デメトン-S-メチル、ダイアジノン、ジクロルボス/DDVP、ジクロトホス、ジメトエート、ジメチルビンホス、ジスルホトン、EPN、エチオン、エトプロホス、ファムフール、フェナミホス、フェニトロチオン、フェンチオン、ホスチアゼート、ヘプテノホス、イミシアホス、イソフェンホス、イソカルボホス、イソキサチオン、マラチオン、メカルバム、メタミドホス、メチダチオン、メビンホス、モノクロトホス、ナレド、オメトエート、オキシジメトン-メチル、パラチオン、パラチオン-メチル、フェントエート、ホレート、ホサロン、ホスメット、ホスファミドン、ホキシム、ピリミホス-メチル、プロフェノホス、プロペタムホス、プロチオホス、ピラクロホス、ピリダフェンチオン、キナルホス、スルホテップ、テブピリンホス、テメホス、テルブホス、テトラクロルビンホス、チオメトン、トリアゾホス、トリクロルホン、バミドチオン;ブロモホス・エチル、BRP、カルボフェノチオン、シアノフェンホス、CYAP、デメトン-S-メチルスルホン、ジアリホス、ジクロフェンチオン、ジオキサベンゾホス、エトリムホス、フェンスルホチオン、フルピラゾホス、ホノホス、ホルモチオン、ホスメチラン、イサゾホス、ヨードフェンホス、メタクリホス、ピリミホス-エチル、ホスホカルブ、プロパホス、プロトエート、スルプロホス。 (B) Organophosphorus: acephate, azamethifos, azinephos-ethyl, azinephos-methyl, kazusaphos, chlorethoxyphos, chlorpyrifos, chlormephos, chlorpyrifos, chlorpyrifos-methyl, bearphos, cyanophos, demeton-S-methyl, diazinone, Dichlorvos / DDVP, Dichlorpyrifos, Dimethoate, Dimethylbinphos, Disulfoton, EPN, Ethion, Etoprophos, Famfur, Fenamiphos, Fenitrothione, Fention, Hostiazeto, Heptenophos, Imiciaphos, Isophenphos, Isocarbofos, Isoxathione, Malathion, Mecarbammid Monochrometophos, Nared, Omethoate, Oxydimethoate-Methyl, Palathion, Palatin-Methyl, Fentate, Holate, Hosalon, Hosmet, Phosphamide, Hoxim, Pyrimiphos-Methyl, Prophenofus, Propetamphos, Prothiophos, Pyraclophos, Pyridafenthion, Kinalphos, Sulfotep Temephos, terbuphos, tetrachlorvos, thiometon, triazophos, trichlorfon, bamidthione; bromophos ethyl, BRP, carbophenothione, cyanophenphos, CYAP, demeton-S-methylsulfos, dichlorpyrifos, dichlorphenthione, dioxabenzophos, ethis , Fensulfothione, flupyrifos, honophos, formotione, phosmethilan, isazophos, iodophenphos, methacryphos, pyrimiphos-ethyl, phosphocarbs, propaphos, protoate, sulprophos.
(2)GABA-作動性塩素イオンチャネルアンタゴニスト:アセトプロール、クロルデン、エンドスルファン、エチプロール、フィプロニル、ピラフルプロール、ピリプロール、カンフェクロル、ヘプタクロル、ジエノクロル。
(3)ナトリウムチャンネルモジュレーター:アクリナトリン、d-シス-トランス アレスリン、d-トランスアレスリン、ビフェントリン、ビオアレスリン、ビオアレスリンS-シクロペンチル異性体、ビオレスメトリン、シクロプロトリン、シフルトリン、ベータ-シフルトリン、シハロトリン、ラムダ-シハロトリン、ガンマ-シハロトリン、シペルメトリン、アルファ-シペルメトリン、ベータ-シペルメトリン、シータ-シペルメトリン、ゼータ-シペルメトリン、シフェノトリン[(1R)-トランス異性体]、デルタメトリン、エンペントリン[(EZ)-(1R)-異性体]、エスフェンバレレート、エトフェンプロックス、フェンプロパトリン、フェンバレレート、フルシトリネート、フルメトリン、タウ-フルバリネート、ハルフェンプロックス、イミプロトリン、カデスリン、ペルメトリン、フェノトリン[(1R)-トランス異性体]、プラレトリン、ピレスラム、レスメトリン、シラフルオフェン、テフルスリン、テトラメトリン[(1R)-異性体]、トラロメトリン、トランスフルトリン、アレスリン、ピレトリン、ピレトリンI、ピレトリンII、プロフルトリン、ジメフルトリン、ビオエタノメトリン、ビオペルメトリン、トランスペルメトリン、フェンフルトリン、フェンピリトリン、フルブロシトリネート、フルフェンプロックス、メトフルトリン、プロトリフェンブト、ピレスメトリン、テラレトリン。
(2) GABA-operated chlorine ion channel antagonists: acetoprol, chlordane, endosulfan, ethiprol, fipronil, pilafprowl, pyriprol, campechlor, heptachlor, dienochlor.
(3) Sodium channel modulators: acrinathrin, d-cis-trans-allethrin, d-trans-allethrin, bifentrin, bioallethrin, bioarethrin S-cyclopentyl isomer, bioresmethrin, cycloprothrin, cifluthrin, beta-cifluthrin, sihalothrin, lambda- Cihalothrin, Gamma-Pyrethrin, Cipermethrin, Alpha-Permethrin, Beta-Cipermethrin, Theta-Permethrin, Zeta-Cipermethrin, Ciphenothrin [(1R) -trans isomer], Deltamethrin, Empentrin [(EZ)-( 1R) -isomer], esphenvalerate, etofenprox, fenpropatrin, fenvalerate, flucitrinate, flumethrin, tau-fluvalinate, halphenprox, imiprothrin, cadesrin, permethrin, phenotrin [(1R) -trans Heterogeneous], Praletrin, Pyrethrum, Resmethrin, Silafluofen, Tefluthrin, Tetramethrin [(1R) -isomer], Tralomethrin, Transfluthrin, Allethrin, Pyrethrin, Pyrethrin I, Pyrethrin II, Profluthrin, Dimefluthrin, Bioethanomethrin Permethrin, transpermethrin, fenfluthrin, fenpyritrin, flubrocitrinate, flufenprox, metoflutrin, protrifenbut, pyrethrin, terraretrin.
(4)ニコチン性アセチルコリン受容体アゴニスト:アセタミプリド、クロチアニジン、ジノテフラン、イミダクロプリド、ニテンピラム、ニチアジン、チアクロプリド、チアメトキサム、スルフォキサフロール、ニコチン、フルピラジフロン。
(5)ニコチン性アセチルコリン受容体アロステリックモジュレーター:スピネトラム、スピノサド。
(6)クロライドチャンネル活性化剤:アバメクチン、エマメクチン安息香酸塩、レピメクチン、ミルベメクチン;イベルメクチン、セラメクチン、ドラメクチン、エプリノメクチン、モキシデクチン、ミルベマイシン、ミルベマイシンオキシム、ネマデクチン。
(7)幼若ホルモン様物質:ヒドロプレン、キノプレン、メソプレン、フェノキシカルブ、ピリプロキシフェン;ジオフェノラン、エポフェノナン、トリプレン。
(8)その他非特異的阻害剤:臭化メチル、クロルピクリン、フッ化スルフリル、ホウ砂、吐酒石。
(9)同翅目選択的摂食阻害剤:フロニカミド、ピメトロジン、ピリフルキナゾン。
(4) Nicotinic acetylcholine receptor agonists: acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, nithiazine, thiacloprid, thiamethoxam, sulfoxaflor, nicotine, flupyradiflon.
(5) Nicotinic acetylcholine receptor allosteric modulator: spinetram, spinosad.
(6) Chloride channel activator: abamectin, emamectin benzoate, repimectin, milbemectin; ivermectin, selamectin, dramectin, eprinomectin, moxidectin, milbemycin, milbemycin oxime, nemadetin.
(7) Juvenile hormone-like substances: hydroprene, quinoprene, mesoprene, phenoxycarb, pyriproxyfen; diophenolan, epophenonan, triprene.
(8) Other non-specific inhibitors: methyl bromide, chloropicrin, sulfuryl fluoride, borax, liquor stone.
(9) Diptera selective feeding inhibitors: fronicamid, pimetrodin, pyrifluquinazone.
(10)ダニ類生育阻害剤:クロフェンテジン、ジフロビダジン、ヘキシチアゾクス、エトキサゾール。
(11)微生物由来昆虫中腸内膜破壊剤:バチルス・チューリンゲンシス亜種イスラエレンシ、バチルス・スファエリクス、バチルス・チューリンゲンシス亜種アイザワイ、バチルス・チューリンゲンシス亜種クルスタキ、バチルス・チューリンゲンシス亜種テネブリオニス、Bt作物タンパク質(Cry1Ab、Cry1Ac、Cry1Fa、Cry1A.105、Cry2Ab、Vip3A、mCry3A、Cry3Ab、Cry3Bb、Cry34Ab1/Cry35Ab1)。
(12)ミトコンドリアATP生合成酵素阻害剤:ジアフェンチウロン、アゾシクロチン、シヘキサチン、酸化フェンブタスズ、プロパルギット、テトラジホン。
(13)酸化的リン酸化脱共役剤:クロルフェナピル、スルフラミド、DNOC、ビナパクリル、ジノブトン、ジノカップ。
(14)ニコチン性アセチルコリン受容体チャンネルブロッカー:ベンスルタップ、カルタップ塩酸塩;ネライストキシン;チオスルタップ一ナトリウム塩、チオシクラム。
(15)キチン合成阻害剤:ビストリフルロン、クロルフルアズロン、ジフルベンズロン、フルシクロクスロン、フルフェノクスロン、ヘキサフルムロン、ルフェヌロン、ノバルロン、ノビフルムロン、テフルベンズロン、トリフルムロン、ブプロフェジン、フルアズロン。
(16)双翅目脱皮かく乱剤:シロマジン。
(17)脱皮ホルモン受容体アゴニスト:クロマフェノジド、ハロフェノジド、メトキシフェノジド、テブフェノジド。
(18)オクトパミン受容体アゴニスト:アミトラズ、デミジトラズ、クロルジメホルム。
(19)ミトコンドリア電子伝達系複合体III阻害剤:アセキノシル、フルアクリピリム、ヒドラメチルノン。
(20)ミトコンドリア電子伝達系複合体I阻害剤:フェナザキン、フェンピロキシメート、ピリミジフェン、ピリダベン、テブフェンピラド、トルフェンピラド、ロテノン。
(10) Tick growth inhibitors: clofentezine, difluorovidazine, hexitiazox, etoxazole.
(11) Microbial-derived insect mid-intestinal membrane-destroying agent: Bacillus thuringiensis subspecies Isla Elenshi, Bacillus thuringiensis subspecies Isla Elenshi, Bacillus thuringensis subspecies Isawai, Bacillus thuringiensis subspecies Kurstaki, Bacillus thuringiensis subspecies Teneblionis, Bt Crop proteins (Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb, Cry34Ab1 / Cry35Ab1).
(12) Mitochondrial ATP biosynthetic enzyme inhibitor: diafentiurone, azocyclotin, cyhexatin, fenbutatin oxide, propargite, tetradiphon.
(13) Oxidative phosphorylation decoupling agent: chlorfenapyr, sulfamide, DNOC, binapacryl, dinobutone, dinocup.
(14) Nicotinic Acetylcholine Receptor Channel Blocker: Bensultap, Cartap Hydrochloride; Nelystoxin; Thiosultap Monosodium Salt, Thiocyclum.
(15) Chitin synthesis inhibitors: bistrifluron, chlorflubenzuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumron, lufenuron, novalron, nobiflumron, teflubenzuron, triflubenzuron, buprofezin, fluazuron.
(16) Diptera molting disturber: Cyromazine.
(17) Moulting hormone receptor agonists: chromaphenozide, halophenozide, methoxyphenozide, tebufenozide.
(18) Octopamine receptor agonists: Amitraz, Demiditraz, Chlordimeform.
(19) Mitochondrial electron transport chain complex III inhibitor: acequinosyl, fluacripirim, hydramethylnon.
(20) Mitochondrial electron transport chain complex I inhibitor: phenazakin, phenpyroximate, pyrimidiphen, pyridaben, tebufenpyrado, tolfenpyrad, rotenone.
(21)電位依存性ナトリウムチャネルブロッカー:インドキサカルブ、メタフルミゾン。
(22)アセチルCoAカルボキシラーゼ阻害剤:スピロジクロフェン、スピロメシフェン、スピロテトラマト。
(23)ミトコンドリア電子伝達系複合体IV阻害剤:リン化アルミニウム、リン化カルシウム、ホスフィン、リン化亜鉛、シアニド。
(24)ミトコンドリア電子伝達系複合体II阻害剤:シエノピラフェン、シフルメトフェン、ピフルブミド。
(25)リアノジン受容体モジュレーター:クロラントラニリプロール、シアントラニプロール、フルベンジアミド、シクラニリプロール、テトラニリプロール。
(26)混合機能オキシダーゼ阻害剤化合物:ピペロニルブトキシド。
(27)ラトロフィリン受容体作用薬:デプシペプチド、環状デプシペプチド、24員環状デプシペプチド、エモデプシド。
(28)その他の剤(作用機構が未知):アザジラクチン、ベンゾキシメート、ビフェナゼート、ブロモプロピレート、キノメチオネート、クリオライト、ジコホル、ピリダリル、ベンクロチアズ、硫黄、アミドフルメット、1,3-ジクロロプロペン、DCIP、フェニソブロモレート、ベンゾメート、メタアルデヒド、クロルベンジレート、クロチアゾベン、ジシクラニル、フェノキサクリム、フェントリファニル、フルベンジミン、フルフェナジン、ゴシップルア、ジャポニルア、メトキサジアゾン、石油、オレイン酸カリウム、テトラスル、トリアラセン、アフィドピロペン(afidopyropen)、フロメトキン、フルフィプロル(flufiprole)、フルエンスルフォン、メペルフルスリン、テトラメチルフルスリン、トラロピリル、ジメフルスリン、メチルネオデカンアミド、フルララネル、アフォキソラネル、フルキサメタミド、5-[5-(3,5-ジクロロフェニル)-5-トリフルオロメチル-4,5-ジヒドロイソオキサゾール-3-イル]-2-(1H-1,2,4-トリアゾール-1-イル)ベンゾニトリル(CAS:943137-49-3)、アシノナピル、ブロフラニリドその他のメタジアミド類。
(21) Voltage-gated sodium channel blockers: indoxacarb, metaflumisone.
(22) Acetyl-CoA carboxylase inhibitor: spirodiclophen, spiromesiphen, spirotetramato.
(23) Mitochondrial electron transport chain complex IV inhibitor: aluminum phosphide, calcium phosphide, phosphine, zinc phosphide, cyanide.
(24) Mitochondrial electron transport chain complex II inhibitor: sienopyraphen, siflumethofen, pifrubmid.
(25) Ryanodine receptor modulators: chloranthraniliprole, cyantraniliprole, flubendiamide, cyclaniliprole, tetraniliprole.
(26) Mixed Function Oxidase Inhibitor Compound: Piperonyl butoxide.
(27) Latrophilin receptor agonists: depsipeptide, cyclic depsipeptide, 24-membered cyclic depsipeptide, emodepside.
(28) Other agents (mechanism of action unknown): azadilactin, benzoximate, biphenazate, bromopropirate, quinomethionate, cryolite, dicoform, pyridalyl, bencrothias, sulfur, amide flumet, 1,3-dichloropropene, DCIP, Phenisobromolate, benzomate, metaldehyde, chlorbenzylate, clothiazoben, disicranyl, phenoxacrim, fentrifanyl, flubenzimine, flufenazine, gossiplua, japonilua, methoxadiazone, petroleum, potassium oleate, tetrasul, triazolesen, afidopyropen ), Fromotkin, flufiprole, fluensulphon, meperfluthrin, tetramethylfluthrin, traropyryl, dimefluthrin, methylneodecanamide, flularanel, afoxolanel, fluxametamide, 5- [5- (3,5-dichlorophenyl) -5-trifluoro Methyl-4,5-dihydroisoxazole-3-yl] -2- (1H-1,2,4-triazole-1-yl) benzonitrile (CAS: 943137-49-3), asinonapill, brofuranilide and other metaldehydes Kind.
(29)駆虫剤:
 (a)ベンズイミダゾール系:フェンベンダゾール、アルベンダゾール、トリクラベンダゾール、オキシベンダゾール、メベンダゾール、オクスフェンダゾール、パーベンダゾール、フルベンダゾール;フェバンテル、ネトビミン、チオファネート;チアベンダゾール、カンベンダゾール;
 (b)サリチルアニリド系:クロサンテル、オキシクロザニド、ラフォキサニド、ニクロサミド;
 (c)置換フェノール系:ニトロキシニル、ニトロスカネート;
 (d)ピリミジン系:ピランテル、モランテル;
 (e)イミダゾチアゾール系:レバミソール、テトラミソール;
 (f)テトラヒドロピリミジン系:プラジカンテル、エプシプランテル;
 (g)その他の駆虫薬:シクロジエン、リアニア、クロルスロン、メトロニダゾール、デミジトラズ;ピペラジン、ジエチルカルバマジン、ジクロロフェン、モネパンテル、トリベンジミジン、アミダンテル;チアセタルサミド、メロルサミン、アルセナマイド。
(29) Anthelmintic:
(A) Benzimidazole system: fenbendazole, albendazole, triclabendazole, oxybendazole, mebendazole, oxfendazole, perbendazole, flubendazole; fevantel, netobimin, thiophanate; thiabendazole, cambendazole;
(B) Salicylanilide system: closantel, oxyclozanide, lafoxanide, niclosamide;
(C) Substituted phenolic system: nitroxynyl, nitroscanate;
(D) Pyrimidines: Pyrantel, Morantel;
(E) Imidazothiazole type: levamisole, tetramisole;
(F) Tetrahydropyrimidines: Praziquantel, Epsiprantel;
(G) Other anthelmintics: cyclodiene, liania, chlorthrone, metronidazole, demiditraz; piperazine, diethylcarbamazine, dichlorophene, monepantel, tribendimidine, amidantel; thiacetalsamide, merolsamine, arsenamide.
 本発明の農園芸用殺菌剤と混用又は併用することができる、植物調節剤の具体例を以下に示す。
 アブシジン酸、カイネチン、ベンジルアミノプリン、1,3-ジフェニルウレア、ホルクロルフェヌロン、チジアズロン、クロルフェヌロン、ジヒドロゼアチン、ジベレリンA、ジベレリンA4、ジベレリンA7、ジベレリンA3、1-メチルシクロプロパン、N-アセチルアミノエトキシビニルグリシン(別名:アビグリシン)、アミノオキシ酢酸、硝酸銀、塩化コバルト、IAA、4-CPA、クロプロップ、2,4-D、MCPB、インドール-3-酪酸、ジクロルプロップ、フェノチオール、1-ナフチルアセトアミド、エチクロゼート、クロキシホナック、マレイン酸ヒドラジド、2,3,5-トリヨード安息香酸、サリチル酸、サリチル酸メチル、(-)-ジャスモン酸、ジャスモン酸メチル、(+)-ストリゴール、(+)-デオキシストリゴール、(+)-オロバンコール、(+)-ソルゴラクトン、4-オキソ-4-(2-フェニルエチル)アミノ酪酸;エテホン、クロルメコート、メピコートクロリド、ベンジルアデニン、5-アミノレブリン酸。
Specific examples of plant growth regulators that can be mixed or used in combination with the agricultural and horticultural fungicides of the present invention are shown below.
Abscisic acid, kinetin, benzylaminopurine, 1,3-diphenylurea, forchlorphenurone, tidiazulone, chlorphenuron, dihydrozeatin, gibberellin A, gibberellin A4, gibberellin A7, gibberellin A3, 1-methylcyclopropane, N-acetyl Aminoethoxyvinylglycine (also known as abscisic acid), aminooxyacetic acid, silver nitrate, cobalt chloride, IAA, 4-CPA, cloprop, 2,4-D, MCPB, indol-3-butyric acid, gibberellin, phenothiol, 1 -Naphtylacetamide, ethicrozeto, cloxyhonac, hydrazide maleate, 2,3,5-triiodobenzoic acid, salicylic acid, methyl salicylate, (-)-jasmonate, methyl jasmonate, (+)-strigol, (+) -Deoxystrigor, (+)-Orovancol, (+)-Solgolactone, 4-oxo-4- (2-phenylethyl) aminobutyric acid; etephon, chlormecoat, mepicote chloride, benzyladenin, 5-aminoleverellin.
〔製剤処方〕
 本発明の農園芸用殺菌剤は、剤形によって特に限定されない。たとえば、水和剤、乳剤、粉剤、粒剤、水溶剤、懸濁剤、顆粒水和剤、錠剤などの剤形を挙げることができる。製剤への調製方法は、特に制限されず、剤形に応じて公知の調製方法を採用することができる。
[Prescription]
The agricultural and horticultural fungicide of the present invention is not particularly limited depending on the dosage form. For example, dosage forms such as wettable powders, emulsions, powders, granules, aqueous solvents, suspensions, granule wettable powders, and tablets can be mentioned. The preparation method for the preparation is not particularly limited, and a known preparation method can be adopted depending on the dosage form.
 以下に、製剤実施例を若干示す。なお、以下に示す製剤処方は単なる例示であり、本発明の主旨に反しない範囲で修正することができ、本発明は以下の製剤実施例によって何ら制限されるものではない。「部」は特段の断りが無い限り「質量部」を意味する。 Some examples of formulations are shown below. It should be noted that the formulation formulation shown below is merely an example and can be modified without contrary to the gist of the present invention, and the present invention is not limited by the following formulation examples. "Part" means "part by mass" unless otherwise specified.
 (製剤例1:水和剤)
 本発明のチエノピリミジン化合物40部、珪藻土53部、高級アルコール硫酸エステル4部及びアルキルナフタレンスルホン酸塩3部を均一に混合して微細に粉砕して、有効成分40%の水和剤を得る。
(Formulation Example 1: Wettable powder)
40 parts of the thienopyrimidine compound of the present invention, 53 parts of diatomaceous earth, 4 parts of higher alcohol sulfate ester and 3 parts of alkylnaphthalene sulfonate are uniformly mixed and finely pulverized to obtain a wettable powder having 40% of the active ingredient.
 (製剤例2:乳剤)
 本発明のチエノピリミジン化合物30部、キシレン33部、ジメチルホルムアミド30部及びポリオキシエチレンアルキルアリルエーテル7部を混合し溶解させて、有効成分30%の乳剤を得る。
(Formulation Example 2: Emulsion)
30 parts of the thienopyrimidine compound of the present invention, 33 parts of xylene, 30 parts of dimethylformamide and 7 parts of polyoxyethylene alkylallyl ether are mixed and dissolved to obtain an emulsion containing 30% of the active ingredient.
 (製剤例3:粒剤)
 本発明のチエノピリミジン化合物5部、タルク40部、クレー38部、ベントナイト10部及びアルキル硫酸ソーダ7部を均一に混合し、微細に粉砕し、その後、粒子直径0.5~1.0mmに造粒して有効成分5%の粒剤を得る。
(Formulation Example 3: Granules)
5 parts of the thienopyrimidine compound of the present invention, 40 parts of talc, 38 parts of clay, 10 parts of bentonite and 7 parts of sodium alkyl sulfate are uniformly mixed, finely pulverized, and then formed into a particle diameter of 0.5 to 1.0 mm. Granules to obtain 5% active ingredient granules.
 (製剤例4:粒剤)
 本発明のチエノピリミジン化合物5部、クレー73部、ベントナイト20部、ジオクチルスルホサクシネートナトリウム塩1部及びリン酸カリウム1部を均一に混合し、粉砕した。これに水を加えてよく練り合せ、その後、造粒し、乾燥させて、有効成分5%の粒剤を得る。
(Formulation Example 4: Granules)
5 parts of the thienopyrimidine compound of the present invention, 73 parts of clay, 20 parts of bentonite, 1 part of sodium dioctyl sulfosuccinate and 1 part of potassium phosphate were uniformly mixed and pulverized. Water is added to this and kneaded well, and then granulated and dried to obtain a granule having 5% of the active ingredient.
 (製剤例5:懸濁剤)
 本発明のチエノピリミジン化合物10部、ポリオキシエチレンアルキルアリルエーテル4部、ポリカルボン酸ナトリウム塩2部、グリセリン10部、キサンタンガム0.2部及び水73.8部を混合し、粒度が3ミクロン以下になるまで湿式粉砕し、有効成分10%の懸濁剤を得る。
(Formulation Example 5: Suspension)
10 parts of the thienopyrimidine compound of the present invention, 4 parts of polyoxyethylene alkylallyl ether, 2 parts of polycarboxylic acid sodium salt, 10 parts of glycerin, 0.2 part of xanthan gum and 73.8 parts of water are mixed, and the particle size is 3 microns or less. Wet grind to obtain a suspension of 10% active ingredient.
 (製剤例6:顆粒水和剤)
 本発明のチエノピリミジン化合物40部、クレー36部、塩化カリウム10部、アルキルベンゼンスルホン酸ナトリウム塩1部、リグニンスルホン酸ナトリウム塩8部及びアルキルベンゼンスルホン酸ナトリウム塩のホルムアルデヒド縮合物5部を均一に混合して微細に粉砕後、適量の水を加えてから練り込んで粘土状にする。粘土状物を造粒し、次いで乾燥させて有効成分40%の顆粒水和剤を得る。
(Formulation Example 6: Granule wettable powder)
40 parts of thienopyrimidine compound of the present invention, 36 parts of clay, 10 parts of potassium chloride, 1 part of sodium alkylbenzene sulfonic acid salt, 8 parts of sodium lignin sulfonic acid salt and 5 parts of formaldehyde condensate of sodium alkylbenzene sulfonic acid salt are uniformly mixed. After finely crushing, add an appropriate amount of water and knead to make it clay-like. The clay-like material is granulated and then dried to obtain a granule wettable powder containing 40% of the active ingredient.
 次に、合成実施例を示し、本発明をより具体的に説明する。ただし、本発明は以下の合成実施例によって何ら制限されるものではない。 Next, a synthetic example will be shown, and the present invention will be described more specifically. However, the present invention is not limited by the following synthetic examples.
〔実施例1〕
3-(1-(2-(5-fluoro-2-methoxyphenyl)-2-hydroxyethyl)-6-((methoxyimino)methyl)-5-methyl-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)-N-isopropyl-2,2-dimethylpropanamideの合成
[Example 1]
3- (1- (2- (5-fluoro-2-methoxyphenyl) -2-hydroxyethyl) -6-((methoxyimino) methyl) -5-methyl-2,4-dioxo-1,4-dihydrothieno [2, 3-d] Synthesis of pyrimidin-3 (2H) -yl) -N-isopropyl-2,2-dimethylpropanamide
 (工程1)
Ethy1 3-(3-(tert-butoxy)-2,2-dimethyl-3-oxopropyl)-5-methyl-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidine-6-carboxylateの合成
(Step 1)
Ethy1 3-(3- (tert-butoxy) -2,2-dimethyl-3-oxopropyl) -5-methyl-2,4-dioxo-1,2,3,4-tetrahydrothieno [2,3-d] pyrimidine -6-carboxylate synthesis
Figure JPOXMLDOC01-appb-C000015
Figure JPOXMLDOC01-appb-C000015
 Diethyl 5-amino-3-methylthiophene-2,4-dicarboxylate(15g)を塩化メチレン(250ml)に溶解させ、氷冷下、トリホスゲン(5.85g)、トリエチルアミン(25ml)を加え室温にて2時間撹拌した後に、tert-butyl 3-amino-2,2-dimethylpropanoate(13g)を加え室温にて更に3時間撹拌した。反応液に飽和塩化アンモニウム水溶液を加え、クロロホルムで抽出、無水硫酸ナトリウムで乾燥した。溶媒を減圧留去し、得られた残渣をt-ブチルアルコール(180ml)に溶解させ、炭酸セシウム(39g)を加え80℃にて5時間撹拌した。反応液を濃縮し、飽和塩化アンモニウム水溶液を加え酢酸エチルで抽出、有機層を水、飽和食塩水で洗浄した後、無水硫酸ナトリウムで乾燥した。溶媒を減圧留去し、得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:クロロホルム/酢酸エチル)で精製し、目的化合物11.5gを得た。収率48%
 得られた目的物のH-NMRを以下に示す。
 1H-NMR (CDCl3) δ: 4.35 (2H, q), 4.19 (2H, s), 2.83 (3H, s), 1.45 (9H, s), 1.37 (3H, t), 1.20 (6H, s).
Diethyl 5-amino-3-methylthiophene-2,4-dicarboxylate (15 g) is dissolved in methylene chloride (250 ml), triphosgene (5.85 g) and triethylamine (25 ml) are added under ice cooling, and the mixture is stirred at room temperature for 2 hours. After that, tert-butyl 3-amino-2,2-dimethylpropanoate (13 g) was added, and the mixture was further stirred at room temperature for 3 hours. A saturated aqueous ammonium chloride solution was added to the reaction mixture, the mixture was extracted with chloroform, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, the obtained residue was dissolved in t-butyl alcohol (180 ml), cesium carbonate (39 g) was added, and the mixture was stirred at 80 ° C. for 5 hours. The reaction mixture was concentrated, saturated aqueous ammonium chloride solution was added, and the mixture was extracted with ethyl acetate. The organic layer was washed with water and saturated brine, and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: chloroform / ethyl acetate) to obtain 11.5 g of the target compound. Yield 48%
The 1 H-NMR of the obtained target product is shown below.
1 1 H-NMR (CDCl 3 ) δ: 4.35 (2H, q), 4.19 (2H, s), 2.83 (3H, s), 1.45 (9H, s), 1.37 (3H, t), 1.20 (6H, s) ).
 (工程2)
Ethyl 1-(2-(5-fluoro-2-methoxyphenyl)-2-oxoethyl)-3-(3-(isopropylamino)-2,2-dimethyl-3-oxopropyl)-5-methyl-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidine-6-carboxylateの合成
(Step 2)
Ethyl 1-(2- (5-fluoro-2-methoxyphenyl) -2-oxoethyl) -3- (3- (isopropylamino) -2,2-dimethyl-3-oxopropyl) -5-methyl-2,4-dioxo Synthesis of -1,2,3,4-tetrahydrothieno [2,3-d] pyrimidine-6-carboxylate
Figure JPOXMLDOC01-appb-C000016
Figure JPOXMLDOC01-appb-C000016
 Ethyl 3-(3-(tert-butoxy)-2,2-dimethyl-3-oxopropyl)-5-methyl-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidine-6-carboxylate(16.5g)をN,N-ジメチルホルムアミド(220ml)に溶解させ、氷冷下、炭酸カリウム(7.60g)、2-ブロモ-5’-フルオロ-2’-メトキシアセトフェノン(13.5g)を加え、室温にて3時間撹拌した。反応液に水を加え、生じた固体を濾過した。得られた固体を塩化メチレン(250ml)に溶解させ、トリフルオロ酢酸(25ml)を加え、室温にて一晩撹拌した。反応液を減圧濃縮し、塩化メチレン(230ml)、イソプロピルアミン(12g)、トリエチルアミン(11g)、2,4,6-トリプロピル-1,3,5,2,4,6-トリオキサトリホスホリナン-2,4,6-トリオキシド(50%酢酸エチル溶液、約1.7mol/L)40mlを加え室温にて一晩撹拌した。反応液に水を加え、クロロホルムで抽出、有機層を、水、1N HCl水溶液、飽和炭酸水素ナトリウム水溶液、飽和食塩水で洗浄した後、無水硫酸ナトリウムで乾燥した。溶媒を減圧留去し、得られた残渣をジエチルエーテルで洗浄し、目的化合物20gを得た。収率89% 得られた目的物のH-NMRを以下に示す。
 1H-NMR (CDCl3) δ: 7.64-7.61 (1H, m), 7.33-7.31 (1H, m), 7.04-7.01 (1H, m), 5.95 (1H, d), 5.30 (2H, s), 4.32 (2H, q), 4.23 (2H, s), 4.09-3.98 (1H, m), 4.03 (3H, s), 2.88 (3H, s), 1.34 (3H, t,), 1.23-1.10 (12H, m).
Ethyl 3-(3- (tert-butoxy) -2,2-dimethyl-3-oxopropyl) -5-methyl-2,4-dioxo-1,2,3,4-tetrahydrothieno [2,3-d] pyrimidine -6-carboxylate (16.5 g) was dissolved in N, N-dimethylformamide (220 ml), and under ice-cooling, potassium carbonate (7.60 g), 2-bromo-5'-fluoro-2'-methoxyacetophenone (. 13.5 g) was added, and the mixture was stirred at room temperature for 3 hours. Water was added to the reaction solution, and the resulting solid was filtered. The obtained solid was dissolved in methylene chloride (250 ml), trifluoroacetic acid (25 ml) was added, and the mixture was stirred overnight at room temperature. The reaction mixture was concentrated under reduced pressure, methylene chloride (230 ml), isopropylamine (12 g), triethylamine (11 g), 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphorinan. 40 ml of -2,4,6-trioxide (50% ethyl acetate solution, about 1.7 mol / L) was added, and the mixture was stirred overnight at room temperature. Water was added to the reaction solution, extracted with chloroform, and the organic layer was washed with water, 1N HCl aqueous solution, saturated sodium hydrogen carbonate aqueous solution, and saturated brine, and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure, and the obtained residue was washed with diethyl ether to obtain 20 g of the target compound. Yield 89% 1 1 H-NMR of the obtained target product is shown below.
1 1 H-NMR (CDCl 3 ) δ: 7.64-7.61 (1H, m), 7.33-7.31 (1H, m), 7.04-7.01 (1H, m), 5.95 (1H, d), 5.30 (2H, s) , 4.32 (2H, q), 4.23 (2H, s), 4.09-3.98 (1H, m), 4.03 (3H, s), 2.88 (3H, s), 1.34 (3H, t,), 1.23-1.10 ( 12H, m).
 (工程3)
 3-(1-(2-(5-fluoro-2-methoxyphenyl)-2-hydroxyethyl)-6-(hydroxymethyl)-5-methyl-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)-N-isopropyl-2,2-dimethylpropanamideの合成
(Step 3)
3- (1- (2- (5-fluoro-2-methoxyphenyl) -2-hydroxyethyl) -6- (hydroxymethyl) -5-methyl-2,4-dioxo-1,4-dihydrothieno [2,3-d] ] Synthesis of pyrimidin-3 (2H) -yl) -N-isopropyl-2,2-dimethylpropanamide
Figure JPOXMLDOC01-appb-C000017
Figure JPOXMLDOC01-appb-C000017
 Ethyl 1-(2-(5-fluoro-2-methoxyphenyl)-2-oxoethyl)-3-(3-(isopropylamino)-2,2-dimethyl-3-oxopropyl)-5-methyl-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidine-6-carboxylate(18g)をテトラヒドロフラン(150ml)、メタノール(150ml)に溶解させ、1N 水酸化ナトリウム水溶液(75ml)を加え室温にて4時間攪拌した。反応液を濃縮後、2N HCl水溶液(50ml)を加え酢酸エチルで抽出、有機層を水、飽和食塩水で洗浄した後、無水硫酸ナトリウムで乾燥した。溶媒を減圧留去し、得られた残渣をテトラヒドロフラン(250ml)に溶解させ、カルボニルジイミダゾール(6g)を加え室温で1時間攪拌した。水素化ホウ素ナトリウム(2.2g)を溶解させた水(250ml)に反応液を加え室温にて一晩攪拌した。反応液に飽和塩化アンモニウム水溶液を加え、酢酸エチルで抽出、有機層を水、飽和食塩水で洗浄した後、無水硫酸ナトリウムで乾燥した。溶媒を減圧留去し、得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)で精製し、目的化合物10.3gを得た。収率62%
 得られた目的物のH-NMRを以下に示す。
 1H-NMR (CDCl3) δ: 7.34-7.27 (1H, m), 6.96-6.79 (2H, m), 5.91 (1H, d), 5.47-5.41(1H, m), 4.77 (2H, s), 4.35-4.01 (5H, m), 3.89 (3H, s), 2.46 (3H, s), 1.28-1.16 (12H, m).
Ethyl 1-(2- (5-fluoro-2-methoxyphenyl) -2-oxoethyl) -3- (3- (isopropylamino) -2,2-dimethyl-3-oxopropyl) -5-methyl-2,4-dioxo -1,2,3,4-tetrahydrothieno [2,3-d] pyrimidine-6-carboxylate (18 g) is dissolved in tetrahydrofuran (150 ml) and methanol (150 ml), 1N aqueous sodium hydroxide solution (75 ml) is added, and room temperature Was stirred for 4 hours. The reaction mixture was concentrated, a 2N HCl aqueous solution (50 ml) was added, the mixture was extracted with ethyl acetate, the organic layer was washed with water and saturated brine, and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure, the obtained residue was dissolved in tetrahydrofuran (250 ml), carbonyldiimidazole (6 g) was added, and the mixture was stirred at room temperature for 1 hour. The reaction solution was added to water (250 ml) in which sodium borohydride (2.2 g) was dissolved, and the mixture was stirred overnight at room temperature. A saturated aqueous solution of ammonium chloride was added to the reaction solution, the mixture was extracted with ethyl acetate, the organic layer was washed with water and saturated brine, and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain 10.3 g of the target compound. Yield 62%
The 1 H-NMR of the obtained target product is shown below.
1 1 H-NMR (CDCl 3 ) δ: 7.34-7.27 (1H, m), 6.96-6.79 (2H, m), 5.91 (1H, d), 5.47-5.41 (1H, m), 4.77 (2H, s) , 4.35-4.01 (5H, m), 3.89 (3H, s), 2.46 (3H, s), 1.28-1.16 (12H, m).
 (工程4)
3-(1-(2-(5-fluoro-2-methoxyphenyl)-2-hydroxyethyl)-6-((methoxyimino)methyl)-5-methyl-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)-N-isopropyl-2,2-dimethylpropanamideの合成
(Step 4)
3- (1- (2- (5-fluoro-2-methoxyphenyl) -2-hydroxyethyl) -6-((methoxyimino) methyl) -5-methyl-2,4-dioxo-1,4-dihydrothieno [2, 3-d] Synthesis of pyrimidin-3 (2H) -yl) -N-isopropyl-2,2-dimethylpropanamide
Figure JPOXMLDOC01-appb-C000018
Figure JPOXMLDOC01-appb-C000018
3-(1-(2-(5-fluoro-2-methoxyphenyl)-2-hydroxyethyl)-6-(hydroxymethyl)-5-methyl-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)-N-isopropyl-2,2-dimethylpropanamide(2.6g)をクロロホルム(40ml)に溶解させ、二酸化マンガン(5g)を加え室温にて2時間撹拌した。反応液を濾過し、母液を濃縮して得られた残渣をエタノール(35ml)に溶解させピリジン(0.6g)、メトキシアミン塩酸塩(0.6g)を70℃で加え10分間攪拌した。反応液を減圧濃縮し、得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)で精製し、目的化合物2.3g(オキシム結合の立体配置E:Z=1:1の混合物)を得た。
 得られた目的物のH-NMRを以下に示す。
 1H-NMR (CDCl3) δ: 8.28, 7.70(1H, s), 7.34-7.22(1H, m), 6.99-6.94 (1H, m), 6.84-6.81(1H, m), 5.87-5.41(2H, m), 4.34-3.94(11H, m), 2.66, 2.53 (3H, s), 1.25-1.16 (12H, m).
3- (1- (2- (5-fluoro-2-methoxyphenyl) -2-hydroxyethyl) -6- (hydroxymethyl) -5-methyl-2,4-dioxo-1,4-dihydrothieno [2,3-d] ] Pyrimidin-3 (2H) -yl) -N-isopropyl-2,2-dimethylpropanamide (2.6 g) was dissolved in chloroform (40 ml), manganese dioxide (5 g) was added, and the mixture was stirred at room temperature for 2 hours. The reaction mixture was filtered, the mother liquor was concentrated, the obtained residue was dissolved in ethanol (35 ml), pyridine (0.6 g) and methoxyamine hydrochloride (0.6 g) were added at 70 ° C., and the mixture was stirred for 10 minutes. The reaction mixture was concentrated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain 2.3 g of the target compound (molecular configuration of oxime bond E: Z = 1: 1). Mixture) was obtained.
The 1 H-NMR of the obtained target product is shown below.
1 1 H-NMR (CDCl 3 ) δ: 8.28, 7.70 (1H, s), 7.34-7.22 (1H, m), 6.99-6.94 (1H, m), 6.84-6.81 (1H, m), 5.87-5.41 ( 2H, m), 4.34-3.94 (11H, m), 2.66, 2.53 (3H, s), 1.25-1.16 (12H, m).
〔実施例2〕
3-(1-(2-(2-cyanoethoxy)-2-(5-fluoro-2-methoxyphenyl)ethyl)-5-methyl-2,4-dioxo-6-(2H-1,2,3-triazol-2-yl)-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)-N-isopropyl-2,2-dimethylpropanamideの合成
[Example 2]
3- (1- (2- (2-cyanoethoxy) -2- (5-fluoro-2-methoxyphenyl) ethyl) -5-methyl-2,4-dioxo-6- (2H-1,2,3-triazol) -2-yl) -1,4-dihydrothieno [2,3-d] pyrimidin-3 (2H) -yl) -Synthesis of N-isopropyl-2,2-dimethylpropanamide
(工程1)
Ethyl 2-(3-(3-(tert-butoxy)-2,2-dimethyl-3-oxopropyl)ureido)-4-methyl-5-(2H-1,2,3-triazol-2-yl)thiophene-3-carboxylateの合成
(Step 1)
Ethyl 2-(3- (3- (tert-butoxy) -2,2-dimethyl-3-oxopropyl) ureado) -4-methyl-5- (2H-1,2,3-triazol-2-yl) thiophene -3-carboxylate synthesis
Figure JPOXMLDOC01-appb-C000019
Figure JPOXMLDOC01-appb-C000019
 Ethyl 2-amino-4-methyl-5-(2H-1,2,3-triazol-2-yl)thiophene-3-carboxylate(4.64g)をジクロロメタン(90ml)に溶解させ、室温下、トリホスゲン(1.86g)を加えた。この溶液に、氷冷下、トリエチルアミン(5.59g)を滴下し、室温にて2時間撹拌した。反応液を再度氷冷し、tert-butyl 3-amino-2,2-dimethylpropanoate(3.20g)を加え、室温にて一晩撹拌した。反応液を飽和塩化アンモニウム水溶液に注加し、ジクロロメタンで抽出、有機層を飽和食塩水で洗浄した後、無水硫酸マグネシウムで乾燥した。溶媒を減圧留去し、目的化合物8.32gを得た。収率100% 得られた目的物のH-NMRを以下に示す。
 1H-NMR (CDCl3) δ:1.05-1.58(m,18H), 2.26(s,3H), 3.39-3.43(m,2H), 4.35(q,2H), 6.24(brs,1H), 7.82(s,2H), 10.89(brs,1H).
Ethyl 2-amino-4-methyl-5- (2H-1,2,3-triazol-2-yl) thiophene-3-carboxylate (4.64 g) was dissolved in dichloromethane (90 ml), and at room temperature, triphosgene (triphosgene) 1.86 g) was added. Triethylamine (5.59 g) was added dropwise to this solution under ice-cooling, and the mixture was stirred at room temperature for 2 hours. The reaction mixture was ice-cooled again, tert-butyl 3-amino-2,2-dimethylpropanoate (3.20 g) was added, and the mixture was stirred overnight at room temperature. The reaction solution was poured into a saturated aqueous solution of ammonium chloride, extracted with dichloromethane, the organic layer was washed with saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 8.32 g of the target compound. Yield 100% 1 1 H-NMR of the obtained target product is shown below.
1 1 H-NMR (CDCl 3 ) δ: 1.05-1.58 (m, 18H), 2.26 (s, 3H), 3.39-3.43 (m, 2H), 4.35 (q, 2H), 6.24 (brs, 1H), 7.82 (s, 2H), 10.89 (brs, 1H).
(工程2)
tert-butyl 2,2-dimethyl-3-(5-methyl-2,4-dioxo-6-(2H-1,2,3-triazol-2-yl)-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)propanoateの合成
(Step 2)
tert-butyl 2,2-dimethyl-3- (5-methyl-2,4-dioxo-6- (2H-1,2,3-triazol-2-yl) -1,4-dihydrothieno [2,3- d] Synthesis of pyrimidin-3 (2H) -yl) propanoate
Figure JPOXMLDOC01-appb-C000020
Figure JPOXMLDOC01-appb-C000020
 Ethyl 2-(3-(3-(tert-butoxy)-2,2-dimethyl-3-oxopropyl)ureido)-4-methyl-5-(2H-1,2,3-triazol-2-yl)thiophene-3-carboxylate(8.32g)をt-ブチルアルコール(120ml)に懸濁させ、炭酸セシウム(18g)を加え、一晩加熱還流した。反応液を飽和塩化アンモニウム水溶液に注加し、酢酸エチルで抽出、有機層を飽和食塩水で洗浄した後、無水硫酸マグネシウムで乾燥した。溶媒を減圧留去し、目的化合物8.32gを得た。収率96%
 得られた目的物のH-NMRを以下に示す。
 1H-NMR (CDCl3) δ: 1.24-1.43(m,15H), 2.63(s,3H), 4.21(s,2H), 7.81(s,2H).
Ethyl 2-(3- (3- (tert-butoxy) -2,2-dimethyl-3-oxopropyl) ureido) -4-methyl-5- (2H-1,2,3-triazol-2-yl) thiophene -3-carboxylate (8.32 g) was suspended in t-butyl alcohol (120 ml), cesium carbonate (18 g) was added, and the mixture was heated under reflux overnight. The reaction solution was poured into a saturated aqueous solution of ammonium chloride, extracted with ethyl acetate, the organic layer was washed with saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 8.32 g of the target compound. Yield 96%
The 1 H-NMR of the obtained target product is shown below.
1 1 H-NMR (CDCl 3 ) δ: 1.24-1.43 (m, 15H), 2.63 (s, 3H), 4.21 (s, 2H), 7.81 (s, 2H).
(工程3)
 tert-butyl 3-(1-(2-(5-fluoro-2-methoxyphenyl)-2-oxoethyl)-5-methyl-2,4-dioxo-6-(2H-1,2,3-triazol-2-yl)-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)-2,2-dimethylpropanoateの合成
(Step 3)
tert-butyl 3-(1-(2- (5-fluoro-2-methoxyphenyl) -2-oxoethyl) -5-methyl-2,4-dioxo-6- (2H-1,2,3-triazol-2) Synthesis of -yl) -1,4-dihydrothieno [2,3-d] pyrimidin-3 (2H) -yl) -2,2-dimethylpropanoate
Figure JPOXMLDOC01-appb-C000021
Figure JPOXMLDOC01-appb-C000021
 tert-butyl 2,2-dimethyl-3-(5-methyl-2,4-dioxo-6-(2H-1,2,3-triazol-2-yl)-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)propanoate(7.14g)をN,N-ジメチルホルムアミド(50ml)に溶解させ、氷冷下、炭酸カリウム(7.3g)、2-ブロモ-5’-フルオロ-2’-メトキシアセトフェノン(4.8g)を加え、室温にて一晩撹拌した。反応液を氷水に注加し、酢酸エチルで抽出、有機層を水、飽和食塩水で洗浄した後、無水硫酸マグネシウムで乾燥した。溶媒を減圧留去し、得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)で精製し、目的化合物5.88gを得た。収率58%
 得られた目的物のH-NMRを以下に示す。
 1H-NMR (CDCl3) δ: 1.12-1.26(m,6H), 1.43(s,9H), 2.69(s,3H), 3.99(s,3H), 4.25(s,2H), 5.26(s,2H), 6.95-7.04(m,1H), 7.24-7.29(m,1H), 7.58-7.63(m,1H), 7.77(s,2H).
tert-butyl 2,2-dimethyl-3- (5-methyl-2,4-dioxo-6- (2H-1,2,3-triazol-2-yl) -1,4-dihydrothieno [2,3- d] Pyrimidin-3 (2H) -yl) propanoate (7.14 g) was dissolved in N, N-dimethylformamide (50 ml), and under ice cooling, potassium carbonate (7.3 g), 2-bromo-5'- Fluoro-2'-methoxyacetophenone (4.8 g) was added, and the mixture was stirred overnight at room temperature. The reaction mixture was poured into ice water, extracted with ethyl acetate, the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was evaporated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain 5.88 g of the target compound. Yield 58%
The 1 H-NMR of the obtained target product is shown below.
1 1 H-NMR (CDCl 3 ) δ: 1.12-1.26 (m, 6H), 1.43 (s, 9H), 2.69 (s, 3H), 3.99 (s, 3H), 4.25 (s, 2H), 5.26 (s) , 2H), 6.95-7.04 (m, 1H), 7.24-7.29 (m, 1H), 7.58-7.63 (m, 1H), 7.77 (s, 2H).
(工程4)
3-(1-(2-(5-fluoro-2-methoxyphenyl)-2-oxoethyl)-5-methyl-2,4-dioxo-6-(2H-1,2,3-triazol-2-yl)-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)-N-isopropyl-2,2-dimethylpropanamideの合成
(Step 4)
3- (1- (2- (5-fluoro-2-methoxyphenyl) -2-oxoethyl) -5-methyl-2,4-dioxo-6- (2H-1,2,3-triazol-2-yl) Synthesis of -1,4-dihydrothieno [2,3-d] pyrimidin-3 (2H) -yl) -N-isopropyl-2,2-dimethylpropanamide
Figure JPOXMLDOC01-appb-C000022
Figure JPOXMLDOC01-appb-C000022
 tert-butyl 3-(1-(2-(5-fluoro-2-methoxyphenyl)-2-oxoethyl)-5-methyl-2,4-dioxo-6-(2H-1,2,3-triazol-2-yl)-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)-2,2-dimethylpropanoate(5.88g)をジクロロメタン(30ml)に溶解させ、氷冷下、トリフルオロ酢酸(6.5ml)を加え、室温で5時間撹拌した。反応液を減圧濃縮し、得られた残渣をジクロロメタン(30ml)に懸濁させ、イソプロピルアミン(1.22g)、N,N-ジイソプロピルエチルアミン(2.66g)、O-(7-アザベンゾトリアゾール-1-イル)-N,N,N’,N’-テトラメチルウロニウムヘキサフルオロホスファート(3.92g)を加え、室温で一晩撹拌した。反応液を減圧濃縮、氷水に注加し、酢酸エチルで抽出、水、飽和食塩水で洗浄した後、無水硫酸マグネシウムで乾燥した。溶媒を減圧留去し、得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)で精製し、目的化合物3.48gを得た。収率61%
 得られた目的物のH-NMRを以下に示す。
 1H-NMR (CDCl3) δ: 1.09-1.12(m,12H), 2.69(s,3H), 4.00(s,3H), 4.25(s,2H), 5.27(s,2H), 5.99-6.03(m,1H), 6.99-7.02(m,1H), 7.24-7.30(m,1H), 7.58-7.76(m,1H), 7.77(s,2H).
tert-butyl 3-(1- (2- (5-fluoro-2-methoxyphenyl) -2-oxoethyl) -5-methyl-2,4-dioxo-6- (2H-1,2,3-triazol-2) -yl) -1,4-dihydrothieno [2,3-d] pyrimidin-3 (2H) -yl) -2,2-dimethylpropanoate (5.88 g) was dissolved in dichloromethane (30 ml), and the mixture was cooled with ice. Fluoroacetic acid (6.5 ml) was added, and the mixture was stirred at room temperature for 5 hours. The reaction mixture was concentrated under reduced pressure, and the obtained residue was suspended in dichloromethane (30 ml), isopropylamine (1.22 g), N, N-diisopropylethylamine (2.66 g), O- (7-azabenzotriazole-). 1-Il) -N, N, N', N'-tetramethyluronium hexafluorophosphate (3.92 g) was added, and the mixture was stirred overnight at room temperature. The reaction mixture was concentrated under reduced pressure, poured into ice water, extracted with ethyl acetate, washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was evaporated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain 3.48 g of the target compound. Yield 61%
The 1 H-NMR of the obtained target product is shown below.
1 1 H-NMR (CDCl 3 ) δ: 1.09-1.12 (m, 12H), 2.69 (s, 3H), 4.00 (s, 3H), 4.25 (s, 2H), 5.27 (s, 2H), 5.99-6.03 (m, 1H), 6.99-7.02 (m, 1H), 7.24-7.30 (m, 1H), 7.58-7.76 (m, 1H), 7.77 (s, 2H).
(工程5)
3-(1-(2-(5-fluoro-2-methoxyphenyl)-2-hydroxyethyl)-5-methyl-2,4-dioxo-6-(2H-1,2,3-triazol-2-yl)-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)-N-isopropyl-2,2-dimethylpropanamideの合成
(Step 5)
3- (1- (2- (5-fluoro-2-methoxyphenyl) -2-hydroxyethyl) -5-methyl-2,4-dioxo-6- (2H-1,2,3-triazol-2-yl) Synthesis of -1,4-dihydrothieno [2,3-d] pyrimidin-3 (2H) -yl) -N-isopropyl-2,2-dimethylpropanamide
Figure JPOXMLDOC01-appb-C000023
Figure JPOXMLDOC01-appb-C000023
 3-(1-(2-(5-fluoro-2-methoxyphenyl)-2-oxoethyl)-5-methyl-2,4-dioxo-6-(2H-1,2,3-triazol-2-yl)-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)-N-isopropyl-2,2-dimethylpropanamide(3.48g)をメタノール(10ml)、テトラヒドロフラン(30ml)の混合溶媒に溶解させ、氷冷下、テトラヒドロホウ酸ナトリウム(0.48g)を加え、室温で2時間撹拌した。反応液を減圧濃縮、氷水に注加し、酢酸エチルで抽出、水、飽和食塩水で洗浄した後、無水硫酸マグネシウムで乾燥した。溶媒を減圧留去し、得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)で精製し、目的化合物3.10gを得た。収率89%
得られた目的物のH-NMRを以下に示す。
 1H-NMR (CDCl3) δ: 1.15-1.26(m,12H), 2.69(s,3H), 3.90(s,3H), 4.00-4.31(m,4H), 5.40-5.48(m,1H), 5.82-5.86(m,1H), 6.80-6.83(m,1H), 6.93-6.98(m,1H), 7.30-7.35(m,1H), 7.82(s,2H).
3- (1- (2- (5-fluoro-2-methoxyphenyl) -2-oxoethyl) -5-methyl-2,4-dioxo-6- (2H-1,2,3-triazol-2-yl) -1,4-dihydrothieno [2,3-d] pyrimidin-3 (2H) -yl) -N-isopropyl-2,2-dimethylpropanamide (3.48 g) mixed with methanol (10 ml) and tetrahydrofuran (30 ml) To, sodium tetrahydroborate (0.48 g) was added under ice-cooling, and the mixture was stirred at room temperature for 2 hours. The reaction mixture was concentrated under reduced pressure, poured into ice water, extracted with ethyl acetate, washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was evaporated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain 3.10 g of the target compound. Yield 89%
The 1 H-NMR of the obtained target product is shown below.
1 1 H-NMR (CDCl 3 ) δ: 1.15-1.26 (m, 12H), 2.69 (s, 3H), 3.90 (s, 3H), 4.00-4.31 (m, 4H), 5.40-5.48 (m, 1H) , 5.82-5.86 (m, 1H), 6.80-6.83 (m, 1H), 6.93-6.98 (m, 1H), 7.30-7.35 (m, 1H), 7.82 (s, 2H).
(工程6)
3-(1-(2-(2-cyanoethoxy)-2-(5-fluoro-2-methoxyphenyl)ethyl)-5-methyl-2,4-dioxo-6-(2H-1,2,3-triazol-2-yl)-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)-N-isopropyl-2,2-dimethylpropanamideの合成
(Step 6)
3- (1- (2- (2-cyanoethoxy) -2- (5-fluoro-2-methoxyphenyl) ethyl) -5-methyl-2,4-dioxo-6- (2H-1,2,3-triazol) -2-yl) -1,4-dihydrothieno [2,3-d] pyrimidin-3 (2H) -yl) -Synthesis of N-isopropyl-2,2-dimethylpropanamide
Figure JPOXMLDOC01-appb-C000024
Figure JPOXMLDOC01-appb-C000024
 3-(1-(2-(5-fluoro-2-methoxyphenyl)-2-hydroxyethyl)-5-methyl-2,4-dioxo-6-(2H-1,2,3-triazol-2-yl)-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)-N-isopropyl-2,2-dimethylpropanamide(0.24g)をジクロロメタン(5ml)に溶解させ、氷冷下、アクリロニトリル(0.23g)、Triton B(0.18g)を加え、室温で2時間撹拌した。反応液を氷水に注加し、酢酸エチルで抽出、有機層を水、飽和食塩水で洗浄した後、無水硫酸マグネシウムで乾燥した。溶媒を減圧留去し、得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)で精製し、目的化合物0.24gを得た。収率91%
 得られた目的物のH-NMRを以下に示す。
 1H-NMR (CDCl3) δ: 1.13-1.26(m,12H), 2.54(t,2H), 2.65(s,3H), 3.45-4.22(m,9H), 5.26-5.30(m,1H), 6.11-6.14(m,1H), 6.80-6.83(m,1H), 6.95-7.02(m,1H), 7.18-7.22(m,1H), 7.82(s,2H).
3- (1- (2- (5-fluoro-2-methoxyphenyl) -2-hydroxyethyl) -5-methyl-2,4-dioxo-6- (2H-1,2,3-triazol-2-yl) -1,4-dihydrothieno [2,3-d] pyrimidin-3 (2H) -yl) -N-isopropyl-2,2-dimethylpropanamide (0.24 g) was dissolved in dichloromethane (5 ml) and cooled with ice. Acrylonitrile (0.23 g) and Triton B (0.18 g) were added, and the mixture was stirred at room temperature for 2 hours. The reaction mixture was poured into ice water, extracted with ethyl acetate, the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was evaporated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain 0.24 g of the target compound. Yield 91%
The 1 H-NMR of the obtained target product is shown below.
1 1 H-NMR (CDCl 3 ) δ: 1.13-1.26 (m, 12H), 2.54 (t, 2H), 2.65 (s, 3H), 3.45-4.22 (m, 9H), 5.26-5.30 (m, 1H) , 6.11-6.14 (m, 1H), 6.80-6.83 (m, 1H), 6.95-7.02 (m, 1H), 7.18-7.22 (m, 1H), 7.82 (s, 2H).
 前記の実施例と同様の方法で製造した本発明化合物の一部を表1及び表2に示す。表中には、各化合物の物性として、性状、融点(m.p.)又は屈折率(nD)を併せて示す。表1中の立体配置のE又はZは、R2におけるオキシム基の幾何異性体を示す。「E」はE配置であることを示し、「Z」はZ配置であることを示し、「E/Z」は化合物が両配置の化合物の混合物であることを示す。第1表中、Meはメチル基を、Etはエチル基を、矢印は結合部位を示す。第2表中の立体配置のE又はZは、オキシム基の幾何異性体を示す。「E」はE配置であることを示し、「Z」はZ配置であることを示し、「E/Z」は化合物が両配置の化合物の混合物であることを示す。 Tables 1 and 2 show some of the compounds of the present invention produced by the same method as in the above Examples. In the table, the physical properties, melting point (mp) or refractive index (n D ) of each compound are also shown. The configuration E or Z in Table 1 indicates the geometric isomer of the oxime group in R 2 . "E" indicates an E configuration, "Z" indicates a Z configuration, and "E / Z" indicates that the compound is a mixture of compounds in both configurations. In Table 1, Me indicates a methyl group, Et indicates an ethyl group, and an arrow indicates a binding site. The configuration E or Z in Table 2 indicates the geometric isomer of the oxime group. "E" indicates an E configuration, "Z" indicates a Z configuration, and "E / Z" indicates that the compound is a mixture of compounds in both configurations.
Figure JPOXMLDOC01-appb-T000025
Figure JPOXMLDOC01-appb-I000026
Figure JPOXMLDOC01-appb-I000027
Figure JPOXMLDOC01-appb-I000028
Figure JPOXMLDOC01-appb-T000025
Figure JPOXMLDOC01-appb-I000026
Figure JPOXMLDOC01-appb-I000027
Figure JPOXMLDOC01-appb-I000028
Figure JPOXMLDOC01-appb-T000029
Figure JPOXMLDOC01-appb-T000029
 第1表及び第2表に示した化合物のうち、粘性オイル又はアモルファスの物性化合物については、H-NMRデータを以下に示す。
化合物番号a-2:H-NMR(CDCl,δppm):0.91-1.49(m,15H), 2.43-2.2.88(m,6H), 3.42-4.39(m,10H), 5.22-5.55(m,2H), 6.75-7.22(m,3H)。
化合物番号a-3:H-NMR(CDCl,δppm):0.91-1.49(m,15H), 2.83(s,3H), 3.01-3.23(m,1H), 3.56-4.39(m,9H), 5.29-5.48(m,2H), 6.75-7.28(m,3H)。
化合物番号a-9:H-NMR(CDCl,δppm):1.17-1.43(m,15H), 2.87(s,3H), 3.93-4.39(m,10H), .5.41-5.49(m,1H), 5.77-5.82(m,1H), 6.82-6.85(m,1H), 6.95-7.00(m,1H), 7.33-7.36(m,1H)。
化合物番号a-10:H-NMR(CDCl,δppm):1.26-1.39(m,9H), 2.49-2.54(m,2H), 2.66(s,3H), 3.45-4.25(m,11H), 5.18-5.21(m,1H), 6.83-7.15(m,3H), 7.56(d,1H), 8.67(d,1H)。
化合物番号a-14:H-NMR(CDCl,δppm):1.03-1.54(m,9H), 2.50-2.74(m,5H), 3.00-4.15(m,10H), 5.13-5.60(m,2H), 6.79-7.33(m,3H), 8.25(s,1H)。
化合物番号a-15:H-NMR(CDCl,δppm):0.95-1.54(m,9H), 2.50-2.74(m,7H), 3.00-4.15(m,12H), 5.13-5.60(m,2H), 6.75-7.26(m,3H), 8.25(s,1H)。
化合物番号a-16:H-NMR(CDCl,δppm):1.23-1.31(m,6H), 2.49-2.52(m,2H), 2.66(s,3H), 3.41-4.28(m,12H), 5.16-5.21(m,1H), 6.84-7.56(m,4H)。
化合物番号a-17:H-NMR(CDCl,δppm):1.26(s,6H), 2.50-2.52(m,2H), 2.66(s,3H), 3.41-4.24(m,12H), 5.22-5.26(m,1H), 6.82-7.18(m,3H), 8.99(s,1H)。
化合物番号a-18:H-NMR(CDCl,δppm):1.09-1.33(m,12H), 2.53-2.55(m,2H), 2.64(s,3H), 2.72-3.20(m,3H), 3.43-4.30(m,7H), 4.61(brs,1H), 5.17-5.20(m,1H), 6.80-7.18(m,3H)。
化合物番号a-27:H-NMR(CDCl,δppm):1.11(d,6H), 1.39(t,3H), 2.48-2.58(m,4H), 2.79(s,3H), 3.39-3.71(m,2H), 3.84(s,3H), 4.00-4.36(m,5H), 5.30-5.32(m,1H), 5.97-6.01(m,1H), 6.84-7.26(m,3H)。
化合物番号a-28:H-NMR(CDCl,δppm):0.99-1.40(m,9H), 2.52-2.58(m,2H), 2.85(s,3H), 3.60-4.40(m,14H), 5.26-5.30(m,1H), 6.79-7.25(m,3H)。
化合物番号a-29:H-NMR(CDCl,δppm):1.13(d,6H), 2.52-2.63(m,2H), 2.69(s,3H), 3.81-4.45(m,10H), 5.34-5.42(m,1H), 5.76-5.82(m,1H), 6.77-7.01(m,2H), 7.24-7.30(m,1H), 7.82(s,2H)。
化合物番号a-30:H-NMR(CDCl,δppm):1.15-1.26(m,12H), 2.18(s,3H), 2.44(s,3H), 3.86(s,3H), 4.00-4.31(m,4H), 6.48(s,1H), 6.58-6.12(m,4H), 7.68-7.72(m,2H)。
化合物番号a-31:H-NMR(CDCl,δppm):1.15-1.26(m,12H), 2.41(s,3H), 3.82(s,3H), 4.00-4.31(m,4H), 5.26-5.30(m,1H), 6.13-6.17(m,1H), 6.46(s,1H), 6.79-6.18(m,3H), 7.68-7.72(m,2H)。
化合物番号a-33:H-NMR(CDCl,δppm):1.19(s,6H), 2.41(s,3H), 2.49-2.55(m,2H), 2.82-2.90(m,2H), 3.39-4.21(m,12H), 5.22-5.29(m,1H), 6.28-6.35(m,1H), 6.46(s,1H), 6.78-7.02(m,4H), 7.13-7.21(m,3H), 7.67(s,1H), 7.72(s,1H)。
化合物番号a-34:H-NMR(CDCl,δppm):1.23(s,6H), 2.43(s,3H), 2.85-2.92(m,2H), 3.41-3.48(m,2H), 3.82(s,3H), 3.84(s,3H), 3.97-4.49(m,4H), 5.40-5.45(m,1H), 6.28-6.32(m,1H), 6.47(s,1H), 6.77-7.36(m,7H), 7.67(s,1H), 7.72(s,1H)。
化合物番号a-36:H-NMR(CDCl,δppm):1.12-1.28(m,12H), 2.43(s,3H), 2.52-2.59(m,2H), 3.24(s,3H), 3.51-3.60(m,2H), 3.84(s,3H), 4.00-4.21(m,5H), 6.10-6.17(m,1H), 6.47(s,1H), 6.57-7.16(m,4H), 7.67(s,1H), 7.73(s,1H)。
化合物番号a-37:H-NMR(CDCl,δppm):1.12-1.28(m,12H), 2.43(s,3H), 3.33(s,3H), 3.51-3.60(m,2H), 3.86(s,3H), 3.95-4.35(m,7H), 6.02-6.12(m,1H), 6.47(s,1H), 6.57-7.16(m,4H), 7.67(s,1H), 7.73(s,1H)。
化合物番号a-41:H-NMR(CDCl,δppm):1.05-1.09(m,6H), 1.39(t,3H), 1.72-2.22(m,6H), 2.85(s,3H), 3.31-3.46(m,1H), 3.72-4.42(m,7H), 5.32-5.72(m,3H), 6.82-7.25(m,3H)。
化合物番号a-42:H-NMR(CDCl,δppm):1.05-1.09(m,6H), 1.39(t,3H), 1.72-2.25(m,6H), 2.61-2.66(m,2H), 2.85(s,3H), 3.23-3.46(m,1H), 3.72-4.41(m,9H), 5.27-5.65(m,2H), 5.98-6.10(m,1H), 6.78-7.25(m,3H)。
化合物番号b-1:H-NMR(CDCl,δppm):1.06-1.32(m,15H), 2.42(s,3H), 3.80(s,3H), 3.99-4.29(m,7H), 4.97(s,2H), 6.47(s,1H), 6.68-7.05(m,3H), 7.64-7.73(m,2H)。
化合物番号b-3:H-NMR(CDCl,δppm):1.15(d,6H), 1.24(s,6H), 2.41(s,3H), 3.05-3.09(m,2H), 3.83(s,3H), 3.99-4.13(m,3H), 4.22(s,2H), 6.13-6.18(m,1H), 6.46(s,1H), 6.81-6.89(m,1H), 7.12-7.25(m,2H), 7.64(s,1H), 7.72(s,1H)。
Among the compounds shown in Tables 1 and 2, 1 H-NMR data is shown below for viscous oil or amorphous physical property compounds.
Compound No. a-2: 1 1 H-NMR (CDCl 3 , δppm): 0.91-1.49 (m, 15H), 2.43-2.2.88 (m, 6H), 3.42-4.39 (m, 10H), 5.22-5.55 ( m, 2H), 6.75-7.22 (m, 3H).
Compound No. a-3: 1 1 H-NMR (CDCl 3 , δppm): 0.91-1.49 (m, 15H), 2.83 (s, 3H), 3.01-3.23 (m, 1H), 3.56-4.39 (m, 9H) , 5.29-5.48 (m, 2H), 6.75-7.28 (m, 3H).
Compound No. a-9: 1 1 H-NMR (CDCl 3 , δppm): 1.17-1.43 (m, 15H), 2.87 (s, 3H), 3.93-4.39 (m, 10H), .5.41-5.49 (m, 1H) ), 5.77-5.82 (m, 1H), 6.82-6.85 (m, 1H), 6.95-7.00 (m, 1H), 7.33-7.36 (m, 1H).
Compound No. a-10: 1 1 H-NMR (CDCl 3 , δppm): 1.26-1.39 (m, 9H), 2.49-2.54 (m, 2H), 2.66 (s, 3H), 3.45-4.25 (m, 11H) , 5.18-5.21 (m, 1H), 6.83-7.15 (m, 3H), 7.56 (d, 1H), 8.67 (d, 1H).
Compound No. a-14: 1 1 H-NMR (CDCl 3 , δppm): 1.03-1.54 (m, 9H), 2.50-2.74 (m, 5H), 3.00-4.15 (m, 10H), 5.13-5.60 (m, 2H), 6.79-7.33 (m, 3H), 8.25 (s, 1H).
Compound No. a-15: 1 1 H-NMR (CDCl 3 , δppm): 0.95-1.54 (m, 9H), 2.50-2.74 (m, 7H), 3.00-4.15 (m, 12H), 5.13-5.60 (m, 2H), 6.75-7.26 (m, 3H), 8.25 (s, 1H).
Compound No. a-16: 1 1 H-NMR (CDCl 3 , δppm): 1.23-1.31 (m, 6H), 2.49-2.52 (m, 2H), 2.66 (s, 3H), 3.41-4.28 (m, 12H) , 5.16-5.21 (m, 1H), 6.84-7.56 (m, 4H).
Compound No. a-17: 1 1 H-NMR (CDCl 3 , δppm): 1.26 (s, 6H), 2.50-2.52 (m, 2H), 2.66 (s, 3H), 3.41-4.24 (m, 12H), 5.22 -5.26 (m, 1H), 6.82-7.18 (m, 3H), 8.99 (s, 1H).
Compound No. a-18: 1 1 H-NMR (CDCl 3 , δppm): 1.09-1.33 (m, 12H), 2.53-2.55 (m, 2H), 2.64 (s, 3H), 2.72-3.20 (m, 3H) , 3.43-4.30 (m, 7H), 4.61 (brs, 1H), 5.17-5.20 (m, 1H), 6.80-7.18 (m, 3H).
Compound No. a-27: 1 1 H-NMR (CDCl 3 , δppm): 1.11 (d, 6H), 1.39 (t, 3H), 2.48-2.58 (m, 4H), 2.79 (s, 3H), 3.39-3.71 (m, 2H), 3.84 (s, 3H), 4.00-4.36 (m, 5H), 5.30-5.32 (m, 1H), 5.97-6.01 (m, 1H), 6.84-7.26 (m, 3H).
Compound No. a-28: 1 H-NMR (CDCl 3 , δppm): 0.99-1.40 (m, 9H), 2.52-2.58 (m, 2H), 2.85 (s, 3H), 3.60-4.40 (m, 14H) , 5.26-5.30 (m, 1H), 6.79-7.25 (m, 3H).
Compound No. a-29: 1 1 H-NMR (CDCl 3 , δppm): 1.13 (d, 6H), 2.52-2.63 (m, 2H), 2.69 (s, 3H), 3.81-4.45 (m, 10H), 5.34 -5.42 (m, 1H), 5.76-5.82 (m, 1H), 6.77-7.01 (m, 2H), 7.24-7.30 (m, 1H), 7.82 (s, 2H).
Compound No. a-30: 1 1 H-NMR (CDCl 3 , δppm): 1.15-1.26 (m, 12H), 2.18 (s, 3H), 2.44 (s, 3H), 3.86 (s, 3H), 4.00-4.31 (m, 4H), 6.48 (s, 1H), 6.58-6.12 (m, 4H), 7.68-7.72 (m, 2H).
Compound No. a-31: 1 1 H-NMR (CDCl 3 , δppm): 1.15-1.26 (m, 12H), 2.41 (s, 3H), 3.82 (s, 3H), 4.00-4.31 (m, 4H), 5.26 -5.30 (m, 1H), 6.13-6.17 (m, 1H), 6.46 (s, 1H), 6.79-6.18 (m, 3H), 7.68-7.72 (m, 2H).
Compound No. a-33: 1 1 H-NMR (CDCl 3 , δppm): 1.19 (s, 6H), 2.41 (s, 3H), 2.49-2.55 (m, 2H), 2.82-2.90 (m, 2H), 3.39 -4.21 (m, 12H), 5.22-5.29 (m, 1H), 6.28-6.35 (m, 1H), 6.46 (s, 1H), 6.78-7.02 (m, 4H), 7.13-7.21 (m, 3H) , 7.67 (s, 1H), 7.72 (s, 1H).
Compound No. a-34: 1 1 H-NMR (CDCl 3 , δppm): 1.23 (s, 6H), 2.43 (s, 3H), 2.85-2.92 (m, 2H), 3.41-3.48 (m, 2H), 3.82 (s, 3H), 3.84 (s, 3H), 3.97-4.49 (m, 4H), 5.40-5.45 (m, 1H), 6.28-6.32 (m, 1H), 6.47 (s, 1H), 6.77-7.36 (m, 7H), 7.67 (s, 1H), 7.72 (s, 1H).
Compound No. a-36: 1 1 H-NMR (CDCl 3 , δppm): 1.12-1.28 (m, 12H), 2.43 (s, 3H), 2.52-2.59 (m, 2H), 3.24 (s, 3H), 3.51 -3.60 (m, 2H), 3.84 (s, 3H), 4.00-4.21 (m, 5H), 6.10-6.17 (m, 1H), 6.47 (s, 1H), 6.57-7.16 (m, 4H), 7.67 (s, 1H), 7.73 (s, 1H).
Compound No. a-37: 1 1 H-NMR (CDCl 3 , δppm): 1.12-1.28 (m, 12H), 2.43 (s, 3H), 3.33 (s, 3H), 3.51-3.60 (m, 2H), 3.86 (s, 3H), 3.95-4.35 (m, 7H), 6.02-6.12 (m, 1H), 6.47 (s, 1H), 6.57-7.16 (m, 4H), 7.67 (s, 1H), 7.73 (s) , 1H).
Compound No. a-41: 1 1 H-NMR (CDCl 3 , δppm): 1.05-1.09 (m, 6H), 1.39 (t, 3H), 1.72-2.22 (m, 6H), 2.85 (s, 3H), 3.31 -3.46 (m, 1H), 3.72-4.42 (m, 7H), 5.32-5.72 (m, 3H), 6.82-7.25 (m, 3H).
Compound No. a-42: 1 1 H-NMR (CDCl 3 , δppm): 1.05-1.09 (m, 6H), 1.39 (t, 3H), 1.72-2.25 (m, 6H), 2.61-2.66 (m, 2H) , 2.85 (s, 3H), 3.23-3.46 (m, 1H), 3.72-4.41 (m, 9H), 5.27-5.65 (m, 2H), 5.98-6.10 (m, 1H), 6.78-7.25 (m, 3H).
Compound No. b-1: 1 1 H-NMR (CDCl 3 , δppm): 1.06-1.32 (m, 15H), 2.42 (s, 3H), 3.80 (s, 3H), 3.99-4.29 (m, 7H), 4.97 (s, 2H), 6.47 (s, 1H), 6.68-7.05 (m, 3H), 7.64-7.73 (m, 2H).
Compound No. b-3: 1 1 H-NMR (CDCl 3 , δppm): 1.15 (d, 6H), 1.24 (s, 6H), 2.41 (s, 3H), 3.05-3.09 (m, 2H), 3.83 (s) , 3H), 3.99-4.13 (m, 3H), 4.22 (s, 2H), 6.13-6.18 (m, 1H), 6.46 (s, 1H), 6.81-6.89 (m, 1H), 7.12-7.25 (m) , 2H), 7.64 (s, 1H), 7.72 (s, 1H).
〔生物試験〕
 本発明のチエノピリミジン化合物が、農園芸用殺菌剤の有効成分として有用であることを以下の試験例で示す。
[Biological test]
The following test examples show that the thienopyrimidine compound of the present invention is useful as an active ingredient of a fungicide for agriculture and horticulture.
(試験用乳剤の調製)
 チエノピリミジン化合物5重量部、N、N-ジメチルホルムアミド93.5重量部、及びポリオキシエチレンソルビタンモノラウレート(TWEEN(登録商標)20)1.5重量部を混合し、溶解させて、有効成分5%の乳剤(I)を得た。
(Preparation of test emulsion)
5 parts by weight of the thienopyrimidine compound, 93.5 parts by weight of N, N-dimethylformamide, and 1.5 parts by weight of polyoxyethylene sorbitan monolaurate (TWEEN® 20) are mixed and dissolved to dissolve the active ingredient. A 5% emulsion (I) was obtained.
 防除価は、下記の式により計算した。 The control price was calculated by the following formula.
[数1]
防除価(%)=100-{処理区における病斑面積率/無処理区における病斑面積率}×100
[Number 1]
Control value (%) = 100- {Ratio of lesion area in treated plot / Ratio of lesion area in untreated plot} × 100
 (試験例1)リンゴ黒星病防除試験
 乳剤(I)にチエノピリミジン化合物濃度が125ppmになるように水を加え、溶解させて薬剤溶液を得た。続いて育苗用ポットで栽培したリンゴ幼苗(品種「王林」、3~4葉期)に、前記薬剤溶液を散布した。風乾後、リンゴ黒星病菌(Venturia inaequalis)の分生胞子を接種した(処理区)。対照として、薬剤溶液を散布しなかったリンゴ幼苗に同様に接種した(無処理区)。それらを、明暗を12時間毎に繰り返す20℃の湿室に静置した。
 接種から2週間経過した日にリンゴ幼苗の葉を目視観察して、病斑面積率を求め、防除価を算出した。
(Test Example 1) Apple scab control test Water was added to the emulsion (I) so that the concentration of the thienopyrimidine compound was 125 ppm, and the mixture was dissolved to obtain a drug solution. Subsequently, the chemical solution was sprayed on apple seedlings (cultivar "Orin", 3-4 leaf stage) cultivated in a seedling raising pot. After air drying, conidia of apple scab (Venturia inaequalis) were inoculated (treatment plot). As a control, apple seedlings that were not sprayed with the drug solution were similarly inoculated (untreated plot). They were allowed to stand in a wet room at 20 ° C. in which light and darkness was repeated every 12 hours.
On the day 2 weeks after inoculation, the leaves of apple seedlings were visually observed to determine the lesion area ratio, and the control value was calculated.
 化合物番号a-1、a-2、a-3、a-4、a-5、a-6、a-7、a-8、a-9、a-10、a-11、a-12、a-13、a-14、a-15、a-16、a-18、a-19、a-20、a-21、a-22、a-23、a-24、a-25、a-26、a-27、a-28、a-29、a-30、a-31、a-32、a-33、a-34、a-35、a-36、a-37、a-38、a-39、a-40、a-41、a-42、b-1、b-2及びb-3のチエノピリミジン化合物について、リンゴ黒星病防除試験を行った。いずれの化合物も75%以上の防除価を示した。 Compound Nos. a-1, a-2, a-3, a-4, a-5, a-6, a-7, a-8, a-9, a-10, a-11, a-12, a-13, a-14, a-15, a-16, a-18, a-19, a-20, a-21, a-22, a-23, a-24, a-25, a- 26, a-27, a-28, a-29, a-30, a-31, a-32, a-33, a-34, a-35, a-36, a-37, a-38, The apple scab control test was carried out on the thienopyrimidine compounds of a-39, a-40, a-41, a-42, b-1, b-2 and b-3. Both compounds showed a control value of 75% or more.
(試験例2)キュウリ灰色かび病防除試験
 乳剤(I)にチエノピリミジン化合物濃度が125ppmになるように水を加え、溶解させて薬剤溶液を得た。続いて育苗用ポットで栽培したキュウリ幼苗(品種「地這」系、子葉期)に、前記薬剤溶液を散布した。風乾後、キュウリ灰色かび病菌(Botrytis cinerea)の分生胞子懸濁液を滴下接種した(処理区)。対照として、薬剤溶液を散布しなかったキュウリ幼苗に上記と同じ方法で滴下接種した(無処理区)。それらを20℃の湿室に静置した。
 接種から4日間経過した日にキュウリ幼苗の葉を目視観察して、病斑面積率を求め、防除価を算出した。
(Test Example 2) Cucumber Botrytis cinerea control test Water was added to the emulsion (I) so that the concentration of the thienopyrimidine compound was 125 ppm, and the mixture was dissolved to obtain a drug solution. Subsequently, the drug solution was sprayed on the cucumber seedlings (cultivar "Crawling" type, cotyledon stage) cultivated in the seedling raising pot. After air-drying, a conidia suspension of Botrytis cinerea was inoculated dropwise (treatment group). As a control, cucumber seedlings to which the drug solution was not sprayed were inoculated by dropping in the same manner as above (untreated plot). They were allowed to stand in a wet room at 20 ° C.
On the day 4 days after inoculation, the leaves of the cucumber seedlings were visually observed to determine the lesion area ratio, and the control value was calculated.
 化合物番号a-1、a-4、a-5、a-7、a-12、a-14、a-18、a-21、a-22、a-23、a-25、a-26、a-28、a-29、a-30、a-31、a-32、a-33、a-34、a-36、a-37、a-38及びb-3のチエノピリミジン化合物について、キュウリ灰色かび病防除試験を行った。いずれの化合物も75%以上の防除価を示した。 Compound Nos. a-1, a-4, a-5, a-7, a-12, a-14, a-18, a-21, a-22, a-23, a-25, a-26, Cucumbers for thienopyrimidine compounds of a-28, a-29, a-30, a-31, a-32, a-33, a-34, a-36, a-37, a-38 and b-3. A gray mold control test was conducted. Both compounds showed a control value of 75% or more.
(試験例3)コムギうどんこ病防除試験
 乳剤(I)にチエノピリミジン化合物濃度が125ppmになるように水を加え、溶解させて薬剤溶液を得た。続いて育苗用ポットで栽培したコムギ幼苗(品種「チホク」、1~2葉期)に前記薬剤溶液を散布した。風乾後、コムギうどんこ病菌(Erysiphe graminis f.sp.tritici)の分生胞子を振りかけて接種した(処理区)。対照として、薬剤溶液を散布しなかったコムギ幼苗に上記と同じ方法で接種した(無処理区)。それらを20℃の温室に静置した。
 接種から6日間経過した日にコムギ幼苗の葉を目視観察して、病斑面積率を求め、防除価を算出した。
(Test Example 3) Wheat powdery mildew control test Water was added to the emulsion (I) so that the concentration of the thienopyrimidine compound was 125 ppm, and the mixture was dissolved to obtain a drug solution. Subsequently, the chemical solution was sprayed on wheat seedlings (cultivar "Chihoku", 1-2 leaf stage) cultivated in a seedling raising pot. After air-drying, conidia of wheat powdery mildew (Erysiphe graminis f.sp.tritici) were sprinkled and inoculated (treatment plot). As a control, wheat seedlings that were not sprayed with the drug solution were inoculated in the same manner as above (untreated plot). They were allowed to stand in a greenhouse at 20 ° C.
On the day 6 days after inoculation, the leaves of wheat seedlings were visually observed to determine the lesion area ratio, and the control value was calculated.
 化合物番号a-1、a-2、a-3、a-4、a-7、a-8、a-9、a-11、a-12、a-13、a-14、a-18、a-19、a-20、a-21、a-22、a-23、a-24、a-25,a-26、a-29、a-30、a-31、a-32、a-33、a-34、a-35、a-36、a-37、a-38、a-39、a-40、a-41、a-42、b-1、b-2及びb-3のチエノピリミジン化合物について、コムギうどんこ病防除試験を行った。いずれの化合物も75%以上の防除価を示した。 Compound Nos. a-1, a-2, a-3, a-4, a-7, a-8, a-9, a-11, a-12, a-13, a-14, a-18, a-19, a-20, a-21, a-22, a-23, a-24, a-25, a-26, a-29, a-30, a-31, a-32, a- 33, a-34, a-35, a-36, a-37, a-38, a-39, a-40, a-41, a-42, b-1, b-2 and b-3 A wheat udonko disease control test was conducted on the thienopyrimidine compound. Both compounds showed a control value of 75% or more.
(試験例4)コムギ赤さび病防除試験
 乳剤(I)にチエノピリミジン化合物濃度が125ppmになるように水を加え、溶解させて薬剤溶液を得た。続いて育苗用ポットで栽培したコムギ幼苗(品種「農林61号」、1~2葉期)に前記薬剤溶液を散布した。風乾後、薬剤溶液を散布したコムギ幼苗にコムギ赤さび病菌(Puccinia recondita)の夏胞子をふり掛けて接種した(処理区)。対照として、薬剤溶液を散布しなかったコムギ幼苗に上記と同様にして接種した(無処理区)。それらを20℃の温室に静置した。
 接種から12日間経過した日にコムギ苗の葉を目視観察して、病斑面積率を求め、防除価を算出した。
(Test Example 4) Wheat Red Rust Control Test Water was added to the emulsion (I) so that the concentration of the thienopyrimidine compound was 125 ppm, and the mixture was dissolved to obtain a drug solution. Subsequently, the chemical solution was sprayed on wheat seedlings (cultivar "Norin 61", 1-2 leaf stage) cultivated in a seedling raising pot. After air-drying, the wheat seedlings sprayed with the chemical solution were inoculated by sprinkling summer spores of wheat leaf rust (Puccinia recondita) (treatment plot). As a control, wheat seedlings to which the drug solution was not sprayed were inoculated in the same manner as above (untreated plot). They were allowed to stand in a greenhouse at 20 ° C.
On the day 12 days after inoculation, the leaves of wheat seedlings were visually observed to determine the lesion area ratio, and the control value was calculated.
 化合物番号a-1、a-4、a-12、a-14、a-15、a-19、a-21、a-22、a-23、a-25,a-26、a-29、a-30、a-31、a-32、a-33、a-34、a-36、a-37、a-38、a-40、a-41及びb-3のチエノピリミジン化合物について、コムギ赤さび病防除試験を行った。いずれの化合物も75%以上の防除価を示した。 Compound Nos. a-1, a-4, a-12, a-14, a-15, a-19, a-21, a-22, a-23, a-25, a-26, a-29, Wheat for the thienopyrimidine compounds of a-30, a-31, a-32, a-33, a-34, a-36, a-37, a-38, a-40, a-41 and b-3. A red rust control test was conducted. Both compounds showed a control value of 75% or more.
 本発明のチエノピリミジン化合物の中から無作為に選択したものが、上記のような効果を奏することから、本発明のチエノピリミジン化合物は、例示しきれなかった化合物を含め、殺菌効果を有し、植物体に薬害を生じることがなく、人畜魚類に対する毒性や環境への影響が少ない化合物であり、農薬として有用である。 Since randomly selected thienopyrimidine compounds of the present invention exert the above-mentioned effects, the thienopyrimidine compounds of the present invention have a bactericidal effect, including compounds that could not be exemplified. It is a compound that does not cause phytotoxicity to plants and has little toxicity to humans, livestock and fish and has little impact on the environment, and is useful as a pesticide.

Claims (2)

  1.  式(I)で表される化合物又はその塩。
    Figure JPOXMLDOC01-appb-C000001
    (式(I)中、
     R1は、置換又は無置換のC1~6アルキル基である。
     R2は、置換若しくは無置換のC1~6アルコキシカルボニル基、置換若しくは無置換の5~6員ヘテロアリール基、シアノ基又は式「-CR=N-OR」で表される基である。
     Rは、水素原子であり、Rは、置換又は無置換のC1~6アルキル基である。
     R、R、R及びRは、それぞれ独立して、水素原子又は置換若しくは無置換のC1~6アルキル基である。
     RとRは、それらが一緒になって、C2~6アルキレン基を形成してもよい。
     RとR は、それらが一緒になって、C1~5アルキレン基を形成してもよい。
    とRは、それらが一緒になって、C2~6アルキレン基を形成してもよい。
     Rは、水素原子、水酸基、置換若しくは無置換のC1~6アルコキシ基、置換若しくは無置換のC1~6アルキルカルボニルオキシ基又は置換若しくは無置換のC2~6アルケニルオキシ基である。
     Rは、水素原子である。
     RとRは、それらが一緒になって、置換又は無置換のC1~6アルコキシイミノ基を形成してもよい。
     Xは、ハロゲノ基又は置換若しくは無置換のC1~6アルコキシ基である。
     nは、0~5のいずれかの整数であり、nが2以上のときXは互いに同じでも異なってもよい。
     Qは、式(Q-1)、式(Q-2)又は式(Q-3)で表される基である。
    Figure JPOXMLDOC01-appb-C000002
     式(Q-1)式(Q-2)及び(Q-3)中、矢印は結合部位を示す。
     式(Q-1)中、R及びRは、それぞれ独立して、水素原子、置換若しくは無置換のC1~6アルキル基、置換若しくは無置換のC1~6アルコキシ基、置換若しくは無置換のC3~8シクロアルキル基、置換若しくは無置換の5員環のヘテロシクリル基 又は式「-CR=N-OR」で表される基である。
     Rは、水素原子であり、Rは置換又は無置換のC1~6アルキル基である。
     式(Q-2)中、R及びRは、それぞれ独立して、水素原子又は置換若しくは無置換のC1~6アルキル基である。
     式(Q-3)中、Rは、水素原子又は置換若しくは無置換のC1~6アルキル基である。)
    A compound represented by the formula (I) or a salt thereof.
    Figure JPOXMLDOC01-appb-C000001
    (In formula (I),
    R 1 is a substituted or unsubstituted C1-6 alkyl group.
    R 2 is a substituted or unsubstituted C1 to 6 alkoxycarbonyl group, a substituted or unsubstituted 5- to 6-membered heteroaryl group, a cyano group or a group represented by the formula "-CR a = N-OR b ". ..
    R a is a hydrogen atom and R b is a substituted or unsubstituted C1-6 alkyl group.
    R 3 , R 4 , R 5 and R 6 are independently hydrogen atoms or substituted or unsubstituted C1-6 alkyl groups.
    R 3 and R 4 may be combined together to form a C2-6 alkylene group.
    R 3 and R 5 may be combined together to form a C1-5 alkylene group.
    R 5 and R 6 may be combined together to form a C2-6 alkylene group.
    R 7 is a hydrogen atom, a hydroxyl group, a substituted or unsubstituted C1 to 6 alkoxy group, a substituted or unsubstituted C1 to 6 alkylcarbonyloxy group, or a substituted or unsubstituted C2 to 6 alkenyloxy group.
    R 8 is a hydrogen atom.
    R 7 and R 8 may be combined together to form a substituted or unsubstituted C1-6 alkoxyimino group.
    X is a halogeno group or a substituted or unsubstituted C1-6 alkoxy group.
    n is an integer of 0 to 5, and when n is 2 or more, X may be the same or different from each other.
    Q is a group represented by the formula (Q-1), the formula (Q-2) or the formula (Q-3).
    Figure JPOXMLDOC01-appb-C000002
    Formula (Q-1) In formulas (Q-2) and (Q-3), arrows indicate binding sites.
    In formula (Q-1), R c and R d are independently hydrogen atoms, substituted or unsubstituted C1 to 6 alkyl groups, substituted or unsubstituted C1 to 6 alkoxy groups, substituted or unsubstituted. It is a C3-8 cycloalkyl group, a substituted or unsubstituted 5-membered heterocyclyl group, or a group represented by the formula "-CR g = N-OR h ".
    R g is a hydrogen atom and R h is a substituted or unsubstituted C1-6 alkyl group.
    In formula (Q-2), R e and R f are independently hydrogen atoms or substituted or unsubstituted C1 to 6 alkyl groups.
    In formula (Q-3), Ri is a hydrogen atom or a substituted or unsubstituted C1-6 alkyl group. )
  2.  請求項1に記載の化合物及びその塩からなる群から選ばれる少なくとも1つを有効成分として含有する農園芸用殺菌剤。
     
    A fungicide for agriculture and horticulture containing at least one selected from the group consisting of the compound according to claim 1 and a salt thereof as an active ingredient.
PCT/JP2020/023546 2019-06-17 2020-06-16 2,4-dioxo-1,4-dihydrothienopyrimidine compound, agricultural and horticultural bactericide WO2020255946A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019-111799 2019-06-17
JP2019111799 2019-06-17

Publications (1)

Publication Number Publication Date
WO2020255946A1 true WO2020255946A1 (en) 2020-12-24

Family

ID=74037131

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2020/023546 WO2020255946A1 (en) 2019-06-17 2020-06-16 2,4-dioxo-1,4-dihydrothienopyrimidine compound, agricultural and horticultural bactericide

Country Status (1)

Country Link
WO (1) WO2020255946A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013071169A1 (en) * 2011-11-11 2013-05-16 Nimbus Apollo, Inc. Acc inhibitors and uses thereof
WO2015007451A1 (en) * 2013-07-15 2015-01-22 Syngenta Participations Ag Microbiocidal heterobicyclic derivatives
WO2017091627A1 (en) * 2015-11-25 2017-06-01 Gilead Apollo, Llc Fungicidal compositions containing derivatives of 2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidine
WO2019031384A1 (en) * 2017-08-07 2019-02-14 日本曹達株式会社 1,3,5,6-tetrasubstituted thieno[2,3-d]pyrimidine-2,4-(1h,3h)dione compound and agricultural or horticultural bactericide
WO2019065483A1 (en) * 2017-09-26 2019-04-04 日本曹達株式会社 1, 3, 5, 6-tetra substituted thieno[2, 3-d]pyrimidine-2, 4(1h, 3h)dione compound and bactericide for agricultural and horticultural use
WO2019107393A1 (en) * 2017-11-30 2019-06-06 日本曹達株式会社 1,3,5,6-tetrasubstituted thieno[2,3-d]pyrimidine-2,4(1h,3h)dione compound and agricultural and horticultural fungicide

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013071169A1 (en) * 2011-11-11 2013-05-16 Nimbus Apollo, Inc. Acc inhibitors and uses thereof
WO2015007451A1 (en) * 2013-07-15 2015-01-22 Syngenta Participations Ag Microbiocidal heterobicyclic derivatives
WO2017091627A1 (en) * 2015-11-25 2017-06-01 Gilead Apollo, Llc Fungicidal compositions containing derivatives of 2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidine
WO2019031384A1 (en) * 2017-08-07 2019-02-14 日本曹達株式会社 1,3,5,6-tetrasubstituted thieno[2,3-d]pyrimidine-2,4-(1h,3h)dione compound and agricultural or horticultural bactericide
WO2019065483A1 (en) * 2017-09-26 2019-04-04 日本曹達株式会社 1, 3, 5, 6-tetra substituted thieno[2, 3-d]pyrimidine-2, 4(1h, 3h)dione compound and bactericide for agricultural and horticultural use
WO2019107393A1 (en) * 2017-11-30 2019-06-06 日本曹達株式会社 1,3,5,6-tetrasubstituted thieno[2,3-d]pyrimidine-2,4(1h,3h)dione compound and agricultural and horticultural fungicide

Similar Documents

Publication Publication Date Title
ES2725630T3 (en) Tetrazolinone compound and use thereof
CN105636957B (en) Terazololine-one compound and application thereof
WO2019022061A1 (en) Oxadiazole compound and fungicide for agricultural and horticultural use
JP2021008403A (en) 1,3,5,6-TETRA-SUBSTITUTED THIENO[2,3-d]PYRIMIDINE-2,4(1H,3H)DIONE COMPOUND AND AGRICULTURAL/HORTICULTURAL FUNGICIDE
KR20220091475A (en) 2,6-dioxo-3,6-dihydropyrimidine compound and agricultural and horticultural fungicides, nematicides, and antifungal agents for medical and animal use
WO2019031384A1 (en) 1,3,5,6-tetrasubstituted thieno[2,3-d]pyrimidine-2,4-(1h,3h)dione compound and agricultural or horticultural bactericide
JP2021028298A (en) 1,3,5,6-tetrasubstituted thieno[2,3-d]pyrimidine-2,4(1h,3h)dione compound, and agricultural and horticultural fungicide
JP6508540B2 (en) Pyridine compound and use thereof
JP6837052B2 (en) Pyridine compounds and their uses
JPWO2019065516A1 (en) Quinoline compounds and fungicides for agriculture and horticulture
WO2016039048A1 (en) Pyridine compound and use thereof
JP6221189B2 (en) Pyridine compounds and uses thereof
JP2020097575A (en) 1,3,5,6-TETRA SUBSTITUTED THIENO[2,3-d]PYRIMIDINE-2,4(1H,3H)DIONE COMPOUND AND HORTICULTURAL BACTERICIDE
WO2020255946A1 (en) 2,4-dioxo-1,4-dihydrothienopyrimidine compound, agricultural and horticultural bactericide
JP6792636B2 (en) Guanidine compounds and fungicides
WO2021100745A1 (en) Oxadiazole compound and germicide for agricultural and horticultural use
JP2019163223A (en) 1,3,5,6-TETRASUBSTITUTED THIENO[2,3-d]PYRIMIDINE-2,4(1H,3H)DIONE COMPOUND, AND AGRICULTURAL AND HORTICULTURAL BACTERICIDE
JP2020147544A (en) Quinoline compound and fungicide for agricultural and horticultural use
JP2020203883A (en) 2,4-dioxo-1,4-dihydro thieno pyrimidine compound and bactericide for agricultural and horticultural use
JP6551397B2 (en) Tetrazolinone compound and use thereof
JP2022035834A (en) 2,4-dioxo-1,4-dihydrothienopyrimidine compound and bactericide for agricultural and horticultural use
JP2020040947A (en) 1,3,5,6-tetra-substituted thieno [2,3-d]pyrimidine-2,4(1h,3h) dione compound and bactericide for agricultural and horticultural use
WO2021112213A1 (en) 2,4-dioxo-1,4-dihydrothienopyrimidine compound, agricultural or horticultural fungicidal agent, or medical/animal antifungal agent, containing this
WO2021054393A1 (en) 2,3-dihydrothienopyrimidin-4(h)-one compound and agricultural and horticultural fungicide
JP2021066672A (en) Agricultural and horticultural fungicide or medical antifungal agent containing pyrrole compound as active ingredient

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20825603

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20825603

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP